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The Gram positive bacterium Staphylococcus aureus is a major cause of human 
disease in industrialized countries. This multifaceted pathogen is adapted to thrive 
in a variety of host niches, including the intracellular compartment. S. aureus 
rapidly develops antibiotic resistance, and infections due to resistant clones pose 
a global threat, calling for novel therapeutic approaches. The ability to exploit 
host nutrients and efficiently metabolize these resources for growth is paramount 
for bacterial pathogenesis. Understanding the nutritional and metabolic 
determinants that underpin bacterial virulence may lead to the identification of 
novel antimicrobial targets. This thesis investigates carbon nutrition and 
metabolism of community-acquired methicillin resistant S. aureus (CA-MRSA) 
USA300, a widely spread, hyper virulent multi-resistant strain.  
The dependence of S. aureus on carbohydrates for growth was considered first. In 
vitro studies in supplemented chemically defined media showed that sugar 
phosphates, such as hexose phosphates and glycerol phosphates, promote 
staphylococcal growth more efficiently than glucose. Deletion mutations were 
introduced to the two putative sugar phosphate transporter genes present in the 
S. aureus genome, uhpT (hexose phosphate permease) and glpT (glycerol 
phosphate permease). Phenotypic analysis of USA300 mutants and heterologous 
expression of the transporters in a previously described Listeria monocytogenes 
Δhpt mutant, totally unable to use sugar phosphates, confirmed that S. aureus 
UhpT and GlpT have different substrate specificities. Whilst both can transport 
glycerol monophosphate (excluding glycerol-2-phosphate) and the 
organophosphate antibiotic fosfomycin, hexose monophosphates are only 
imported via UhpT. Since sugar phosphates are only present in significant 
amounts inside living tissues, particularly the intracellular compartment, the role 
of S. aureus UhpT and GlpT in pathogenesis was investigated by constructing a 
double deletion mutant. The ΔuhpTΔglpT USA300 mutant was used to infect 
several relevant mammalian cell lines. In the conditions tested, it was found that 
UhpT and GlpT played no role in the intracellular replication of S. aureus. By 
contrast, Listeria exploits sugar phosphates from the host cell cytosol via the 
homologous hexose phosphate transporter, Hpt, to maximise replication and 
enhance virulence. The distinct requirement of sugar phosphates for intracellular 
 
 
proliferation may reflect intrinsic differences in carbon nutrient dependence 
between the two organisms. It was confirmed that S. aureus can efficiently use 
other readily available carbon sources for growth, such as amino acids. In 
contrast, Listeria is strictly dependent upon sugar-derived carbon for growth, due 
to an incomplete tricarboxylic acid cycle. Whilst the double uhpTglpT mutation 
had no effect in S. aureus, expression of staphylococcal uhpT or glpT restored 
wild-type intracellular growth in the L. monocytogenes hpt mutant. Taken 
together, the results illustrate that sugar phosphate permeases have a contextual 
role in bacterial virulence, where the background in which the genes are 
expressed determine their contribution as a virulence factor.  
The intracellular dynamics of S. aureus was also explored using 
immunofluorescence microscopy. It was observed that, during epithelial cell 
infection, USA300 remains enclosed in a membrane-bound vacuole. This 
localisation may form a barrier to cytosolic sugar phosphates and potentially 
explain the absence of effect of the sugar phosphate permease deletions in 
intracellular proliferation. Preliminary characterisation of the S. aureus containing 
vacuole (SACV) was performed and it was found to be positive for the Rab7 late-
endosomal GTPase and for trans-Golgi markers. This suggests that SACVs 
converge at the Golgi apparatus. Interestingly, a USA300 mutant lacking the global 
regulatory system agr was unable to proliferate intracellularly and did not acquire 
Rab7 or Golgi markers. Since the Δagr mutation did not cause any impairment in 
carbon source dependent growth, these preliminary data suggest that 
modification of the SACV by Agr-regulated effectors may play a key role in 
modulating cellular processes that control staphylococcal intracellular survival 
and/or replication. 
Evidence presented in this thesis provides a platform for further exploration of S. 
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1.1 Host cell bacterial invasion 
Pathogenic bacteria have evolved mechanisms to invade and colonise host 
cells (Cossart & Sansonetti 2004; Pizarro-Cerdá & Cossart 2006; Kumar & 
Valdivia 2009). Host cell niches provide refuge to pathogens from the 
hostile extracellular environment. It provides shelter from physical stress, 
shear stress, complement deposition, antibody labelling and exposure to 
effectors of the adaptive immune defence system (Hornef et al. 2002; 
Pizarro-Cerdá & Cossart 2006). Protection in this niche can also present 
bacteria with nutritional supplies for replication (Fuchs et al. 2012).  
Professional phagocytes, such as macrophages, and non-professional 
phagocytes, for example epithelial cells, can engulf pathogens via 
phagocytosis (Rabinovitch 1995). In normally non-phagocytic cells, 
phagocytosis is actively induced by invasive bacteria by mediating specific 
protein interactions between host-pathogen membranes. These 
interactions initiate a molecular response by host cells and bacteria are 
ingested by endocytosis (Pizarro-Cerdá & Cossart 2006). Staphylococcus 
aureus, for example,  induces this event primarily through  expression of 
fibronectin binding proteins A and B (Sinha et al. 1999). These surface 
proteins anchor the extracellular matrix glycoprotein, fibronectin, which 
forms a bridge connecting to host cell α5β1 integrins. These staphylococcal 
MSCRAMMs (microbial surface components recognizing adhesion matrix 
molecules) are integral to efficient internalisation of S. aureus by epithelial 
cells (Dziewanowska et al. 1999). Upon internalisation, the majority of 
pathogens are immediately bound within a membraneous compartment, 
the phagosome (Pizarro-Cerdá & Cossart 2006; Flannagan et al. 2009).  
The cellular endosomal pathway acts to traffic vesicles containing lipids, 
receptors and enzymes to various cell locations. Cell effector proteins are 
recruited to the endosomal membrane, such as Rab GTPases and 
phosphoinositides, which regulate protein sorting, trafficking and signalling 
of these compartments (Gruenberg & Van der Goot 2006). Endosomes 
[3] 
 
containing lipids and proteins may be trafficking to the trans-Golgi network 
where they are recycled back to the membrane. However, bacterial 
containing endosomes (phagosomes) are targeted for maturation and 
fusion with the cell lysosome to form a phagolysosome (Gruenberg & Van 
der Goot 2006). The phagolysosome creates a highly acidic, degradative 
environment in which  proteases, nucleases, lipases and superoxide 
radicals are injected to destroy pathogens (Luzio et al. 2007). A summary of 
the phagosome degradation pathway is illustrated in Figure 1.1. 
Phagosome maturation is characterised by association of trafficking 
proteins belonging to the cellular endocytic pathway. Early endosome 
related proteins, such as EEA1 and Rab5 may integrate with the 
phagosome membrane to initiate the maturation process (Gruenberg & 
Van der Goot 2006). Late endosome proteins are recruited, such as Rab7 
and cathepsins, which then potentiates the recruitment of lysosomal 
markers such as lysosomal associated membrane proteins (LAMPs) and V-








Figure 1.1. Phagosome trafficking to the phagolysosome. Host cell 
endocytic pathway proteins associate with the bacterial phagosome 
interface to mediate the transition to lysosome fusion (taken from 
Flannagan et al. 2009). 
[4] 
 
The risks associated with seeking shelter in the host cell endosome has led 
to evolutionary pressure to avoid obliteration via phagolysosome 
entrapment (Gruenberg & Van der Goot 2006). Bacteria have developed 
mechanisms to bypass this innate host cell defence against microbial 
invasion (Cossart & Sansonetti 2004; Gruenberg & Van der Goot 2006). 
Diverse adaptations have arisen among bacterial species which allow 
modification and manipulation of the phagosomal compartment (Sinai & 
Joiner 1997; Gruenberg & van der Goot 2006). Unique manipulation of host 
cell processes by bacterial effectors, allows pathogens to replicate and/or 
survive in a cellular compartment (Cossart & Sansonetti 2004; Kumar & 
Valdivia 2009; Saka & Valdivia 2010; Knodler & Steele‐Mortimer 2003; 
Isberg et al. 2009). These strategies also allow acquisition of host derived 
nutrients which are produced by the metabolic and catabolic pathways of 
the cell (Fuchs et al. 2012). Bacteria can process these host cell nutrients 
via a number of endogenous metabolic pathways. 
1.2 Bacterial metabolism 
Bacteria may generate energy through 6 known endogenous metabolic 
pathways; glycolysis, pentose phosphate pathway (PPP), gluconeogenesis, 
the tricarboxylic acid cycle (TCA), glyoxylate shunt pathway and the Entner-
Doudoroff pathway (ED). Figure 1.2 outlines the metabolic pathways, 
indicating the substrates and intermediates that are integral to their 
processes. The hexose sugar, glucose, is imported to the bacterial cell 
primarily via glucose specific phosphotransferase system (PTS) 
transporters, where import is coupled to phosphorylation, forming glucose-
6-phosphate (Postma et al. 1993). Glucose-6-phosphate, and other 
phosphorylated hexoses, can also be directly imported via hexose 
phosphate transporters (UhpT) (Dietz 1976). Glucose-6-phosphate can be 
converted to pyruvate via the glycolysis pathway to generate ATP energy. 
Alternatively, glucose-6-phosphate can be converted to gluconate-6-





pathway or the Entner-Doudoroff pathway. By converting glucose-6-
phosphate into ribose phosphates, the PPP generates NADPH, which acts 
to combat oxidative stress. Ribose phosphates are used to fuel nucleotide 
synthesis. The interconversion of ribose phosphates synthesizes 
glyceraldehyde-3-phosphate and fructose-6-phosphate sugars which can 
feed the glycolysis pathway (Wammelink et al. 2008). ED pathway enzymes 
are encoded mainly by Gram negative bacteria and are essentially used to 
convert glucose-6-phosphate to glyceraldehyde-3-phosphate in alternate 
reactions to the energy expending phase of glycolysis (Fuchs et al. 2012; 
Eisenreich et al. 2010).  
Glycerol uptake facilitator protein, GlpF, is a major intrinsic protein family 
transporter that non-specifically allows passive uptake of glycerol (Heller et 
al. 1980). Glycerol is phosphorylated inside the bacterial cell to glycerol-3-
phosphate, which can also be scavenged directly by glycerol phosphate 
permeases (GlpT) (e.g. Lemieux et al. 2004). Glycerol phosphate is 
metabolised to glyceraldehyde-3-phosphate which drives glycolysis.  
Energy can be generated from non-carbohydrate sources using the TCA 
cycle, the glyoxylate shunt pathway and gluconeogenesis pathway. The 
TCA cycle utilises organic intermediates such as pyruvate from 
carbohydrate metabolism and acetyl Co-A from lipid metabolism to 
generate energy as well as intermediates for amino acid synthesis. Lipid 
fatty acids can be degraded by β-oxidation to acetyl CoA, and can be 
converted into TCA cycle intermediates via the glyoxylate shunt pathway 
enzymes, which allows simple non-carbohydrate carbon sources to be used 
for energy (Bishai 2000). Oxaloacetate can also be converted to 
phosphoenolpyruvate (PEP) which can be metabolised by enzymes in the 






Figure 1.2. Bacterial metabolic pathways. Central metabolic pathways 
(purple boxes) are summarised by key interconversions. Substrates in red 
represent major carbon sources that can initiate pathway processes. 
Metabolic fluxes are shown for glucose / G-6-P (black arrows), glycerol, 
Gol-P and phosphoenolpyruvate (PEP) (dashed black arrows) and C3/C2 
substrates (red arrows). Metabolites are highlighted in blue, showing fatty 
acids and amino acids (3 letter codes) that can be synthesized from 





1.3 Bacterial metabolism in host cell pathogenesis 
Bacterial pathogens can invade host cells using two strategies; 
i) Remain inside a vacuole which can be modified to promote survival and 
replication. 
ii) Escape the vacuole to the cell cytosol, where host nutrients are 
compartmentalised. 
The adaptations used in host phagosome modification, mechanisms of 
nutrient acquisition and metabolic pathways employed are diverse among 
a range of invasive pathogens. Examples will be illustrated for both 
strategies of host cell colonisation by bacteria.  
1.3.1 Intravacuolar replication 
Pathogens that remain within a membrane bound compartment must 
devise ways to actively acquire the means to replicate. This results in a fine 
balance between vacuole modification/ host cell protein commandeering 
and host nutrient scavenging for growth.  
1.3.1.1 Salmonella enterica 
The Gram negative bacterium Salmonella enterica is one of the most 
common food-borne pathogens which penetrate the intestine epithelial 
cells to cause salmonellosis (Bowden et al. 2010). Salmonella containing 
vacuoles (SCVs) have been relatively well characterised. Salmonella can 
escape the degradation pathway to the lysosome through uncoupling of 
the late endosomal marker Rab7 GTPase from Rab7-interacting lysosomal 
protein (RILP) using a bacterial effector, SifA (Harrison et al. 2004). S. 
Typhimurium mutants defective in SifA fail to replicate in murine 
macrophages and are highly attenuated in vivo (Harrison et al. 2004). SCVs 
depend upon Rab7 recruitment for association with microtubule motor 
proteins (Méresse et al. 1999; Gruenberg & van der Goot 2006). This allows 
migration of SCVs to the perinuclear region of the cell where extensive 
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modification of the SCV membrane occurs at the endoplasmic reticulum 
(ER). The Salmonella vacuole is targeted to the trans-Golgi network by an 
effector protein, SseG, allowing the replication stage of infection to 
commense, which is thought to be the stage of nutrient acquisition 
(Salcedo & Holden 2003).  Disruption of SCV-Golgi association significantly 
reduces replication in epithelial cells and macrophages (Salcedo & Holden 
2003).  
The nutritional requirements of vacuolar Salmonella replication appear to 
be diverse. Screening metabolic gene expression in mice infected with 
Salmonella revealed extensive redundancy in functional metabolic 
networks (Becker et al. 2006). The large majority of metabolic enzymes 
cited in this study were found to have a non-essential role in S. enterica 
pathogenesis. This may highlight the flexibility of nutrient acquisition in this 
species during in vivo infection. Partial attenuation in mutations for 
catabolic and transport genes revealed that host cell nucleosides, 
mannose, ribose and glycerol are likely to be used as nutrition sources 
during infection (Becker et al. 2006). A role for glucose uptake and 
metabolism in mouse macrophages has been shown for S. Typhimurium 
(Bowden et al. 2009). Deletion mutants in enzymes of the glycolytic 
pathway, in addition to deletion mutants in the major glucose and 
mannose PTS transporters, decreased replication in the host compartment. 
In addition, intracellular carbon nutrient analysis revealed that uptake and 
incorporation of host cell 13C glucose into amino acids was high, citing 
glucose as the primary carbon source when available in epithelial cells 
(Götz et al. 2010) This would suggest that the SCV is not impervious to host 
sugars. A separate study failed to see an effect upon replication of S. 
Typhimurium in human intestinal epithelial cells when glucose PTS, 
mannose PTS and UhpT systems were all deleted in one strain (Götz & 
Goebel 2010). Seemingly, growth differences between PTS sugar uptake 
mutants in epithelial cells and macrophages suggest dependence on sugars 
may differ according to the host cell environment of Salmonella.  
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S. enterica may rely more heavily upon more alternative nutrient sources 
for replication. Deletion of high affinity glutamine uptake transporters, 
glnH and glnQ , did not significantly affect the virulence of S. Typhimurium 
in mice (Klose & Mekalanos 1997). However, in a glutamine auxotroph 
mutant, deletion of either glnH or glnQ caused significant attenuation of 
virulence in mice, suggesting that biosynthesis and/or host acquisition of 
glutamine is important in replication. Strong attenuation in mice was noted 
in mutants in which biosynthesis of aromatic amino acids is obstructed 
(Eisenreich et al. 2010). The TCA cycle has also shown to be an important 
energy pathway in Salmonella infection. Deletion mutants in TCA enzymes 
resulted in a marked reduction in replication of S. Typhimurium in 
epithelial cells and in murine infection models, showing a complete TCA 
cycle is essential for full virulence  (Bowden et al. 2010; Yimga et al. 2006). 
By contrast, the gluconeogenesis pathway is not required for Salmonella 
virulence in vivo (Yimga et al. 2006). In Gram negative bacteria, the TCA 
cycle is subject to repression during growth in glucose (Nanchen et al. 
2008). Evidence suggests therefore that metabolism of non-carbohydrate 
sources by the TCA cycle may provide the primary source of energy for 
salmonellosis, rather than carbohydrate metabolism pathways. 
Furthermore, studies have demonstrated that Salmonella strains 
auxotrophic for various amino acids are attenuated in mice and in 
macrophages (Appelberg 2006). 
1.3.1.2 Mycobacterium tuberculosis 
Mycobacterium tuberculosis is an obligate aerobe and the acid-fast Gram 
positive causative agent of the pulmonary disease tuberculosis (McKinney 
et al. 2000). Upon infection of lung macrophages, the Mycobacterium 
pathogen vacuole (MPV) acquires typical early endosomal markers such as 
Rab5 GTPase (Kumar & Valdivia 2009). However, the pathway to 
degradation is arrested at this early step as the pathogen excretes a mimic 
of phosphatidylinositol which inhibits the activity of PI(3)Kinase and 
interrupts the signalling cascade for phagosome maturation (Kumar & 
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Valdivia 2009). In addition, MPVs require association with Rab 14 GTPase 
for maintained arrest of phagosome maturation to lysosome fusion (Kyei et 
al. 2006). Rab14 is primarily involved in the recycling endosome pathway, 
which traffics lipids and receptors back to the cell membrane (Junutula et 
al. 2004). This interaction is also thought to deliver nutrients such as lipids 
to the MPV for replication (Kumar & Valdivia 2009).  
Lipid metabolism is a primary feature of M. tuberculosis pathogenesis  
(Eisenreich et al. 2010). A study reports that lipid droplets, which are 
abundant inside macrophages, are a source of host acquired triacylglycerol 
for M. tuberculosis and are required for fatty acid metabolism contributing 
to virulence (Daniel et al. 2011). A transcriptome analysis of macrophages 
infected with M. tuberculosis revealed that enzymes required for fatty acid 
degradation, in addition to glyoxylate cycle enzymes, where the most 
common and highly up-regulated genes (Schnappinger et al. 2003). The 
persistence of M. tuberculosis in mice is dependent upon the action of 
isocitrate lyase (McKinney et al. 2000). Isocitrate lyase is an enzyme that 
catalyses the conversion of TCA cycle isocitrate to glyoxylate, a step which 
maintains the glyoxylate cycle that provides energy from fatty acid 
metabolism (Bishai 2000). A  study demonstrated that M. tuberculosis 
mutants devoid in enzymes that catalyse β-oxidation of fatty acids to acetyl 
Co-A were also highly attenuated in virulence (Rengarajan et al. 2005). 
Uptake and catabolism of cholesterol may also play a role in M. 
tuberculosis survival and replication (Pandey & Sassetti 2008). This 
highlights the strict dependence of vacuole based Mycobacterium upon 
host derived lipids and fatty acid biosynthesis pathways for pathogenesis. 
1.3.1.3 Chlamydia species 
The intracellular metabolic requirements of obligate intravacuolar 
Chlamydia pathogens appear to be more particular. Pathogenic Chlamydia 
spp. most commonly cause infections of the genital epithelium (Yasir et al. 
2011). The chlamydial inclusion, the membrane bound replicative vacuole 
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of Chlamydia,  is totally independent of the endocytic pathway and does 
not fuse with components of the lysosome degradation pathway (Sinai & 
Joiner 1997; Kumar & Valdivia 2009). The chlamydial inclusion localises at 
the Golgi apparatus and lies on the exocytic pathway (Saka & Valdivia 
2010). From this position, the inclusion subverts exocytic vesicle trafficking 
by recruiting various specific Rab GTPases and SNARE proteins, which 
function to allow vesicle fusion (Saka & Valdivia 2010). The secretory 
vesicles of the Golgi apparatus offer a healthy supply of sphingomyelin and 
cholesterol to the bacterial inclusion, which are crucial for bacterial 
replication (Heuer et al. 2009). It has also been shown that interference 
with Rab14 GTPase, significantly reduces the bacterial inclusion 
sphingolipid uptake and subsequently decreases the replication rate 
(Capmany et al. 2011). Membrane bound lipid droplets localise to and 
enter the chlamydial inclusion, which supply another host cell derived 
nutrient that contributes to bacterial metabolism and replication (Kumar et 
al. 2006).  
Recently it has been investigated that Chlamydia actively implement 
fragmentation of the Golgi apparatus by cleaving the Golgi matrix protein 
golgin-84 (Heuer et al. 2009). Inhibition of this Golgi restructuring results in 
markedly reduced delivery of lipid containing vesicles to the inclusion, and 
causes severe attenuation of bacterial replication. This provides another 
example of intravacuolar pathogenesis that is heavily reliant upon host cell 
lipids for efficient replication. Intracellular chlamydial infection is obligate, 
meaning other than the specific human intracellular niche the pathogen 
cannot proliferate elsewhere. The reliance upon the host for nutrition can 
be reflected in the metabolic make-up of the Chlamydia genome. This 
pathogen lacks biosynthetic enzymes for de novo synthesis of vitamins, 
purines, pyramidines, most amino acids and ATP (Fuchs et al. 2012). This 
genus relies upon a multitude of transport systems for amino acid uptake, 
RNA uptake and ATP intake exclusively dependent upon the host cell 
supplies (Saka & Valdivia 2010). This would strongly suggest that the 
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chlamydial inclusion is permeable to a wide variety of host derived 
nutrients.  Lack of a complete TCA cycle, and lack of a glucose uptake 
system (Fuchs et al. 2012) could propose that lipid sources from Golgi 
derived vesicles may be the most primary source of nutrition for this 
adapted pathogen.  
1.3.1.4 Legionella pneumophilla 
Legionella pneumophilla is the Gram negative etiological agent of 
Legionnaires disease, a form of pneumonia contracted by inhaling 
contaminated water droplets (Robinson & Roy 2006). Upon invasion of 
macrophages, the Legionella containing vacuole (LCV) becomes rapidly 
dissociated from markers of the early endocytic pathway (Sinai & Joiner 
1997). The LCV recruits Sar1, Rab1 and Arf1 to the membrane surface, 
GTPases which are normally involved in vesicle trafficking from ER to Golgi 
(Kumar & Valdivia 2009). The fusion of ER derived vesicles leads to 
remodelling of the LCV. Deposition of ER derived components to the lumen 
of the LCV may deliver peptides and other nutrients to utilise as growth 
sources (Robinson & Roy 2006). The modification of the LCV, the 
manipulation of host cell proteins and the intravacuolar replication is 
dependent upon a type IV secretion system (Isberg et al. 2009). The 
Dot/Icm translocation complex operates to secrete effector protein 
substrates across the vacuole membrane into the host cytoplasm (Laguna 
et al. 2006). Without the function of this translocase system, cell pathway 
targeting ability is lost and the LCV is rapidly tagged for lysosome 
degradation (Laguna et al. 2006). In addition to deletion of specific dot/icm 
genes which impair replication, there are translocated effector substrates 
that are required for effective persistence (Isberg et al. 2009). An example 
is the SdhA protein which is essential for Legionella persistence, but does 
not influence LCV formation (Laguna et al. 2006). This study postulates that 
SdhA is important in preventing macrophage destruction, allowing 
prolonged replication inside the vacuole. Legionella represents a prime 
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example for highlighting the importance of vacuole modifying mechanisms 
that are required to promote effective replication.   
Legionella lack a PTS transport system for carbohydrates and a permease 
for glucose phosphates (Fuchs et al. 2012) meaning alternative carbon 
sources are essential for pathogenesis. Legionella are unable to 
biosynthesize many amino acids, and the abundance of amino acid 
permeases, proteases and peptidases in addition to a possession of a 
complete TCA cycle would suggest that these raw materials are the most 
likely host derived source of growth (Fuchs et al. 2012).  A study 
demonstrated that deletion of an amino acid importer, SLC1A5, completely 
inhibited Legionella replication (Wieland et al. 2005). In addition, this study 
also showed that restriction of the amino acid content of host cell media 
resulted in a substantial inhibition in intracellular LCV replication.  
The adaptations of various pathogens for initiating and sustaining vacuole 
based survival and replication are extremely sophisticated. It would seem 
that the specific interplay between bacterial effectors and host cell vesicle 
pathways can support nutritional requirements for growth. Studies have 
shown that microinjection of intravacuolar pathogens directly into the 
cytosol of host cells does not lead to effective cytosolic replication in the 
majority of cases (Goetz et al. 2001). Similarly, Salmonella expressing 
Listeria pore forming toxin listeriolysin O was able to escape the SCV but 
was not able to replicate in the cytosol (Gentschev et al. 1995). Low 
percentages of Salmonella naturally escape the vacuole to the cytosol, 
where they are rapidly targeted for ubiquitination and degradation (Kumar 
& Valdivia 2009). Salmonella enterica encodes genes to complete every 
available metabolic pathway for energy production in bacteria (Eisenreich 
et al. 2010). In theory, this pathogen should be equipped to capitalize upon 
nutrients made available in the cytosolic niche, but in practice this 




1.3.2 Cytosolic replication 
In contrast to vacuole based pathogenesis, studies citing nutritional 
determinants of bacteria that escape the phagosome are less well 
established. 
Enteroinvasive Escherichia coli (EIEC) and Shigella flexineri are Gram 
negative pathogens which cause gastroenteritis via infection of the 
intestinal epithelium (Van den Beld & Reubsaet 2012). Both of these 
species rapidly escape the phagosome to increase bacterial numbers inside 
the cytosolic compartment (Fuchs et al. 2012). These pathogens are 
extensively equipped for scavenging nutrients from the cytosol for growth. 
They possess a complete set of biosynthetic enzymes for all known 
bacterial metabolic pathways, in addition to copious transporters for 
uptake of diverse carbon and nitrogen sources for growth (Fuchs et al. 
2012, Eisenreich et al. 2010). The metabolic adaptability of E. coli has been 
highlighted in the employment of separate metabolic pathways when 
distinct niches are colonised. During urinary tract infection, this pathogen 
utilises the gluconeogenic energy pathway and TCA cycle (Alteri et al. 
2009), By contrast, the glycolysis and Entner-Doudoroff pathways are 
employed during intestinal epithelial infection (Chang et al. 2004). In one 
study, glucose was determined as the primary carbon source for EIEC 
strains infecting intestinal cells (Götz et al. 2010). However, this study 
found that when glucose uptake, in addition to hexose phosphate import 
was abolished, intracellular replication was unaffected suggesting 
redundant nutrient uptake mechanisms can maintain growth. During 
macrophage infection, Shigella flexineri down regulates expression of 
glucose and glucose-6-phosphate transport systems and glycolysis 
enzymes. Instead, carbon metabolism is maintained through uptake of C3 
substrates and the use of the gluconeogenesis pathway (Lucchini et al. 
2005). Nutritional requisites of pathogens that are adapted to escape to 
the cytosol appear to be much broader.  This may highlight the adaptation 
of these pathogens to ensure efficient replication in the host cytosol. 
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Listeria monocytogenes rapidly escapes the phagosome and replicates in 
the host cell cytosol (Scortti et al. 2007). L. monocytogenes represents a 
rare example of a Gram positive human pathogen with well established 
metabolic determinants of virulence. 
1.4 Listeria monocytogenes pathogenesis and metabolism 
Listeria monocytogenes is an important pathogen of humans. This Gram 
positive bacterium is ubiquitous in the environment, existing as a 
saprophyte (Farber & Peterkin 1991). It is transmitted by food 
contamination and consumption results in the penetration of the intestinal 
epithelia causing gastroenteritis (De las Heras et al. 2011). L. 
monocytogenes can cross the intestinal barrier to the blood, causing 
bacteraemia and also spread to the central nervous tissue accounting for 
10% of community acquired bacterial meningitis (Vázquez-Boland et al. 
2001). Dissemination of Listeria, can frequently lead to colonisation of the 
liver tissue causing abscesses and hepatitis (Scholing et al. 2007).  
Listeriosis is particularly important in high case fatality neonatal sepsis (De 
las Heras et al. 2011). Serotype 4b strains, for example P14, account for 
more than 50% of human infections (Vázquez-Boland et al. 2001). Listeria 
monocytogenes is still very much at the forefront of infectious diseases and 
gained notoriety in 2011 when an outbreak of listeriosis spread across 
America. Consumption of cantaloupe contaminated with L. monocytogenes 
resulted in 147 cases of listeriosis and 33 deaths. According to the Centres 
for Disease Control and Prevention, this was one of the worst epidemics of 
foodbourne illness based upon deaths since records began.  
1.4.1 L. monocytogenes pathogenesis 
The intracellular life cycle of L. monocytogenes is centred upon cytosolic 
replication for cell to cell spread. Figure 1.3 depicts a schematic of listerial 
pathogenesis and virulence factors that determine infection (adapted from 
Scortti et al. 2007).  
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Figure 1.3. Invasive pathogenesis of L. monocytogenes depicting PrfA 
dependent virulence factors affecting the infection lifecycle (adapted 
from Scortti et al. 2007). 
 
L. monocytogenes expresses surface attachment proteins internalin A and 
internalin B (InlA, InlB) which interact with host cell receptors E-cadherin 
and c-MET respectively, to induce phagocytosis (Pizarro-Cerdá & Cossart 
2006). Upon engulfment, Listeria are trapped within a membrane bound 
compartment that transiently acquires cellular markers of the early 
endosome (Gruenberg & Van der Goot 2006). However, the maturation 
process of this vacuole is abruptly impeded almost immediately upon 
invasion. Listeria expresses the pore forming hemolysin toxin, listeriolysin 
O (LLO), which mediates rupture and escape from the phagosome (Scortti 
et al. 2007). In addition to LLO, phospholipase enzymes A and B (PlcA, PlcB) 
also contribute to degradation of the vacuole lipid bilayer (Vázquez-Boland 
et al. 2001). Rupture of the phagosome allows the bacteria to enter the cell 
cytosol where extensive replication occurs. An identified metabolic 
virulence factor involved in enhancing listerial replication is the hexose 
phosphate transporter, Hpt (Chico-Calero et al. 2002). Cytosolic                   
L. monocytogenes can disseminate throughout the cytosol by expression of 
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the effector protein ActA (De las Heras et al. 2011). ActA polymerises 
cellular actin, in order to propel the bacteria arbitrarily towards the 
periphery of the cell (Cossart & Sansonetti 2004). Cell to cell spread is 
mediated by secreted internalin C (InlC), and Listeria protrude into 
neighbouring cells, which results in a double membrane surrounding the 
invading bacterium (De las Heras et al. 2011). The cell infection cycles to 
culminate in widespread tissue infection (Vázquez-Boland et al. 2001).  
 The virulence factors that are required for efficient pathogenesis, 
highlighted in Figure 1.2, all are under the control of central virulence 
regulator PrfA (Scortti et al. 2007). PrfA is a member of the Crp/ Fnr family 
of bacterial transcription factors and activates transcription of virulence 
genes by binding to a specific palindromic DNA sequence known as the 
PrfA box (De las Heras et al. 2011). In the extracellular environment, PrfA 
remains weakly active at basal levels of transcription but an allosteric 
change in conformation occurs when sensing host cells, switching on the 
activity (Scortti et al. 2007). The transition from the extracellular 
environment to the intracellular host, conferring ‘activation’ of PrfA 
initiates a positive feedback loop which up regulates the expression and 
translation of prfA, heightening virulence factor expression (De las Heras et 
al. 2011).  
1.4.2 L. monocytogenes metabolism 
Compared to other cytosolic based pathogens, nutrition driven replication 
of L. monocytogenes is better understood. Listeria relies upon glycolysis, 
gluconeogenesis, the pentose phosphate pathway and pyruvate 
metabolism for energy production (Eisenreich et al. 2010). L. 
monocytogenes is unable to grow on amino acids as a source of energy, 
due to an incomplete TCA cycle (Joseph & Goebel 2007). Listeria is strictly 
dependent upon the host cell cytosol for cysteine, thiamine, branched 
chain amino acids, biotin, riboflavin and lipoate due to lack of biosynthetic 
enzymes (Fuchs et al. 2012). The genome of L. monocytogenes contains 88 
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carbohydrate uptake permeases, mostly PTS dependent transporters, 
which is twice the number encoded by E. coli (Glaser et al. 2001). Given 
that Listeria infiltrates the rich intracellular milieu, but can only rely 
primarily upon carbohydrate metabolism pathways for energy, the large 
redundancy for carbohydrate importers reflects the adaptation of this 
species.  A study demonstrated severely impaired in vitro growth in glucose 
of a L. monocytogenes  strain mutated in the ptsG and manXYZ uptake 
systems (Stoll & Goebel 2010). However, replication of this strain was 
unaffected in the epithelial cytosol which can underpin the redundancy of 
sugar transport for replication energy. Indeed, studies highlight glycerol to 
be an important cellular sugar energy source during infection. Intracellular 
up regulation of genes specific for glycerol uptake and metabolism was 
observed in macrophages (Chatterjee et al. 2006). In addition, a study 
showing a mutant strain defective in the same glycerol metabolism genes 
had an impaired intracellular replication rate and a decreased 13C 
incorporation into endogenous amino acids (Eylert et al. 2008). In addition, 
a mutant strain lacking glycerol-3-phosphate dehydrogenase, the enzyme 
responsible for conversion of glycerol monophosphate to glycerone 
phosphate in glycerol metabolism, was markedly impaired in the ability to 
replicate inside epithelial cells (Schauer et al. 2010). Oxaloacetate is an 
intermediate of the TCA cycle, and is an important precursor for amino acid 
biosynthesis in L. monocytogenes (Schär et al. 2010). The production of 
oxaloacetate is predominantly due to carboxylation of pyruvate during 
intracellular infection (Eisenreich et al. 2010). Deletion of the enzyme that 
catalyses this reaction leads to loss of intracellular replication and strongly 
attenuated virulence in mouse models of infection (Schär et al. 2010). 
Despite having multiplicity of sugar permeases glycerol uptake and 
metabolism, possibly through the gluconeogenesis pathway, is thought to 
be one of the main strategies of Listeria pathogenesis (Fuchs et al. 2012) .  
A role for the hexose phosphate transporter, Hpt, has been determined for 
Listeria during infection and is a demonstration of the highly adapted 
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nature of L. monocytogenes to replicate inside the cytosolic compartment. 
A study noted knock down of PrfA conferred reduced ability to grow upon 
glucose-1-phosphate as the primary carbon source (Ripio et al. 1997). The 
hpt chromosomal locus was identified as a monocistron, under the control 
of the PrfA promoter (Chico-Calero et al. 2002). Mutational analysis 
showed that hexose phosphates such as glucose-1-phosphate and glucose-
6-phosphate were exclusively transported into L. monocytogenes through 
the expressed Hpt, and promoted substantial growth in vitro (Chico-Calero 
et al. 2002). Intracellular infection studies in epithelial cells and 
macrophages found a marked reduction in replication in strains deficient in 
Hpt. This was also noted in vivo, as bacterial replication in mouse liver 
tissue was attenuated, suggesting that metabolic processing of glucose to 
glycogen provided favourable intermediates that promoted growth, 
accessible through Hpt (Chico-Calero et al. 2002). Import of sugar 
phosphates from the host cytosol therefore represents a significant source 
of nutrition for Listeria contributing to pathogenesis.  
Figure 1.4 depicts the functionality of Hpt during intracellular infection. 
Hexose sugars, such as glucose, are phosphorylated inside the host cell 
compartment which uses ATP energy. Expression of the Hpt protein via 
activated PrfA allows import of these intermediates into the listerial 
cytoplasm. An energy expending step is therefore bypassed in Listeria 
metabolism. This strategy provides substrates that can be directly 
incorporated into the two carbohydrate energy pathways existing in L. 
monocytogenes (glycolysis and pentose phosphate pathway). This 
mechanism allows scavenging of important usable nutrients from the host 
cell. Substrates transported through the Hpt protein are considered to be 
preferable to glucose as an intracellular carbon source (Fuchs et al. 2012). 





















1.5 Hpt related transporters 
Putative hexose phosphate transporters are conserved among a host  of 
important Gram positive and Gram negative bacterial species, including 
Staphylococcus aureus and Escherichia coli (Winkler 1973). Hexose 
phosphate transporters, most commonly termed UhpT, belong to the 
Major Facilitator Superfamily (MFS) of membrane transport systems (Law 
et al. 2008). These permeases are organophosphate: inorganophosphate 
antiporters which couple the export of inorganic phosphate to the uptake 
of sugar phosphates (Pao et al. 1998). Highly similar to UhpT is the glycerol 
phosphate permease, GlpT, which falls under the same family of 
transporters (Pao et al. 1998). The structure, topology and functionality of 
these two transport systems has been best characterised in E. coli, which 
encode both permeases (Lemieux et al. 2004; Lloyd & Kadner 1990; Island 
et al. 1992). These proteins consist of 12 transmembrane domains which 
insert into the bacterial membrane as a monomer in an inverted pyramid 
conformation (Lemieux et al. 2005). In E. coli, uhpT and glpT genes exist in 
distinct operons in which genes are linked to tightly regulate expression of 
these permeases through sensory inducible mechanisms (Merkel et al. 
1995; Lemieux et al. 2004). For example, the uhpABC genes are situated 
directly upstream of uhpT (Island et al. 1992). UhpC acts as a membrane 
associated sensory receptor for the presence of extracellular glucose-6-
phosphate. UhpA and UhpB act as the signal receiver and response 
regulator unit for UhpC, similar to a two-component system, which then 
induces expression of UhpT to uptake the sugar phosphates (Merkel et al. 
1995; Island et al. 1992). Despite the characterisation of UhpT and GlpT in 
E. coli, the relevance of these transporters in bacterial infection is poorly 
established and generally not well researched. In fact, the role of the 
putative Hpt permease in L. monocytogenes infection is the only certifiable 
example of sugar phosphate permeases having a contributory role in 
intracellular replication and pathogenesis (Lucchini et al. 2005; Götz & 
Goebel 2010; Chico-Calero et al. 2002).  
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The UhpT and GlpT permeases provide the only entry route for the broad-
spectrum organophosphate antibiotic fosfomycin (Popovic et al. 2010). In 
the current climate of increasing antimicrobial resistance, fosfomycin is 
being revisited as a therapeutic approach, due to the high conservation of 
UhpT and GlpT throughout important human pathogens (Falagas et al. 
2008; Popovic et al. 2010). In L. monocytogenes, for example, PrfA 
controlled expression of Hpt during in vivo infection also confers significant 
susceptibility to fosfomycin treatment and causes severe attenuation of 
virulence  (Scortti et al. 2006). 
The therapeutic potential of sugar phosphate permeases makes these 
systems desirable for research. However, little work has gone into 
determining a nutritional function for these transporters and the 
importance that they may carry in bacterial replication during infection. In 
the case of L. monocytogenes, an important role has been established 
which may be echoed in other bacterial species. As another Gram positive 
bacterium and a clinically important pathogen of humans, Staphylococcus 












1.6 Staphylococcus aureus pathogenesis and metabolism 
Staphylococcus aureus is the foremost cause of septicaemia, lower 
respiratory tract infections and skin and soft tissues infections (SSTIs) in 
industrialised countries (Deleo & Chambers 2009). This facultative 
pathogen is the second leading cause of pneumonia and endocarditis 
(States et al. 2007). Other more serious infections are commonly attributed 
to this pathogen, such as osteomyelitis, meningitis and toxic shock 
syndrome (TSS) (Hidron et al. 2009). Methicillin resistant S. aureus (MRSA) 
strains are the most frequently isolated bacterial pathogen in hospital 
acquired infections (World Health Organisation, 2013). In Europe alone, 
Healthcare Associated MRSA infections account for over 170,000 bacterial 
infections (almost half of all bacterial pathogen infections), causing 5400 
deaths and over a million extra days of hospitalization each year (Gould et 
al. 2012). The ability of S. aureus to acquire multiple resistance to 
mainstream antibiotics and persist in the environment has made this 
pathogen notoriously difficult to treat (Rice 2006).  
In the 21st century, community associated MRSA (CA-MRSA) strains have 
emerged and prevailed. These hyper-virulent lineages of S. aureus  can 
cause serious and invasive infections to otherwise healthy people who 
have not had contact with the healthcare environment (Thurlow et al. 
2012). A dramatic increase in CA-MRSA infections has occurred over the 
last 2 decades and in the USA these strains have reached unprecedented 
levels (Dukic et al. 2013). By far the most dominant CA-MRSA strain that 
has become endemic in hospitals around America and spread globally is 
USA300 (Nimmo 2012). USA300 has rapidly become as the most frequently 
isolated S. aureus isolate in infections, and now even represents 98% of all 
CA-MRSA SSTIs in America (Chadwick et al. 2013). In this strain of CA-MRSA  
resistance  to β-lactams and ciprofloxacin is chromosomally encoded, while 
resistance to tetracycline, macrolides, lincosamides, streptogramin B and 
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mupirocin is encoded on native plasmids pUSA02 and pUSA03 (Diep et al. 
2006).  
1.6.1 S. aureus pathogenesis 
USA300 has been recognised as the most virulent CA-MRSA strain in animal 
models of infection  (Li et al. 2010; Thurlow et al. 2012). This lineage 
encodes an extensive repertoire of virulence factors that enhance 
pathogenesis (Watkins 2012). Panton-Valentine leukocidin is a pore 
forming toxin that has strong epidemiological association with CA-MRSA 
strains and causes cell lysis (Gordon & Lowy 2008). This secreted toxin has 
been demonstrated to cause necrotizing pneumonia in animal models  and 
is strongly associated to necrotizing fasciitis (Lehman et al. 2010; 
Labandeira-Rey et al. 2007). Pulmonary infections by USA300, in particular, 
lead to aggressive and often fatal acute haemorrhagic necrotizing 
pneumonia in young and otherwise healthy people (Thurlow et al. 2012; 
Hidron et al. 2009).  
USA300 uniquely harbours a DNA transposon known as the arginine 
catabolic mobile element (ACME) (Thurlow et al. 2012). ACME encodes the 
arcA gene, which translates to an arginine deaminase enzyme. Enzymatic 
modification of host cell L-arginine may deplete the substrate required for 
nitric oxide production, the antimicrobial toxic metabolite produced by 
host cells (David & Daum 2010). This mobile genetic element may enhance 
USA300 virulence by allowing colonisation of skin surfaces, proliferate in 
low oxygen conditions such as abscesses and evade host defences (Gordon 
& Lowy 2008). Studies have shown that absence of ACME significantly 
decreases the in vivo fitness of USA300 which suggests a key role in 
pathogenesis (David & Daum 2010).  
Virulence of S. aureus is mainly controlled by the accessory gene regulator 
(agr), a global regulatory quorum sensing system. Figure 1.5 illustrates the 











Figure 1.5. The agr quorum sensing system of S. aureus (taken from 
Novick & Geisinger 2008). AgrD gene encodes a peptide precursor which is 
cleaved and secreted by transport protein AgrB to form active auto-
inducting peptide (AIP). This extracellular signalling molecule interacts with 
AgrC receptors of S. aureus cells in the locality to initiate upregulation of 
the agr operon. 
 
The agr locus encodes genes which ensure autoactivation and quorum 
sensing to induce activation of neighbouring S. aureus agr systems. AgrD 
encodes a small peptide precursor, which is processed by a 
transmembrane endopeptidase, AgrB, and secreted. This active 
autoinducing peptide (AIP) is a signalling molecule that can interact with 
the extracellular domain of transmembrane protein AgrC. AgrC and AgrA 
act as a two component system in which AgrA is activated to bind to target 
DNA. AgrA binds specifically to two promoters, P2 which induces up 
regulation of this signalling system and P3 which activates transcription of 
the effector molecule, RNAIII. This RNA transcript acts to induce 
transcription of a host of virulence genes (Novick & Geisinger 2008). Up 
regulation of the agr system in USA300 induces production of cytolytic 
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toxins such as phenol soluble modulins, δ-toxin and α-toxin (Cheung et al. 
2011). These toxins contribute significantly to the severity of mouse skin 
infections and also in the pathogenesis of necrotising pneumonia 
(Kobayashi et al. 2011, Wardenburg et al. 2007). In addition, the agr 
system is responsible for expression of peptidases, proteases and lipases 
which act to destroy cell tissue and promote dissemination (Gordon & 
Lowy 2008, Cheung et al. 2011). In USA300 in particular, the agr system is 
highly overactive, due to high frequency polymorphisms in the agr locus, 
which promotes overproduction of toxins and proteases, and is one of the 
primary reasons for extreme virulence (Thurlow et al. 2012). USA300 
lacking agr are highly attenuated in the ability to cause sepsis, skin abscess 
and pneumonia in animal models of infection (Montgomery et al. 2010, 
Cheung et al. 2011, Kobayashi et al. 2011).  
Staphylococcal infections are most commonly found in the extracellular 
environment, but research over recent years has determined that S. aureus 
can invade and survive in host cells (Sinha & Fraunholz 2010). Studies have 
demonstrated intracellular persistence in epithelial cells, endothelial cells, 
osteoblasts, fibroblasts and keratinocytes (Garzoni & Kelley 2009). 
Laboratory infection studies have determined that the intracellular fate of 
various strains of S. aureus is extremely variable and this pathogen does 
not categorically behave as an intravacuolar pathogen nor as a cytosolic 
bound pathogen (Sinha & Fraunholz 2010). For example, a study 
investigated the localisation of S. aureus RN6390 in tracheal epithelial cells 
(Jarry & Cheung 2006). In this study, infection of cystic fibrosis tracheal 
epithelial cells (CFT-1) by RN6390 was characterised by phagosomal escape 
and replication in the cytosol which caused destruction of cells. However, 
in the wild type tracheal cell line, the same strain remained within an 
endosome where it was degraded and cleared from lung cells. It is not 
clearly defined whether invasive S. aureus infections lead to replication or 
just persistence. S. aureus NOVEL invades bovine mammary epithelial cells, 
escapes the endosome and replicates efficiently (Bayles et al. 1998) 
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whereas S. aureus 6390 can invade enterocytes and survive for several 
days without replication or destruction of cells (Hess et al. 2003). Virulent 
S. aureus wild type strains invading endothelial cells neither persisted or 
replicated and were uniformly targeted to the lysosome for destruction 
(Schröder et al. 2006). Escape from the staphylococcal containing vacuole 
and bacterial persistence is largely thought to be dependent upon the 
expression of pore forming toxin α-hemolysin which is under the control of 
the agr virulence regulator system (Sinha & Fraunholz 2010). A study has 
demonstrated that S. aureus lacking α-hemolysin failed to escape from 
CFT-1 cell phagosomes and became entrapped in acidified lysosomal 
compartments (Jarry et al. 2008).  
1.6.2 S. aureus metabolism 
The metabolic profile of S. aureus, in addition to encoded nutrient uptake 
systems are well characterised (Fuchs et al. 2012). S. aureus encode 
enzymes which complete the glycolysis, gluconeogenic, PPP and TCA cycle 
metabolic pathways. This pathogen encodes a plethora of transport 
proteins including PTS specific hexose and ribose permeases, iron 
acquisition transporters, sugar phosphate permeases, glycerol facilitator 
and amino acid / peptide transporters. In addition, S. aureus encode all of 
the enzymes required for de novo biosynthesis of every amino acid (Nuxoll 
et al. 2012). 
 Despite extensive genome annotation of the membrane proteins that can 
act to acquire host cell nutrients, investigation of S. aureus metabolism 
during intracellular infection is a poorly studied topic. One publication 
analysed the transcriptome of  S. aureus in human lung epithelial cells 
(Garzoni et al. 2007). The glycerol uptake facilitator GlpF and sugar 
phosphate permeases UhpT and GlpT were significantly up-regulated 
throughout infection. Intense up regulation of genes encoding transporters 
of nucleotides, oligopeptides, urea and iron was notable during infection. A 
transient shutdown of metabolic pathways was apparent, as genes 
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involved in the TCA cycle, pyruvate metabolism and oxidative 
phosphorylation were dramatically down regulated. This may highlight a 
role for the glycolytic pathway in infection metabolism of S. aureus, as 
glucose uptake is associated with strong repression of the TCA cycle (Seidl 
et al. 2009). Mutagenesis studies are crucial to investigate the nutritional 

























1.7 Justification and Objectives 
In the battle between antimicrobial treatment and bacterial resistance, 
bacteria are rapidly gaining the upper hand. The exhaustion of current 
antibiotic treatment calls for more rigorous research into bacterial 
pathogenesis to find alternative therapeutic targets. S. aureus is a prolific 
pathogen which has prevailed in the presence of antibiotic pressures. The 
evolution and ascendancy of hyper-virulent, multi-resistant lineages, such 
as CA-MRSA USA300, emphasises the need for novel strategies.  Bacterial 
nutrition underpins the ability to multiply inside host cells. Host cell 
nutrient scavenging and bacterial metabolism is necessary for energy 
production needed to fuel virulence factor expression, promoting infection. 
Better understanding of bacterial mechanisms that drive replication and 
support pathogenesis can identify important factors that are required for 
virulence.   
Work in this thesis aims to evaluate organic substrates that can be utilised 
by S. aureus USA300 to promote replication. Permease dependent sugar 
phosphate uptake contributes to replication of L. monocytogenes in the 
intracellular compartment. The significance of sugar phosphate acquisition 
has not been explored in S. aureus. The major objectives addressed in this 
thesis were; 
1. Investigate the ability of S. aureus strains to grow on sole carbon 
nutrient sources which are present inside the cellular compartment, 
including sugar phosphates. 
2. Identify candidate sugar phosphate transport proteins in S. aureus 
USA300 for targeted mutagenesis in order to abolish function and 
characterise substrate specificity.  
3. Complement hpt deficient L. monocytogenes with staphylococcal 
sugar phosphate permeases for further substrate analysis and 




4. Standardise and characterise a reproducible model of mammalian 
epithelial cell infection by S. aureus USA300 to measure intracellular 
replication. 
5. Analyse the intracellular replicative ability of permease deficient S. 
aureus USA300 in order to determine the role of sugar phosphate 
transporters in host cell pathogenesis. 
6. Explore the host cell dynamics that predispose S. aureus USA300 
replication. Direction can be given to research to uncover 
mechanisms that support staphylococcal growth through host cell 




























2.1 Bacterial strains, plasmids and oligonucleotides 
Bacterial strains produced and used in this study are described in the 
appendix Table A1. Plasmids employed and constructed in this thesis are 
described in appendix Table A2. Oligonucleotide primers designed and 
used in this research are illustrated in appendix Table A3.  Bacterial strains 
and plasmids were constructed and handled in accordance with the 
genetically modified organisms (GMO) regulations of The University of 
Edinburgh. 
2.2 Bacterial culture and antibiotics 
E. coli strains were routinely cultured in Luria-Bertani (LB) broth. L. 
monocytogenes and S. aureus strains were regularly cultured in Brain Heart 
Infusion (BHI) broth. Liquid cultures were grown at 37oC (unless otherwise 
stated) in a shaking incubator at 200rpm. E. coli strains were plated on LB 
agar medium (1.6%(w/v) AgarB (MP Biomedicals) / LB medium). L. 
monocytogenes and S. aureus strains were plated on BHI agar medium 
(1.6%(w/v) AgarB (MP Biomedicals) / BHI medium). Bacterial plates were 
incubated overnight at 37oC (unless specifically stated). The composition of 
BHI and LB medium are listed in appendix Table A4 and A5 respectively. 
Antibiotics were used to select for plasmid constructs. Table 2.1 describes 
the antibiotic concentrations used when selecting strain dependent 
plasmid constructs.  












L. monocytogenes pPL2 Chloramphenicol 7.5
S. aureus  RN4220 pMAD-Cm Erythromycin 10
S. aureus  USA300 LAC pMAD-Cm Chloramphenicol 10
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2.3 Molecular techniques 
2.3.1 DNA extraction 
Genomic DNA was extracted from bacteria using the GenElute Bacterial 
Genomic DNA kit (Sigma). Bacterial DNA was extracted according to the 
manufacturers’ protocol. Plasmid DNA was extracted using the QIAprep 
Spin Miniprep kit (Qiagen) according to the manufacturers’ protocol. In the 
initial re-suspension of bacterial pellets, S. aureus strains required the 
addition of 5µl (5mg/ml) lysostaphin (Ambi) to the kit buffer solution. The 
staphylococcal re-suspension was incubated at 37oC for at least 30 minutes 
to allow the lysostaphin to degrade the cell wall, before continuing with 
the DNA extraction processes. DNA quality and quantity was assessed using 
a nanodrop machine. For plasmid transformation, If DNA quantity was less 
than 100ng/µl, the concentration was increased by using a speed vacuum.  
Colony PCR screening of E. coli and L. monocytogenes required rapid DNA 
extraction. Single bacterial colonies were collected onto the end of a sterile 
pipette tip, streaked onto a fresh agar plate and the same tip used to re-
suspend the remaining biomass into 50µl sterile pure water (Sigma) in a 
1.5ml eppendorf tube. The suspension was boiled at 100oC for 10 minutes 
in a eppendorf heat block. The lysate was briefly vortexed and 3µl used as 
template DNA for PCR reactions.  
A technique was developed in this study for faster extraction of 
staphylococcal DNA for colony PCR screening. Staphylococcal colonies were 
collected onto the end of a sterile pipette tip, streaked onto a fresh agar 
plate and the same tip used to re-suspend the remaining biomass in 200µl 
Instagene Matrix Beads (Biorad) containing 5 µl lysostaphin in a 1.5ml 
eppendorf tube. The eppendorf was vortexed for 20 seconds to physically 
weaken the cell wall. The suspension was incubated at 56oC for 20 minutes, 
vortexed for another 20 seconds and then incubated at 100oC for 10 





Denaturation 95 30 seconds
Primer annealing 55-60 30 seconds
Extension 72











Table 2.2C. Taq PCR Thermocycling
Component Volume (µl) Component Volume (µl)
Pure water (Sigma) 40 Pure water (Sigma) 38
Taq Polymerase 5U/µl (Biotools) 1 Taq Polymerase 5U/µl (Biotools) 1
5x phusion buffer (Biotools) 5 10x Reaction Buffer (Biotools) 5
dNTPs 10mM each (Biotools) 1 dNTPs 10mM each (Biotools) 1
Forward primer 10mM 1 Forward primer 10mM 1
Reverse primer 10mM 1 Reverse primer 10mM 1
Template DNA  50-100ng/µl 1 Lysate 3
50 50
Table 2.2A. Quantified DNA PCR Reactions Table 2.2B. Lysate (Colony PCR) Rections
(8000rpm, 5min) and 3 µl of the suspension was used as template DNA for 
PCR reactions. 
2.3.2 DNA digestion and ligation 
Plasmid DNA was digested using restriction endonuclease enzymes (New 
England Biolabs). High fidelity enzymes were used wherever possible. The 
recommended optimal conditions for reactions were followed. Plasmid 
constructs were created through ligation of open ended sequences. This 
was performed using T4 DNA Ligase (Promega) following the 
recommended protocol and provided reagents. 
2.3.3 Polymerase chain reactions (PCR) 
For routine PCR screening reactions, DNA was amplified using Taq DNA 
Polymerase (Biotools). Reaction compositions for purified template DNA 
and lysate DNA are described in Table 2.2A and 2.2B respectively. 













Denaturation 98 10 seconds
Primer annealing 55-60 30 seconds
Extension 72
30 seconds per 










Table 2.3B. Phusion PCR Thermocycling
High fidelity amplification of sugar phosphate transporter genes by proof 
reading Phusion Polymerase was performed for gene complementation. 
Table 2.3A lists the composition of high fidelity reactions and Table 2.3B 









2.3.4 Gel electrophoresis 
DNA products were loaded to a 1% (w/v) agarose TAE (Sigma) gel including 
a 1.5kb PLUS DNA ladder (Invitrogen). DNA was allowed to migrate at 200V 
for 25 minutes. Gels were added to a TAE vessel containing small amounts 
of ethidium bromide for 10-15 minutes to allow DNA staining. DNA was 
illuminated under ultraviolet light. Specific DNA products were isolated and 
extracted from the gel or directly from a PCR reaction mixture by using 
Illustra GFX PCR DNA and gel band purification kit (GE Healthcare). 
Component Volume (µl)
Pure water (Sigma) 32.5
Phusion Polymerase 2U/µl (New England Biolabs) 0.5
5x phusion buffer (New England Biolabs) 10
dNTPs 10mM each (Biotools) 1
Forward primer 10mM 2.5
Reverse primer 10mM 2.5
Template DNA  50-100ng/µl 1
50




DNA products were prepared for sequencing in accordance with the Sanger 
Institute guidelines. Sequencing of DNA fragments was completed by 
Sanger Sequencing Institute, University of Edinburgh. Sequences were 
analysed and aligned using ApE Plasmid Editor Software.  
2.3.6 S. aureus USA300 LAC mutagenesis 
Gene deletion mutations were constructed in S. aureus USA300 LAC in 
accordance with an established protocol (Fitzgerald, 2007). Figure 2.1 
outlines the protocol via schematics, and uses the uhpT gene as an 
example.  
Figure 2.1A illustrates the method used to construct and introduce a 
plasmid into USA300 LAC suitable for allele replacement of target 
transporter genes. Sequences flanking the target gene were amplified in-
frame by PCR, using primer pairs UhpT1b_EcoRI – UhpT2 and UhpT3 – 
UhpT4b_BamHI (described in appendix Table A3). Primers UhpT2 and 
UhpT3 were designed with complementary sequences to facilitate 
overlapping PCR amplification. The purified PCR products were used as 
template DNA (in equal concentrations ~100ng) to perform overlapping 
PCR using UhpT1b_EcoRI and UhpT4b_BamHI as the forward and reverse 
primers respectively. This generated a mutant allele which was cloned into 
pTOPO/pCRBlunt (Invitrogen) for high copy replication. The fragment was 
sequenced using primers M13 Forward and M13 Reverse, described in 
appendix Table A3. The mutant allele fragment was digested with 
restriction enzymes EcoRI and BamHI for 3h at 37oC, purified and ligated 
into shuttle vector pMAD-Cm, to create the construct pMAD-Cm UhpT. 
Recombinant allele pMAD-Cm constructs are illustrated in appendix Figure 
A4. The purified construct was transformed into E. coli and plated on LB – 
erythromycin for 24h at 37oC. Positive colonies were selected using colony 
PCR to identify the mutant allele via UhpT1b_EcoRI-UhpT4b_BamHI 
amplification. In addition, the fragment was confirmed by sequencing using 
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UhpT1b_EcoRI and UhpT 4b_BamHI primers. The construct was purified 
from E. coli and transformed into S. aureus RN4220 strain via 
electroporation (Lee 1995). Transformed RN4220 was plated on BHI-
erythromycin and incubated at 30oC (the permissive temperature for 
pMAD replication) for at least 24h. Colonies harbouring the plasmid 
construct were confirmed as previously described. Purified constructs were 
transformed into USA300 LAC via electroporation and plated on BHI-
chloramphenicol. Plates were incubated for at least 24h at 30oC and 
constructs were confirmed by PCR and sequencing.  
Figure 2.1B outlines the steps implemented to induce homologous 
recombination of pMAD-Cm UhpT in USA300 LAC. S. aureus USA300 LAC 
containing pMAD-Cm UhpT was cultured in BHI broth + chloramphenicol 
(30oC, 200rpm). Serial dilutions were plated on BHI – chloramphenicol  and 
incubated at 45oC for 24 - 48h. At this temperature, plasmid replication is 
non-permissive and the construct is forced to integrate into the 
chromosome by homologous recombination at the gene locus. Integrants 
were confirmed by PCR amplification of the mutant allele by UhpT1b_EcoRI 
and UhpT4b_BamHI primers. Integrants were grown in BHI broth without 
antibiotic for 24h at 30oC. Serial dilutions were plated onto BHI without 
antibiotic and incubated at 30oC for 24h. These conditions promote 
excision of the plasmid. Double cross-over excisants (where the WT uhpT 
gene is extracted with the plasmid DNA and the mutant allele remains 
integrated) were screened for chloramphenicol sensitivity. Colonies were 
selected and patched onto BHI – chloramphenicol and BHI without 
antibiotic and incubated at 30oC for 24h. Sensitive colonies conferred loss 
of plasmid. Genomic DNA was extracted and the mutant allele was 
confirmed by PCR using primers UhpT1b_EcoRI - UhpT4b_BamHI and UhpT 











To construct the double mutation, ΔuhpTΔglpT, the same protocol was 
administered using the single mutant strain ΔuhpT as the recipient and 
pMAD-Cm GlpT as the plasmid construct for homologous recombination. 
Primer combinations used for corresponding gene mutations are displayed 
in appendix Table A3. Native plasmids were extracted and profiled on an 
agarose gel to assess the isogenicity of mutant strains compared to wild 
type. A wild type USA300 LAC strain was constructed which was cured of 
the native pUSA03 plasmid. At the final stage of the protocol, antibiotic 
sensitivity screening, WT uhpT revertant colonies were confirmed by PCR, 
and the loss of pUSA03 was confirmed by plasmid profiling. 
2.3.7 Gene complementation of L. monocytogenes P14-A Δhpt 
Genes were complemented via the listerial integrative vector pPL2 (Lauer 
et al. 2002). This vector provides highly stable, site specific integration into 
the listerial chromosome (Monk et al. 2008) and has been employed in 
previous studies to successfully demonstrate heterologous gene expression 
in Listeria (Kim et al. 2012; Lemon et al. 2010).  
Vector integrated genes required a constitutive promoter to drive 
expression. The superoxide dismutase gene promoter of Listeria, Psod, was 
used to demonstrate high intensity, constitutive expression (Kohler et al. 
2000). Psod was digested from purified pBC(gfp)Psod plasmid using SalI and 
PstI enzymes and ligated into these pPL2 vector sites directly upstream of 
permease gene insertion sites. As Psod was found insufficient for 
generating intense expression, the Psod region was substituted for the 
PprfA promoter region. The PrfA DNA binding region, known as the PrfA 
box is located 180-196bp upstream of the hpt gene start codon in L. 
monocytogenes. Approximately 200bp of genomic DNA directly upstream 
of the hpt gene was amplified with Phusion polymerase using primers 
PprfA_KpnI and PprfA_BamHI. This sequence contained the PrfA box and 
the -10 binding motif, sequences targeted for transcription activation of 
hpt expression. This promoter sequence replaced Psod in the KpnI and 
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BamHI restriction sites of pPL2. The promoter sequences are presented in 
appendix Figure A3.  
Sugar phosphate transporter gene sequences were amplified by high 
fidelity Phusion polymerase (New England Biolabs). L. monocytogenes hpt 
was amplified from genomic DNA extracted from L. monocytogenes P14. S. 
aureus uhpT and glpT genes were amplified from genomic DNA extracted 
from USA300 LAC. Primer combinations relating to these reactions are 
described in appendix Table A3. Gene products were cloned into pCRBlunt 
(Invitrogen) and sequenced using M13 Forward and M13 Reverse primers. 
Gene sequences were excised from purified pCRBlunt using restriction 
enzymes BamHI and SpeI, incubated for 3h at 37oC. Genes were ligated 
into pPL2 constructs in the BamHI – SpeI restriction sites directly 
downstream of the promoter. Constructs were transformed into E. coli 
which was plated onto LB - chloramphenicol and incubated for 24h at 37oC. 
Constructs were confirmed by colony PCR using the appropriate gene 
primers to amplify transporters. The promoter region and gene sequence 
were sequenced using T3 and pPL2 1R primers (appendix Table A3). 
Constructs created for complementation are illustrated in appendix Figure 
A1 and A2.  
Purified constructs were electroporated into L. monocytogenes P14-A Δhpt 
using an established transformation protocol (Lauer et al. 2002). 
Transformed Listeria were plated onto BHI-chloramphenicol and incubated 
at 37oC for 24h. Integrants were checked by PCR using PL95 and NC16 
primers (appendix Table A3). The prfA gene was amplified with MR2 KpnI 
and MR10 SpeI (appendix Table A3) to confirm L. monocytogenes. 
Appropriate gene primers were used to confirm the presence of 
transporter genes. Characterisation of complemented strains was 






OD600  /  0.02
Volume (µl) =
2.3.8 Bioinformatic analysis 
S. aureus gene sequences were located using the NCBI genome database. 
Homologous protein sequences to S. aureus transporters were found using 
ExPasy Blast protein alignment tool, and searched using default 
parameters. Relevant data, including protein accession numbers and 
percentage sequence identity were collated for 10 highly similar 
sequences. Conserved domains across all homologous proteins were found 
using NCBI conserved domain search, following the set parameters.  
2.4 In vitro assays  
2.4.1 Bacterial growth 
L. monocytogenes and S. aureus strains were cultured overnight in BHI. 
Strains were sub-cultured in BHI (dilution 1:50) until reaching Optical 
Density 600nm (OD600) 0.6 – 1 (the mid exponential growth phase). 1ml of 
culture was added to a sterile eppendorf and pelleted via desktop 
centrifugation (5000rpm, 5 minutes). The bacterial pellet was washed in 
sterile 1x Phosphate Buffered Saline (PBS), pelleted and re-suspended in 
1ml PBS to form the stock inocula.  
250µl of stock inocula was added to a separate eppendorf, diluted 1:4 with 
1x PBS and vortexed. The OD600 of this solution was measured to calibrate 
the concentration of stock inocula (= OD600 x4). The following calculation 
was then applied to determine the volume of inocula to add to 1ml of 
growth media; 
 
Growth media was aliquoted into 1ml samples. A fixed starting number of 
bacteria were added to sample according to the calculated volume. After 
vortexing, 200 µl of each sample was added in triplicate to a Costar 96 well 
flat bottom plate. Blanks of growth media were added appropriately. The 
96 well plate was loaded into a Fluostar Optima Reader (BMG Labtech). 
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The OD600 of each well was measured every 30 minutes whilst shaking at 
200rpm and incubated at 37oC. Average growth over time was calculated 
from single experiments in triplicate ± standard deviation from the mean. 
Replicate experiments were pooled to generate an overall average growth, 
and the standard error was calculated. 
2.4.1.1 Minimal growth media for carbon nutrient growth analysis 
A chemically defined minimal growth media was employed to regulate 
background in vitro growth of S. aureus.  A staphylococcal minimal media 
has been previously described, named Hussain-Hastings-White modified 
medium (HHWm) (Toledo-arana et al. 2005). This media contains glucose 
as a carbon source, a mixture of amino acids as a source of nitrogen and a 
variety of vitamins and minerals as trace elements to supplement basal 
growth. For the purposes of this study the composition of this media was 
modified to suit the investigation. This study focuses upon the uptake of 
phosphorylated sugars through OAP transporters. In this family of 
permeases, the import of organophosphate substrates is coupled to the 
export of inorganic phosphate and is dependent upon the chemiosmotic 
gradient for function (Pao et al. 1998). It has been previously demonstrated 
that high external inorganic phosphate had a marked inhibition upon 
glucose-6-phospate uptake via UhpT due to disruption of the chemiosmotic 
gradient (Schwöppe et al. 2002). The concentration of phosphate buffers in 
the media composition was reduced as to lessen the disruption of 
organophosphate substrate import. Glucose was removed as the sole 
carbohydrate source of this media, in order to analyse individual 
supplemented substrates. The composition of this formulation, designated 
HHWm*, is detailed in Table 2.4. 
















Sodium Phosphate Dibasic 14.2 0.01M 1.42
Potassium Phosphate Monobasic 13.6 0.01M 1.36
Ammonium Sulphate 20 0.015M 2.00
Solution B (50x)
Magnesium Sulphate 7H2O 2.5 0.2mM 0.05
Manganese Sulphate monohydrate 0.19 22.5uM 0.0038
Ferrous Sulphate Heptahydrate 0.14 10.0uM 0.0028
Solution C (100x)
Biotin 0.01 0.409uM 0.0001
Nicotinic acid 0.2 16.2uM 0.002
D-Panthothenic acid Ca Salt 0.2 8.39uM 0.002
Pyridoxal hydrochloride 0.39 19.45uM 0.0039
Riboflavin 0.2 5.31uM 0.002
Thiamine Hydrochloride 0.2 5.93uM 0.002
Adenine Solution  (20x)
Adenine 1/2 H2SO4 0.3 50 81.5uM 0.015
Guanine Solution (20x)
Guanine HCl 0.375 50 100uM 0.019
Trace Elements Solution  (100x)
Calcium Chloride 0.55 49.5uM 0.0055
Zinc Chloride 0.17 12.5uM 0.0017
Copper Chloride 2H20 0.043 2.52uM 0.00043
Cobalt Chloride 6H20 0.06 2.52uM 0.0006
Sodium Molybdate 2H20 0.06 2.48uM 0.0006
RPMI1640 amino acids (50x) 
(Sigma)
20 Variable Variable
Glutamine Solution  (100x)
L-Glutamine 29.2 10 2mM 0.292
Calcium Solution  (1000x)






Table 2.4. Composition of HHWm* minimal medium.  
 
2.4.1.2 Carbon nutrient supplementation of minimal media 
Sugar substrates were added as carbon based growth sources to minimal 
media at a concentration of 20mM. Apart from glucose and glycerol 
solutions, sugar powders were dissolved in ddH20 and stored at -20
oC. The 
exact nomenclatures of all sugars used in this thesis are stated in Table 2.5. 
All sugars were purchased from Sigma.  





Table 2.5. Carbohydrate compounds used in this study. 
 
 
2.4.2 Mammalian cell cytotoxicity 
The integrity of the mammalian cell monolayer, grown in Costar 24 well 
plates, was tested using the Tox7 Lactic Dehydrogenase Based In Vitro 
Toxicology Assay Kit (Sigma). Cells that become detached from the 
monolayer are released into suspension. The suspension is collected and 
subjected to lysis, which releases lactate dehydrogenase (LDH) enzyme. 
LDH is used to produce an enzymatic reaction in vitro, which causes a 
colorimetric change (measured at OD490). This quantifiably measures the 
amount of LDH in the suspension. Doubling dilutions of suspended 
uninfected mammalian cells were subjected to the Tox7 assay as a control 
to correlate absorbance with cell total. The percentage of the monolayer 
that became detached due to bacterial cytotoxicity was therefore 
calculated using the control assay. The assay was performed in accordance 





D (+) Glucose solution G8769
D (-) Fructose F0127
D (+) Mannose M2069
Glycerol G5516
D-Glucose-1-phosphate disodium salt hydrate G7000
D-Glucose-6-phosphate disodium salt hydrate G7250
D-Fructose-6-phosphate disodium salt hydrate F3627
D-Fructose-1,6-bisphosphate trisodium salt hydrate F6803
racGlycerol-1-phosphate disodium salt hydrate G2138
Glycerol-2-phosphate disodium salt hydrate G6501
snGlycerol-3-phosphate bis(cyclohexylammonium) salt G7886
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2.4.3 Haemolytic titre 
A haemolytic titre was performed using S. aureus USA300 LAC strains to 
assess the potency of haemolytic toxin production as a measure of agr 
activity. Rabbit erythrocytes were isolated from whole blood. Whole blood 
was centrifuged at 5000rpm for 10minutes at 4oC. The supernatant was 
removed and erythrocytes were washed three times with an equal volume 
of 1xPBS (1500xg 10min 4 oC). Erythrocytes were re-suspended in 1xPBS to 
2% (w/v) and stored at 4oC. S. aureus strains were cultured overnight in 
BHI, 1ml centrifuged (6000rpm, 5minutes) and the supernatant retained 
for titre. Doubling dilutions of bacterial supernatant were prepared with 
1xPBS (100µl/well), in a Costar 96 well round bottom plate. Rabbit 
erythrocytes were added to each well in an equal volume (100µl/well). The 
plate was incubated at 37oC for 1 hour and stored overnight at 4oC. The 
plate was briefly centrifuged to pellet intact erythrocytes. A visualisation of 
pelleted erythrocytes was correlated with increase in dilution of bacterial 
supernatant. The plate was visualised using a desktop scanner.  
2.4.4 Fosfomycin susceptibility testing 
The minimum inhibitory concentration (MIC) of fosfomycin was 
determined for S. aureus strains. MICs were verified using Fosfomycin 
Epsilometer-Test antibiotic strips (Biomerieux), and performed in 
accordance with the British Society for Antimicrobial Chemotherapy 
methods for antimicrobial susceptibility testing. A scraping of at least half a 
dozen fresh bacterial colonies were suspended in saline solution and 
adjusted to OD600 0.2. 120µl of inocula was coated onto agar plates using a 
swab. Once the surface was dry, the E-test strip was placed on the bacterial 
lawn and gently pressed to maximize surface contact. The plate was 
incubated for 18-24 hours at 37oC. The exponential concentration gradient 
(µg/ml) of the antibiotic strip diffuses into the agar. The point at which the 
bacterial lawn ceases to grow can be measured on both sides of the 
concentration scale imprinted on the strip.  The point of bacterial 
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convergence at the E-test strip represents the minimum inhibitory 
concentration.  
Fosfomycin disodium salt (Sigma) was dissolved in sterile ddH2O and added   
to in vitro growth assay media (2.4.1). 
2.5 Mammalian cell culture 
2.5.1 Cells and maintenance  
Mammalian cells were grown in 80cm3 tissue culture flasks, at 37oC 5% 
CO2, until ~80% confluent. All cells were maintained in Delbucco’s Modified 
Eagle‘s Medium (DMEM, Invitrogen) containing 2mM L-Glutamine and 
25mM glucose. Fetal bovine serum (FBS) was added to the culture medium 
at a concentration specific to cell type. A summary of cells and growth 
conditions used in this study are presented in Table 2.6. 
Table 2.6. Cell lines maintained in this thesis. 
 
2.5.2 Carbon source manipulation 
 The glucose content of the growth medium was altered to manipulate the 
intracellular nutrient environment in preparation for bacterial infection. 
The normal physiological blood glucose level (which supplies cells) was 
created by adding 5mM glucose to DMEM[-glucose] (Invitrogen) containing 
appropriate concentration of FBS (see Table 2.6). After flask culture cells 
were trypsinized, they were centrifuged (1000rpm, 3min) in 15ml falcon 
tubes and re-suspended in the 5mM Glucose DMEM medium. This 
Cell 
type












Basal epithelial DMEM 10% (v/v) FBS
Hupp Lab 
(ECRC)
FTO2B Rat hepatoma Hepatocyte  DMEM 10% (v/v) FBS Our Lab
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suspension was used to seed 24 well plates which were incubated 
overnight to set up infection experiments at 5mM glucose.  
Cells were also starved of extracellular glucose. Firstly cells suspended in 
5mM glucose media were seeded to 24 well plates and allowed to attach 
during incubation for 4-5 hours. This media was replaced by DMEM[-
glucose] containing FBS and incubated overnight ready for infection.  
2.5.3 Bacterial intracellular proliferation assays 
2.5.3.1 S. aureus infection 
Mammalian cells were trypsinized from 80cm3 culture flasks, counted using 
a haemocytometer and seeded into 24 well plates at a concentration of 
~150,000 cells per well. Cells were incubated in specific carbon source 
conditions and allowed to reach confluence overnight. S. aureus strains 
were cultured overnight in BHI broth. On the day of infection, the 
overnight bacterial cultures were sub-cultured in BHI to OD600 0.4. 1ml of 
sub-culture was pelleted using a table top centrifuge (8000rpm, 4min), 
washed in sterile 1xPBS before pelleting and re-suspended in 1ml 1xPBS. 
The CFU/ml of this inocula suspension was calculated by replicate serial 
dilution plating. The appropriate volume of inocula required to infect each 
well of mammalian cells at a specific multiplicity of infection (MOI) was 
calculated:  
 
Media was aspirated from confluent monolayers, washed with sterile 
1xPBS, and fresh media containing the bacterial inocula was added. The 24 
well plates were centrifuged at 1000rpm for 3 minutes before cells were 
incubated for 35 minutes (37oC) allowing the bacteria to attach and invade. 
Media containing bacteria was aspirated from cells and fresh media 
containing 100 µg/ml gentamicin (Sigma) and 10 µg/ml lysostaphin (Ambi) 
was directly overlaid. This media ensures killing of extracellular S. aureus, 
(Ratio no.bacteria : no.cells) x 150000 
CFU/ml inocula
Volume of inocula   




CFU/ml at t=0h 
Bacterial MOI











allowing specific monitoring of intracellular bacterial replication. After 30 
minutes of incubation, this represented time 0h and the commencement of 
the time course infection. At appropriate time points, antibiotic media was 
aspirated, cells were washed twice in 1xPBS and 100µl of 0.1% (v/v) 
TritonX-100 (Sigma) was applied to the monolayer for 10 minutes whilst 
the plate was incubated at 37oC. 400µl of 1xPBS was added to the well and 
using a sterile pipette tip, cells were scraped from the well in a systematic 
manner. The samples were serially diluted and 100µl of appropriate 
dilutions were plated on BHI overnight at 37oC. The numbers of colony 
forming units per ml were calculated for each time point. Time points for 
each infection were preferentially performed in triplicate. The average 
CFU/ml was calculated over biological replicates to generate mean values 
for comparison. 
The percentage bacterial invasion is defined as the number of bacteria 
isolated at time 0h as a percentage of the total number of bacteria that 




The mean generation time is defined as the average time taken for 




Standard error was calculated for all experiments. 
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CFU/ml at t=8h   -  Mean CFU/ml at t=0h 




2.5.3.2 L. monocytogenes infection 
L. monocytogenes strains were cultured overnight in BHI broth. Cultures 
were sub-cultured in 200ml BHI until reaching an OD600 of 1. Bacterial 
culture was transferred to a sterile 500ml centrifugation bottle and 
pelleted (8000rpm, 10mins, 4oC). The bacterial pellet was washed three 
times in ice cold 1xPBS before re-suspending the pellet in ice cold 20% (v/v) 
glycerol / PBS. Inoculum was aliquoted into eppendorfs to store at -80oC. 
Three aliquots were thawed and pooled for replicate serial dilution plating 
to calculate an average CFU/ml for the inoculum. Three frozen inoculum 
aliquots were pooled and vortexed before each infection experiment to 
minimise variation from the calibrated CFU/ml.  
The same general mammalian cell infection procedure was followed as 
described for S. aureus. Inoculum was exposed to cells at an MOI of 1-3, 
with an invasion time of 20 minutes. Inoculated media was removed, cells 
washed in 1xPBS and media containing 100µg/ml gentamicin was added. 
Incubation of antibiotic media for 1 hour constituted time 0h, where 1% 
(v/v) Triton X-100 was used to break open cells. At 8-10 hours post invasion 
intracellular bacteria were plated via serial dilution and the CFU/ml was 
calculated at appropriate dilutions.  
For experiments where time 0h and 8h were measured only, the 
intracellular growth coefficient (IGC) was calculated. This effectively 
measures the fold change in intracellular bacterial numbers at time 8h 
relative to the numbers isolated at time 0h. This quantification allows a 







For each experiment, average CFU/ml was calculated at time 0h which was 
used to calculate IGC for technical replicates. The IGC values from separate 
experiments were pooled to calculate a mean IGC ± standard error. 
2.5.4 Immunofluorescence microscopy 
2.5.4.1 Preparation of coverslips 
Sterile round 23mm glass cover slips were added to 24 well plates using 
sterile tweezers. Mammalian cells were seeded to ~150,000 cells per well 
and incubated overnight until confluent. S. aureus infection protocols were 
performed as previously described in 2.5.3.1, until removal of antibiotic 
killing media. Coverslips were transferred to a fresh 24 well plate and 
washed twice with sterile 1xPBS. 500µl of 4% (w/v) paraformaldehyde was 
overlaid and incubated for 15minutes at room temperature (RT) to fix cells. 
Paraformaldehyde was aspirated and coverslips were washed three times 
with 1xPBS before storage in 1xPBS at 4oC.  
2.5.4.2 Antibody staining 
PBS was removed from coverslips and cells were immersed in 0.2% (v/v) 
TritonX-100 for 10 minutes to permeablize the cell membrane. Triton was 
removed and non-specific epitope blocking was then completed by sterile 
PBS 3% (w/v) bovine serum albumin (BSA) application for 1 hour at RT. 
Primary antibodies were diluted as appropriate in PBS 3% BSA. Blocking 
solution was exchanged for primary antibody suspension and incubated at 
RT for 1 hour. Primary antibodies were taken off and cells were washed 
three times in 1xPBS. Secondary antibodies and/or fluorophores were 
diluted as appropriate in PBS 3% BSA. Secondary antibodies/ fluorophores 
were incubated for 30 minutes at RT. A comprehensive table of 
antibodies/fluorophores used including the working dilutions is presented 
in Table 2.7. Cells were washed three times in 1xPBS. Coverslips were 
placed face up on Whatman blotting paper for 10-15 minutes to remove 













aureus Rabbit Polyclonal 
IgG
1:1000
Labelling intracellular S. 
aureus
Abcam              
(Ab20920)
1o
Anti-58K Golgi Protein 
Mouse monoclonal IgG
1:1000
Labelling cell Golgi 
membranes






Labelling cell vacuole marker 
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Staphylococcus aureus IgG 
Invitrogen               
(A-11011)
2o
Alexa Fluor568 Goat anti-
Mouse IgG
1:1000
Detection of anti-Rab7 IgG 
and anti-LAMP1 IgG
Invitrogen                     
(A-11004)
2o
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1:100,000 Staining nuclear DNA Invitrogen
Alexa Fluor 488- 
conjugated Phalloidin 
1:1000 Staining cell F-actin
Invitrogen            
(A12379)
Superfrost glass slides by mounting medium (Invitrogen) containing 
dissolved antifade reagent (Invitrogen). Slides were stored at RT on a dark, 
flat surface until required for microscopy analysis.  
 
 







2.5.4.3 Microscopy analysis 
Coverslip slides prepared for fluorescence microscopy were viewed under a 
Leica DMI 6000 inverted microscope with 63x objective (oil immersion). 
Imaging was captured using Leica LAS imaging software and pictures were 
processed for presentation using Adobe Photoshop.  
Duplicate cell coverslip preparations were used to quantify infection. At 
each time point, 10 random samples (5 from each coverslip) were imaged 
using the same imaging area size (field). Cells with nuclei within these areas 
were counted as were the number of cells that contained at least a single 
bacterium. The numbers of bacterial clusters inside infected cells were also 
counted. A bacterial ‘cluster’, for the purposes of this study, was defined as 
a free standing body of bacteria, ranging from a single bacterium to an 
infinite number, as long as the bacteria were in contact as part of that 
cluster. As the sampling areas contained variable numbers of cells, the 
average values were calculated by summing the raw values and dividing by 
the sample size.  
Co-localisation of fluorescent S. aureus clusters and cellular proteins was 
qualified by visual association. Duplicate cell coverslip preparations were 
analysed by selecting at least 10 random fields from each time point. The 
number of bacterial clusters that were positively associated with 
mammalian cell proteins was expressed as a percentage of the total 
number of intracellular clusters that were observed in all fields. This 
calculation determined the % co-localisation and standard error was 
applied for each time point.  
Phase contrast images were captured of cell monolayers within 24 well 
plates at 20x objective.  
2.5.5 Inhibitor treatment of mammalian cells 
Golgicide A (Sigma) is a reversible inhibitor of the cis-Golgi GTPase GF1, and 
designed to disrupt Golgi assembly. Golgicide A was dissolved in dimethyl 
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sulphoxide (Sigma) at a stock concentration of 10mg/ml and stored at 4oC. 
During the S. aureus infection assay (2.5.3.1) inhibitor was added at a 
working concentration of 10µg/ml to the antibiotic killing media. Golgicide 
A remained exposed to cells for the remainder of the infection course.  
2.6 Statistical analysis 






























Staphylococcus aureus is a prolific animal and human pathogen. It is 
estimated that S. aureus  naturally colonises the nasal passages of 20% of 
the human population, while 60% are intermittent carriers (Kluytmans 
1997).  This pathogen is most commonly isolated from skin and soft tissue 
infections, such as impetigo and foliculitis. Infection can reach the 
subcutaneous and connective tissue and cause inflammation, known as 
cellulitis. In addition, infections have been localised to the fatty connective 
tissue of the breast (mastitis). S. aureus is frequently found to be the 
underlying cause of more serious diseases such as blood sepsis, 
endocarditis (inner heart tissue infection), pneumonia (lung tissue 
infection) and osteomyelitis (bone infection) (Nimmo 2012). This organism 
demonstrates colonisation of multiple, diverse niches for successful 
replication. The genomic make-up of S. aureus incorporates a host of 
transport systems to capture nutrients from these environments, in 
addition to redundant metabolic energy pathways (Fuchs et al. 2012). The 
ability of pathogens to exploit nutrients from the host environment is 
integral to replication and pathogenesis. S. aureus is a pathogen that has 
the metabolic versatility to do this in various niches; however the 
nutritional determinants that support this ability are poorly understood. 
3.2 Objectives 
The primary aim was to identify and compare carbon based substrates that 
promote in vitro media based growth of S. aureus strains. Individual 
carbohydrate substrates were investigated which can be metabolised using 
the glycolytic pathway outlined in Figure 3.1. This strategy integrated 
phosphorylated sugars which were particularly scrutinized as nutrient 
sources contributing to replication. S. aureus USA300 LAC, a hyper-virulent 
clinical CA-MRSA isolate, was primarily investigated to probe nutritional 
determinants of virulence. This isolate was compared to S. aureus 8325-4, a 







3.3 Relevant materials and methods 
In vitro assays (2.4) Bacterial growth (2.4.1) 
Statistical analysis (2.6) Significant difference was calculated between 
un-supplemented vs supplemented data sets of in vitro growth at the final 



















S. aureus strains were characterised in vitro using nutrient supplemented 
media to monitor bacterial growth and assess the capacity for nutrient 
metabolism. A minimal media was required to support a basal growth of S. 
aureus. In this media, individual carbon sources could be added to compare 
bacterial growth and assess the value of substrates towards replication.  
3.4.1 Multi-nutrient media 
Two different complex bacterial broths were used to assess the capacity of 
S. aureus to replicate in multi-nutrient environments. Brain heart infusion 
(BHI) broth is an extremely nutritious media containing an abundance of 
proteins, peptones, carbohydrates and lipids. It also includes ~10mM 
glucose. Luria Bertani (LB) broth is a rich source of peptides and amino 
acids whilst is relatively poor in sugars compared to BHI. The composition 
of BHI and LB media can be compared in appendix Tables A4 and A5. L. 
monocytogenes was analysed in parallel to provide a reference strain to 
compare the growth capacity in BHI and LB.  
Figure 3.2 shows the in vitro growth of S. aureus strains in BHI and LB 
media, compared to L. monocytogenes strain P14-A. Panels A and B show 
that 8325-4 and USA300 LAC strains can derive rapid, high growth yield 
from both BHI and LB broth. Notably, Listeria can reach an optical density 
at 600nm (OD600nm) of around 1 in BHI (Figure 3.2C), which was calculated 
via dilution plating to be ~5 - 7 x1010 CFU/ml. At the same optical density, S. 
aureus strains were calculated to reach 2 – 5 x1010 CFU/ml in this media.  S. 
aureus strains can reach higher bacterial yields than L. monocytogenes 
among the same rich nutrient composition of BHI. In addition, the lag 
phase of growth in both BHI and LB is at least half the time in S. aureus 
strains compared to P14-A. This indicates that S. aureus strains are 







Figure 3.2C demonstrates LB media cannot support replication of L. 
monocytogenes in the same manner as BHI due to the nutritional 
dependence of Listeria upon carbohydrate sources. LB broth can act as a 
minimal media to measure growth of L. monocytogenes when carbon 
sources are supplemented. S. aureus strains replicate in LB to an optical 
density of approximately 6 fold higher than P14-A, which nullifies this broth 
as a minimal medium for monitoring staphylococcal growth.  
3.4.2 Chemically defined minimal media 
As LB and BHI promote rapid and high capacity growth of S. aureus, neither 
could serve as a basal medium to characterise replication upon addition of 
specific carbon sources. Chemically defined staphylococcal minimal 
medium, termed HHWm*, was formulated to fulfil this requirement. The 
formulation of this media is outlined in 2.4.1.1 and the composition is 
illustrated in Table 2.4.  
Selected non-phosphorylated sugars and phosphorylated 3 carbon (C3) and 
6 carbon (C6) carbohydrate intermediates (as highlighted in Figure 3.1) 
were supplemented individually to HHWm* media.  The capacity of S. 
aureus 8325-4 and USA300 LAC to replicate in these conditions are 









3.4.2.1 Non-phosphorylated sugars 
Figure 3.3A and 3.4A shows the average growth of S. aureus 8325-4 and 
USA300 LAC in sugar supplemented HHWm* relative to un-supplemented 
HHWm*. When both strains are supplemented with non-phosphorylated 
sugars, the lag phase of growth is consistent, lasting 2 hours. Glucose 
provides the most efficient energy source as both strains enter the 
exponential growth phase most rapidly and reach stationary phase by 5 
hours. PTS dependent sugars fructose and mannose are also utilised rapidly 
in both strains and support replication to an optical density of 0.1-0.2 
higher than glucose. Glycerol serves as an effective supplement of growth 
in both S. aureus strains. In 8325-4, glycerol is metabolised in a similar 
capacity to glucose whilst in USA300 LAC, this source provides a 2 fold 
higher level of optical density than glucose. All individual sugar sources 
benefit growth of 8325-4 by 2-3 fold more than HHWm* alone at 18h. 
Glucose, fructose and mannose offer USA300 LAC the capability to 
replicate to 0.5-1 fold more than HHWm* alone at 18h but the levels of 
optical density reached are at least 0.5 fold greater than 8325-4 growth. 
Glycerol is the outstanding growth supplement for USA300 LAC, improving 
replication to 3-fold higher than HHWm* alone and 3-fold higher than the 
8325-4 counterpart at 18h. These significant differences in growth by 18h 
were confirmed via T-test, presented in Table 3.1.  
3.4.2.2 Phosphorylated C6 sugars 
Figure 3.3B and 3.4 B charts the growth of S. aureus strains in HHWm* 
media supplemented with hexose phosphate sugars. Neither strain can 
derive a growth benefit beyond the basal minimal medium from glucose-1-
phosphate (G-1-P) or fructose-1,6-bisphosphate (F-1,6-BP). By contrast 
glucose-6-phosphate (G-6-P) and fructose-6-phosphate (F-6-P) are utilised 
to produce pronounced levels of growth beyond un-supplemented media. 
In strain 8325-4, the optical density of these hexose phosphates reaches 5 
times the level of HHWm* alone by 18h and 1.5 times greater than glucose 
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and glycerol. Similarly in USA300 LAC, the OD600 rises over 2 fold higher 
than HHWm* alone and replication levels exceed double the value of 
glucose at 18h. Significant differences are confirmed in Table 3.1. However, 
the lag phase of growth elicited by hexose phosphates is double the length 
of glucose, which is consistent in both S. aureus strains. The exponential 
growth of S. aureus 8325-4 in HHWm* + glucose was OD600 0.2 per hour. By 
contrast, exponential growth of hexose phosphates was 2 fold lower than 
glucose in 8325-4. In USA300 LAC, exponential growth in glucose and 
hexose phosphates was similar, at OD600 0.2 per hour. 
3.4.2.3 Phosphorylated C3 sugars 
Figure 3.3C and 3.4C illustrates the value of glycerol monophosphates as 
growth promoting nutrients of S. aureus strains. Glycerol-1-phosphate 
(Gol-1-P) is utilised by both strains to generate a significant growth benefit 
by 18h (Table 3.1). In 8325-4, growth is supported to 3 times the level of 
un-supplemented media and 0.5 fold higher than glucose supplementation. 
Despite offering a higher yield of growth, glycerol-1-phosphate elicits an 
exponential growth of approximately OD600 0.05 per hour in 8325-4 , which 
is 6 times lower than that of glucose. In USA300 LAC, glycerol-1-phosphate 
is an effective nutrient source, offering a 1.5 fold higher growth yield than 
un-supplemented media, reaching levels almost as high as hexose 
phosphates at approximately half the exponential growth rate. Glycerol-2-
phosphate (Gol-2-P) and glycerol-3-phosphate (Gol-3-P) are not utilised as 
sources for replication in USA300 LAC whereas glycerol-3-phosphate can 
provide a growth advantage twice the basal level in 8325-4. Again, the lag 
phase of growth in glycerol monophosphates is a least double the length of 






Table 3.1. Results of T-test analysis comparing sugar supplemented 










3.4.2.4 Amino acids 
In HHWm* minimal media alone, S. aureus strains exhibited poor growth. 
However, it was noticeable after 10 hours, especially in USA300 LAC, that 
growth gradually increased. Components of the HHWm* media were 
proving a source of nutrition for S. aureus. In vitro grow assays were 
performed over a longer period of time to determine the extent of growth 
exhibited by USA300 LAC in HHWm* media without carbohydrates. Figure 
3.5 shows that over a 24 hour period, USA300 LAC could reach yields 
similar to those attained in hexose phosphates and glycerol by growing in 
this media alone. 
The HHWm* media composition incorporates an amino acids solution 
which supplies all amino acids ranging from 25µM to 1mM in 
concentration. The proficient growth of USA300LAC in peptide rich-
carbohydrate poor LB media suggested that amino acids may provide a 
nutrient source. Removal of amino acids as part of the HHWm* media 
composition (HHWm* -αα) completely abolishes any growth of USA300 
Supplement 8325-4 USA300 LAC
+ Glucose 0.004 0.042
+ Glycerol 0.014 0.0008
+ Fructose 0.002 0.008
+ Mannose 0.016 0.009
+ G-1-P 0.51 0.71
+ G-6-P 0.001 0.0008
+ F-6-P 0.002 <<0.05
+ F-1,6-BP 0.82 0.09
+ Gol-1-P 0.0029 <<0.05
+ Gol-2-P 0.068 0.77
+ Gol-3-P 0.002 0.68
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LAC (Figure 3.5). Although the lag phase is 10 hours (5 times longer than 
glucose supplemented growth), this demonstrates that small quantities of 
amino acids (relative to 20mM sugar supplementation) can provide an 
important nutrient source to support growth of S. aureus USA300 LAC.  
Taken together, the results show that S. aureus USA300 LAC, in particular, 
can effectively and readily use a diverse range of nutrients to generate a 

















In vitro growth analysis has demonstrated the extent of S. aureus 
replication derived from the utilisation of distinct exogenous substrates. 
3.5.1 S. aureus is metabolically adept 
S. aureus strains encode a putative glycerol uptake facilitator, in addition to 
independent PTS systems specific to glucose, fructose and mannose, 
almost certainly owing to the growth phenotype shown in each of these 
supplementations. Hexose sugars offer a rapidly metabolised source of 
nutrition for S. aureus which boosts replication to an arrested stationary 
level. Glycerol can also provide a valuable in vitro nutrient source to S. 
aureus. Glycerol is a precursor for the synthesis of triacylglycerols and 
phospholipids inside mammalian cells (Guo 1999) and may be considered 
an alternative nutrient source for bacterial growth. Discernible up 
regulation of glycerol uptake and metabolism genes has been observed in 
S. aureus infection of human lung cells (Garzoni et al. 2007) which suggests 
glycerol may be an important nutrient in this cellular environment. S. 
aureus USA300 LAC utilises glycerol to replicate to significantly higher 
yields than with hexose sugar supplementation. Given this information, this 
may implicate a role for glycerol scavenging as a means to replicate during 
invasive CA-MRSA pneumonia infection.  
Hexose phosphate substrates glucose-6-phosphate and fructose-6-
phosphate were utilised by S. aureus to generate the highest measured 
levels of replication, far exceeding the stationary levels of growth elicited 
by most non-phosphorylated sugars. Glycerol monophosphate (excluding 
glycerol-2-phosphate) also stimulated replication to a level greater than 
that of glucose albeit at a reduced rate. Specific sugar phosphates have the 
potential to offer a valuable intracellular source of nutrition for S. aureus. 
These substrates have singular capacity, as a carbon nutrient source, to 
induce high level replication which can directly influence pathogenesis and 
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virulence of S. aureus. It was noted that S. aureus strains underwent a 2-
fold longer lag phase upon growth in sugar phosphates compared to non-
phosphorylated sugars. Speculation can be made that this pause is 
attributed to the sensory inducible expression mechanism that governs the 
sugar phosphate transport systems (Winkler 1973; Dietz 1976). Upon 
identification of external substrate, single genomic expression systems 
must initiate production of permease proteins which are incorporated to 
the cell membrane. The time taken to reach the exponential growth phase 
may represent the accumulation of permeases at the membrane interface.  
S. aureus USA300 LAC demonstrated a noticeable growth benefit from 
amino acids as sole carbon sources. S. aureus encode a number of amino 
acid permeases such as proline permease (putP), glutamine permease 
(glnP), arginine antiporter (arcD) and the putative amino acid permease 
(pheP) (Horsburgh et al. 2004; Wengender & Miller 1995; Zhu et al. 2007; 
Zhu et al. 2009). S. aureus encodes all enzymes involved biosynthesis of 
amino acids (Nuxoll et al. 2012), meaning the endogenous metabolic 
pathways are capable of producing these raw materials from other nutrient 
sources.  Exogenous amino acids are therefore not exclusively taken up by 
S. aureus to fulfil a metabolic deficiency and so they apparently serve as a 
suitable alternative carbon nutrient source. 
3.5.2 S. aureus USA300 LAC has greater metabolic proficiency 
Clinical, hyper-virulent CA-MRSA strain USA300 LAC revealed a greater 
capacity for utilising substrates over the laboratory strain 8325-4. In 
virtually every analysis, USA300 LAC exploited substrates to a notably 
greater replicative yield than 8325-4. The clinical strain displayed similar 
rates of exponential growth to 8325-4 upon non-phosphorylated sugars. 
Noticeably, USA300 LAC derived growth from hexose phosphates as 
efficiently as glucose and only reduced rate of growth in glycerol 
monophosphate by 0.5 fold. By contrast, 8325-4 shows marked reduction 
in growth efficiency upon sugar phosphates relative to glucose growth. S. 
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aureus USA300 has the ability to replicate extensively from a range of 
exogenous substrates, with similar efficiency. This analysis suggests why 
this pathogen has become so dominant in establishing infection in diverse 
niches. 
3.5.3 Intrinsic differences between S. aureus and L. monocytogenes 
may account for divergent nutritional gains 
 The high growth yields of S. aureus strains derived from LB media suggest 
that amino acids are utilised from this broth. By contrast, LB is not a 
nutritious media for L. monocytogenes. This suggests intrinsic differences 
between L. monocytogenes and S. aureus in the ability to derive growth 
from peptide and amino acid sources. L. monocytogenes encodes 
numerous amino acid and peptide transport systems, which are necessary 
to scavenge important substrates during host cell infection (Fuchs et al. 
2012). Although Listeria are dependent upon exogenous uptake of several 
amino acids (Eisenreich et al. 2010), these substrates cannot act as a 
growth source (Premaratne et al. 1991). This may be attributed to 
differences in the constitution of the tricarboxylic acid (TCA) cycle. Figure 
3.6 shows the metabolic enzymes that are encoded in the genome of S. 
aureus which act to convert substrates of the TCA cycle. Figure 3.6 
compares the encoded enzymes of L. monocytogenes.  
S. aureus has a complete set of TCA enzymes and in addition, a ferrodoxin 
oxidoreductase enzyme is encoded which serves to shorten the cycle and 
improve the efficiency. By contrast, Listeria species lack three enzymes 
necessary to convert 2-oxoglutarate to succinate meaning the cycle is 
bifurcated. TCA cycle function produces NADH, which is used to set up a 
proton gradient in the bacterial transport chain. Electrons donated by 
NADH oxidation drives export of H+ protons, which are ultimately coupled 
to  production of ATP by ATP synthase (Alberts et al. 2002). In short, the 











In addition the synthesis of oxaloacetate can potentiate the gluconeogenic 
energy pathway. Amino acids can be metabolised to one of a number of 
TCA cycle precursors and intermediates which are incorporated into the 
energy cycle (according to Kegg Pathways). The TCA cycle may provide an 
efficient energy mechanism for S. aureus to replicate in an environment 
where amino acids/ peptides become the most primary carbon nutrient 
source. This may reflect the superior efficiency and high capacity 
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S. aureus strains exploited exogenous hexose phosphates and glycerol 
monophosphate from minimal media to replicate to bacterial yields 
significantly higher than those attained through PTS-dependent sugars. 
Sugar phosphates can be recognised as highly nutritious sources from 
which S. aureus may thrive during invasive infection. In particular, S. aureus 
USA300 LAC growth benefitted greatly from sugar phosphates in vitro. 
Intracellular replication, and subsequent pathogenesis, may be attributed 
to the exploitation of these substrates. Given the highly destructive, 
disseminate and invasive nature of USA300, it was essential to investigate 
the value of sugar phosphate acquisition towards CA-MRSA infection.  
4.2 Objectives 
The means by which S. aureus imports exogenous hexose phosphates and 
glycerol monophosphate needed to be established by bioinformatic 
analysis. The S. aureus genes encoding putative transporters were subject 
to mutagenesis in order to disable access to extracellular sugar 
phosphates. The substrate specificity could then be investigated for each 
channel. In addition to single mutants, a double deletion mutation was 
constructed with the intent of abolishing the ability of USA300 LAC to 
derive in vitro growth from G-6-P, F-6-P and Gol-1-P as sole carbon nutrient 
sources. This strategy was implemented to establish whether redundant 
mechanisms contributed to sugar phosphate uptake, and to create a strain 
that was impaired specifically in sugar phosphate uptake for analysis of 
intracellular replication. 
It has been known for decades that the organophosphate antibiotic 
fosfomycin penetrates susceptible bacteria almost exclusively through 
UhpT and GlpT transporters (Kahan et al. 1974). It is well documented, that 
S. aureus strains are particularly vulnerable to fosfomycin in vitro (Alvarez 
et al. 1985; Falagas et al. 2010; Popovic et al. 2010). Fosfomycin was 
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therefore investigated in the context of a transporter substrate to 
determine specificity of fosfomycin uptake in USA300 LAC.   
4.3 Relevant materials and methods 
Molecular Techniques (2.3);  S. aureus USA300 LAC mutagenesis (2.3.6), 
Bioinformatic analysis (2.3.8).  
In vitro assays (2.4); Bacterial growth (2.4.1), Haemolytic titre (2.4.3), 
Fosfomycin susceptibility testing (2.4.4). 
Statistical analysis (2.6) Significant difference was calculated between 
un-supplemented vs supplemented data sets of in vitro growth at the final 

















4.4.1 Bioinformatic analysis of putative sugar phosphate permeases 
4.4.1.1 Localisation of putative transporter genes in S. aureus USA300 
The genome of S. aureus USA300 has been sequenced (Diep et al. 2006) 
and it contains two chromosomally encoded putative sugar phosphate 
permease genes, uhpT and glpT. 
 
Figure 4.1 illustrates the USA300 chromosome locus of both these alleles. 
The putative hexose phosphate transporter, uhpT (annotated sugar 
phosphate antiporter) is encoded between 254 and 257 kb in the 2.76 
million base pair genome of USA300. A designated glycerol-3-phosphate 
transporter gene, glpT, is encoded between 389 and 391 kilobase pairs of 
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Accession Gene Designation Species
% Amino acid 
sequence identity
Q8CN35 SE_2047 Glycerol-3-phosphate transporter Staphylococcus epidermidis 86
N0DBP7 glpT Glycerol-3-phosphate permease Bacillus subtilis 62
J1YHA1 glpT Glycerol-3-phosphate transporter Vibrio cholerae 61
Q1ZMV1 VAS14_08945 Glycerol-3-phosphate transporter Photobacterium angustum 60
A6VE09 glpT Glycerol-3-phosphate transporter Pseudomonas aeruginosa 57
P08194 glpT Glycerol-3-phosphate transporter Escherichia coli 55
P96335 glpT Glycerol-3-phosphate transporter Haemophilus influenzae 50
A7FD94 glpT Glycerol-3-phosphate transporter Yersinia pseudotuberculosis 56
Q8XNV0 glpT Glycerol-3-phosphate transporter Clostridium perfringens 42
A0Q5L4 glpT Glycerol-3-phosphate transporter Francisella tularensis 42
Accession Gene Designation Species
% Amino acid 
sequence identity
Q8CQE4 SE_0164 Hexose phosphate transport protein Staphylococcus epidermidis 96
H2I4B4 uhpT Sugar phosphate antiporter Corynebacterium diphtheriae 76
B2V3Q5 CLH_1068 Hexose phosphate transport protein Clostridium botulinum 65
T2KWZ2 uhpT Hexose phosphate transport protein Listeria monocytogenes 53
H8IC88 uhpT Sugar phosphate antiporter Pasteurella multocida 53
V3M5E4 L386_04434 Hexose phosphate transporter Klebisella pneumoniae 51
V2GQY6 uhpT Sugar phosphate antiporter Salmonella enterica 51
H1R2P0 uhpT Sugar phosphate antiporter Vibrio fischeri 50
C8TZ30 uhpT Hexose phosphate transporter Escherichia coli 48
Q329E9 uhpT Hexose phosphate transport protein Shigella dysenteriae 48
the genome, in the reverse sense. These two homologous proteins are the 
only putative sugar phosphate transporters present in the S. aureus 
genome. All sequenced S. aureus genomes encode identical gene 
sequences for uhpT and glpT.  
4.4.1.2 Homology of putative sugar phosphate transporters 
Protein residue sequence analysis of S. aureus UhpT and GlpT was 
performed using Blast alignment. Amino acid sequences were matched to 
documented similar sequences, which indicate homology between 
proteins. Table 4.1 lists a variety of bacterial species encoding proteins 
which scored highly in sequence identity to S. aureus USA300 LAC UhpT. 
Table 4.2 lists bacterial proteins with high homology referenced to S. 
aureus USA300 LAC GlpT protein sequence.  
 
Table 4.1. Blast alignment analysis showing highly similar proteins using 
USA300 LAC UhpT as the reference sequence. 
 
Table 4.2. Blast alignment analysis showing highly similar proteins using 
USA300 LAC GlpT as the reference sequence. 
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Homologous UhpT and GlpT protein sequences were analysed for 
conserved domains in order to confirm functional commonalities. Figure 
4.2A and 4.2B shows the common structural domains detected for 
homologous UhpT and GlpT proteins respectively, as compared in Table 4.1 
and 4.2. Together the bioinformatics analysis confirms that S. aureus 
USA300 LAC UhpT and GlpT are major facilitator superfamily (MFS) 
proteins that are highly related to widespread, redundant bacterial MFS 
transporters with roles in organophosphate transport. These proteins are 

















4.4.2 Mutagenesis of putative sugar phosphate permeases 
In-frame gene deletion mutations were introduced to uhpT and glpT alleles 
encoding the hexose phosphate and glycerol phosphate permease of S. 
aureus USA300 LAC respectively. These mutants, ΔuhpT and ΔglpT, were 
constructed by allelic replacement of truncated genes via homologous 
recombination using pMAD-Cm shuttle vectors. In addition to single 
mutants, a USA300 LAC strain was created with gene deletions in both 
transporter alleles, termed ΔuhpTΔglpT. 
4.4.3 Genotypic characterisation of transporter mutants 
Allelic replacement of specific sugar phosphate transporters was confirmed 
by PCR of mutant genomic DNA and compared to WT gene amplification 
(Figure 4.3A and B). Native plasmid profiles of all strains were visualised to 
assess the isogenicity of mutants after undergoing the mutagenesis 
protocol. Figure 4.3C highlights that the large 27kbp native plasmid of 
USA300, pUSA03, is only present in the clinical WT strain, with an absent 
band above 10,000 base pairs for all mutant strains. Further investigation 
revealed that pUSA03 was lost at the stage of temperature dependent 
pMAD-Cm excision from the chromosome. Figure 4.3D shows that WT 
strains containing genome integrated constructs displayed a complete 
native plasmid profile, while in the single mutant ΔglpT strain, pUSA03 is 
already absent.  
Native plasmid pUSA03 was recurrently lost in repeated mutagenesis. 
Mutant strains were not isogenic to the clinical wild type USA300 LAC 
background. The cost of replication of pUSA300 may have an impact on the 
fitness of USA300 LAC and therefore it was important to assess strains in 
the same genetic background. Allelic replacement of the glpT gene yielded 
a wild type glpT revertant strain which was cured of the pUSA03 plasmid, 
termed WT(-p03) . Figure 4.3C shows the native plasmid profile of WT(-p03) 
with an absent plasmid DNA band above 10,000 bp relative to the clinical 







4.4.4 Phenotypic characterisation of transporter mutants 
4.4.4.1 agr activity 
 It is paramount that genetic modification of chromosomal DNA does not 
cause unspecific mutations in the agr system and subsequently affect 
virulence regulation of USA300 LAC. This system is responsible for 
controlling haemolytic toxin secretion which causes lysis of erythrocytes. 
The functionality of agr was measured using a haemolytic titre to compare 
toxin secretion among USA300 LAC strains. Figure 4.3E shows the titration 
of bacterial supernatant incubated in a fixed amount of rabbit red blood 
cells. Dark red agglutination of erythrocytes in the centre of the well 
indicates unaffected, whole red blood cells. In all strains, erythrocytes start 
to become visible at a dilution of 1/64, indicating that haemolytic toxins 
are reaching a concentration insufficient to cause full lysis. Toxin 
production, dependent upon agr, causing blood lysis is comparable 
between all mutants and WT USA300 LAC. This figure confirms that agr 
regulatory activity in mutated strains has not been disturbed by mutant 
construction and virulence is unaffected.  
4.4.4.2 General in vitro nutrient growth 
Mutant strains were analysed in multi-nutrient media using in vitro growth 
assays in order to verify that the general metabolic capacity was 
unaffected. Figure 4.4A and B show replication of isogenic strains in BHI 
and LB media respectively. Rapid and high yield growth of all mutant 
strains is virtually identical to WT USA300 LAC up to 18h (p= <<0.05). In 
vitro growth of mutants was also examined in glucose supplemented 
HHWm* media to ensure that metabolism of non-phosphorylated sugar 
remained stable. Figure 4.4C illustrates that mutant strains metabolise 








4.4.4.3 Substrate specific in vitro growth 
S. aureus USA300 LAC mutant strains were monitored in HHWm* 
chemically defined minimal media supplemented with single sugar 
phosphate substrates that promote WT growth. Figure 4.5 charts the 
replication of mutant strains in G-6-P, F-6-P and Gol-1-P, comparing the 
level reached by WT USA300 LAC in the same conditions. The mutant 
ΔuhpT strain does not have the ability to grow in G-6-P or F-6-P beyond 
basal level (p= <0.05). By 16h, there is a 5.5 – 6 fold reduction in growth 
yield compared to WT replication in these hexose phosphate sugars. The 
ΔglpT mutant retains the capacity for growth upon hexose phosphates, 
reaching a similar yield to the WT, with the same efficiency (OD600 0.2 per 
hour). Hexose phosphates therefore are transported exclusively through 
the UhpT transporter in S. aureus USA300 LAC. 
Both ΔuhpT and ΔglpT single mutant strains maintain the ability to grow 
upon Gol-1-P to a level significantly higher than the un-supplemented 
medium at 24h (p= 0.001, p= 0.007). WT USA300 LAC utilised Gol-1-P to 
reach OD600 1.1 by 16h with an efficiency of OD600 0.1 per hour. By contrast 
ΔuhpT replicated to 4.5 times lower yield by the same time with a marked 
reduced efficiency. Single mutant ΔglpT utilised Gol-1-P to half the yield 
and half the efficiency of the WT. Glycerol monophosphate is exploited 
with greater efficiency through the UhpT channel as opposed to the GlpT 
channel, although simultaneous expression is required to have a synergistic 
effect upon growth.  
Deletion of both sugar phosphate transporters, ΔuhpTΔglpT, ensures that 
S. aureus USA300 LAC is totally unable to utilise any sugar phosphate 
substrates and concludes that no other transport systems exist in this 
















4.4.4.4 Fosfomycin specificity 
S. aureus USA300 LAC mutants were initially analysed via in vitro growth 
assays, performed in LB medium supplemented with fosfomycin solution. 
Un-supplemented LB media stimulates rapid, high level replication by 
USA300 LAC strains, providing a platform to study effects of fosfomycin 
inhibition. Figure 4.6 shows the inhibitory effect of fosfomycin upon 
isogenic S. aureus USA300 LAC strains relative to the collective average 
growth in un-supplemented LB media. The WT strain, able to express both 
UhpT and GlpT, is totally inhibited by fosfomycin. Single transporter 
mutants are severely inhibited in growth until 15h where there is evidence 
of replication by resistant bacteria. When both UhpT and GlpT are deleted, 
fosfomycin does not have an effect upon the exponential growth, nor the 
bacterial yield reached. This evidence indicates that S. aureus USA300 LAC 





Fosfomycin susceptibility of S. aureus USA300 LAC strains was quantified 
using an Epsilometer test (E-test). A strip infused with increasing 
concentrations of fosfomycin was placed on an LB nutrient agar plate 
containing a lawn of S. aureus USA300 LAC. Figure 4.7 displays the 
inhibitory action of fosfomycin upon mutant and WT strains. The zone of 
inhibition exhibited by fosfomycin action can be observed until the 
bacterial lawn converges with the strip. This indicates the minimum 
inhibitory concentration (MIC). According to Figure 4.7, the MIC for each 
strain is presented in Table 4.3. 
Table 4.3. Minimum inhibitory fosfomycin concentration for S. aureus 








The E-test confirms that S. aureus USA300 LAC UhpT and GlpT transporters 
can uptake fosfomycin at similar capacity. Removal of a single permease 
does not significantly affect fosfomycin susceptibility, although it increases 
the frequency of resistant colonies growing within the zone of inhibition. 

















Through bioinformatic analysis and mutagenesis research, the status of 
UhpT and GlpT as sugar phosphate transporters was confirmed for S. 
aureus USA300 LAC.  
4.5.1 Specificity determination 
A single deletion mutation in the hexose phosphate transporter gene of 
USA300 LAC, ΔuhpT, eliminated in vitro growth in hexose phosphate sugars 
G-6-P and F-6-P. The exclusive uptake of hexose phosphates by UhpT is 
consistent with mutagenesis studies in other species, such as L. 
monocytogenes, E. coli, S. enterica, S. flexineri and (Chico-calero et al. 
2002; Goetz & Goebel 2010; Runyen-Janecky & Payne 2002). Only one 
study uncovers a novel, redundant and unknown mechanism for uptake of 
glucose-6-phosphate in the absence of UhpT which occurs in a strain of 
enteroinvasive E. coli (Goetz & Goebel 2010). In E. coli, other hexose 
phosphates have been identified as specific substrates for UhpT, such as 2-
deoxyglucose-6-phosphate, fructose-1-phosphate, glucose-1-phosphate 
and mannose-6-phosphate (Dietz 1976). The latter two substrates have 
also been confirmed as growth substrates channelled through the  listerial 
Hpt (Chico-Calero et al. 2002; Ripio et al. 1997).  
Construction of a glycerol-3-phosphate transporter mutant, ΔglpT, did not 
abolish growth of S. aureus USA300 LAC in glycerol monophosphate. Only 
when the double deletion mutation was created, ΔuhpTΔglpT, did 
replication cease upon Gol-1-P. This indicates that the hexose phosphate 
permease does not stringently transport hexose phosphates into the 
bacterial cell. Indeed, a study identified glycerol-3-phosphate and 
glyceraldehyde-3-phosphate as substrates transported through the 
homologous E. coli UhpT channel (Guth et al. 1980). It has been 
demonstrated that the UhpT permease of E. coli has the capacity to 
transport a more structurally diverse range of organophosphates, such as 
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pentose phosphates, heptose phosphates and amino hexose phosphates 
(Dietz 1976). Similarly, substrate analysis of the Salmonella UhpT permease 
showed that D-arabinose-5-phosphate and D-sedoheptulose-6-phosphate 
were transported with similar affinity to glucose-6-phosphate (Eidels et al. 
1974). The selection of 3, 5, 6 and 7 carbon cyclic and linear substrates that 
are imported via the hexose phosphate permease represents a non-
stringent capacity for organophosphate substrates. This may denote a 
proficient and energy conserving strategy of nutrient acquisition by which 
many resources can be encompassed using a single channel. Perhaps this 
may increase the value of the UhpT channel in nutrient scavenging during 
infection. 
Glycerol monophosphate was the only verified organophosphate nutrient 
imported by USA300 LAC GlpT in the in vitro conditions of this study. The 
only known verified substrates specific for the putative GlpT permease are 
glycerol monophosphate, fosfomycin and arsenate (Law et al. 2009; Elvin 
et al. 1985). Several specific side chain residues in the lumen of the GlpT 
channel require interaction with glycerol and inorganic phosphate (Pi) 
moieties of glycerol monophosphate (and residues interacting with the Pi 
moiety of fosfomycin) in order for the permease to operate (Law et al. 
2009). This may account for the stringent specificity relative to UhpT.  
A S. aureus USA300 LAC strain with deletion mutations in both the UhpT 
and GlpT transporter genes was completely unable to grow in sugar 
phosphate substrates as sole carbon sources in vitro. This confirms that no 
redundant mechanisms exist in the USA300 LAC genome which allows 
import of sugar phosphates. The ΔuhpTΔglpT strain was unimpaired in 
capability to grow on other important non-organophosphate nutrients such 
as amino acids and PTS dependent sugar. This strain can be employed to 
directly investigate the role of sugar phosphate acquisition in intracellular 
replication of USA300 LAC.  
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The organophosphate antibiotic fosfomycin was able to penetrate USA300 
LAC, causing inhibition of growth, through UhpT and GlpT permeases to an 
equal capacity. Deletion mutation of both transporters coincided with 
complete resistance to the antibiotic, demonstrating that there is no other 
high capacity import mechanism for fosfomycin.  
4.5.2 Emergence of fosfomycin resistant colonies 
Upon deletion of a single permease gene, the frequency of fosfomycin 
resistant colonies increased. Like the majority of antibiotics in use, 
fosfomycin action is subject to bacterial resistance mechanisms (Popovic et 
al. 2010). S. aureus USA300 strains contain a chromosomally encoded 
fosfomycin resistance protein, FosB (Tenover et al. 2006). FosB is an 
intracellular metallo-enzyme which catalyses the opening of the epoxide 
ring of fosfomycin, thereby changing its structure and eliminating its 
function (Wright 2005). FosB expression is one possible mechanism by 
which resistant USA300 colonies can develop. Alternative strategies of 
fosfomycin resistance have been verified among other bacteria. A single 
amino acid mutation in the active site of the fosfomycin target, UDP-
GlcNAc enolpyruvyl transferase (MurA) conferred resistance in E. coli  
isolates (Kim et al. 1996). A recent study found that the most common 
traits of resistant clinical E. coli isolates were mutations to the UhpT and 
GlpT protein sequences. In some isolates the entire uhpT gene was lost, 
and frequently the GlpT protein was severely truncated (Takahata et al. 
2010). Similarly, the single fosfomycin resistance mechanism found in P. 
aeruginosa  was mutation to the GlpT transporter, the only sugar 
phosphate permease found in this species, which conferred a lack of 
uptake of glycerol-3-phosphate and fosfomycin (Castañeda-García et al. 
2009). The connotations of these studies are that bacterial sugar 
phosphate permeases can be dispensable in order to promote fitness 
under fosfomycin pressure. This raises questions regarding importance of 
sugar phosphate uptake as a mechanism to promote intracellular 
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A narrow range of organophosphate substrates was confirmed to be 
imported by S. aureus USA300 LAC through UhpT and GlpT channels. The 
unexamined expression system of S. aureus UhpT and GlpT, together with 
the complex metabolic background of this species, complicates the direct 
study of sugar phosphate metabolism. L. monocytogenes has a metabolic 
background that relies upon carbohydrates for growth (Eisenreich et al. 
2010). In particular, the uptake of sugar phosphates, via the listerial hexose 
phosphate transporter, has a demonstrable advantage both intracellularly 
(ex vivo) and in vivo (Chico-calero et al. 2002). In the genetic background of 
L. monocytogenes, sugar phosphates are a valuable carbon nutrient source 
and as expression of Hpt is inducible by the endogenous virulence 
regulator PrfA, substrate specificity is not discriminated by extracellular 
sensory induction of expression by organophosphates. L. monocytogenes 
therefore offers a background in which S. aureus UhpT and GlpT can be 
expressed to explicitly analyse substrate specificity and functionality. 
5.2 Objectives 
L. monocytogenes strain P14-A Δhpt was used as a recipient strain for 
complementation of S. aureus permease genes. In this background 
staphylococcal permeases were compared to listerial Hpt in an expanded 
range of transported organophosphates and their capacity for growth on 
these sugar phosphate nutrients. Replication of S. aureus permease 
complemented strains was monitored during cell infection to determine 
whether transporters performed a similar intracellular function to listerial 
Hpt. Complementation analysis was performed in order to consolidate the 
functionality of S. aureus UhpT and GlpT relative to the established 





5.3 Relevant materials and methods 
Molecular techniques (2.3) Gene complementation of L. monocytogenes 
P14-A Δhpt (2.3.7) 
In vitro assays (2.4) Bacterial growth (2.4.1) 
Mammalian cell culture (2.5) L. monocytogenes infection (2.5.3.2) 
Statistical analysis (2.6) Significant difference was calculated between;   
i) Un-supplemented vs supplemented data sets of in vitro growth at the 
final measured point (18h).   

















 5.4.1 Complementation of L. monocytogenes P14-A Δhpt 
L. monocytogenes P14-A is a prfA mutant, conferring constitutive activation 
of PrfA regulator which induces continual expression of hpt. P14-A 
therefore has the ability to grow in vitro upon sugar phosphates as single 
carbon nutrient sources. For this reason P14-A was used in order to 
compare replication of permease complemented strains with a background 
strain expressing WT listerial hpt. Complementation of L. monocytogenes 
P14-A Δhpt was performed using a stable, integrative listerial plasmid, 
pPL2, which incorporated an appropriate constitutive promoter for 
permease gene expression. The construction methods are outlined in 2.3.8.  
5.4.2 Substrate specific in vitro growth of P14-A strains 
In vitro growth assays were performed in LB medium, which produced a 
basal level of replication, to which sugar phosphate carbon sources were 
added individually.  
5.4.2.1 P14-A and P14-A Δhpt 
L. monocytogenes P14-A and Δhpt were analysed to establish the 
parameters for listerial growth in sugar phosphates. Figure 5.1A shows the 
capability of P14-A to grow in a range of C6 and C3 phosphorylated sugars. 
G-6-P and F-6-P were utilised equally efficiently (OD600 0.2 per hour) to 
reach the same level, 5.5 fold higher than the un-supplemented growth 
level (p=<<0.05). G-1-P was utilised to 3 fold higher yield than basal level 
(p=<<0.05). G-1-P was exploited as efficiently as other hexose phosphates 
but growth is arrested at 60% of their stationary level. Glycerol-1-
phosphate was metabolised to reach double the level of LB alone 
(p=<<0.05) while Gol-3-P was utilised to reach double the basal level by 
14h with very poor efficiency. Gol-2-P does not contribute to replication 
above the background level (p=0.85) and therefore was excluded from 
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further analyses. Figure 5.1B illustrates the capacity of hpt deficient L. 
monocytogenes P14-A for replication in the same range of sugar 
phosphates as Figure 5.1A. This strain cannot exploit any sugar phosphate 
substrates from supplemented media, as growth is non-significantly 
different from un-supplemented LB (p= >0.05). The conditions provide 
explicit evidence that listerial Hpt is responsible for exclusive uptake of 
exogenous C6 and C3 phosphorylated sugars. These parameters form a 











































5.4.2.2 pPL2(Psod) complemented strains 
Sugar phosphate permease genes were firstly expressed in L. 
monocytogenes P14-A Δhpt under the control of listerial superoxide 
dismutase promoter (Psod). In addition to S. aureus uhpT and glpT, P14-A 
Δhpt was complemented with the listerial hpt gene to serve as a positive 
control for sugar phosphate uptake.  
Complemented strains were analysed for in vitro growth capacity in core 
sugar phosphates using LB as minimal medium. Figure 5.2A shows 
replication of Δhpt expressing listerial hpt upon individual sugar 
phosphates. This strain is able to use G-6-P and F-6-P to replicate to OD600 
0.9 – 1 by 18h, which is to 80% of the level reached by P14-A. However, the 
efficiency of exponential growth in these substrates was half the rate of 
P14-A (OD600 0.1 per hour). Replication of pPL2(Psod)hpt using G-1-P follows 
a similar projection to other hexose phosphates. Importantly, P14-A 
utilised hexose phosphates to attain stationary phase growth by 6-8h 
(Figure 5.1A). By contrast pPL2(Psod)hpt utilised the same hexose 
phosphates with poor efficiency and by 18h growth was still in exponential 
phase. Figure 5.2A demonstrates the Δhpt strain expressing listerial hpt 
was incapable of replicating upon Gol-1-P or Gol-3-P (p=>0.05) which is in 
contrast to the background parameters established for P14-A (Figure 5.1A).  
Figure 5.2B shows the replication of Δhpt expressing staphylococcal uhpT 
using the same substrate range. The projection of growth using hexose 
phosphate sugars follows a similar pattern to pPL2(Psod)hpt. Notably, 
complementation of Δhpt with staphylococcal UhpT allows exploitation of 
G-1-P for replication. Strain pPL2(Psod)uhpT was unable to use Gol-1-P or 
Gol-3-P to replicate beyond the minimal level (p=>0.05). This trait was 








Taken together, the data concludes that while the complementation of L. 
monocytogenes Δhpt with sugar phosphate permeases was successful, the 
expression of transporters from the Psod promoter was not strong enough 
to provide sugar phosphate uptake equivalent to P14-A. 
5.4.2.3 pPL2(PprfA) complemented strains 
The listerial sod promoter was substituted for the listerial hpt gene PrfA 
binding promoter region (PprfA) in an effort to influence increased 
expression of permeases. Complemented genes were placed under the 
control of constitutively expressed PrfA regulator, which represented the 
closest technique to replicate listerial hpt expression in control strain P14-
A. L. monocytogenes P14-A Δhpt strain was complemented with an empty 
expression vector, designated pPL2(PprfA) to serve as a negative control.  
In vitro replication of complemented strains was monitored in LB 
supplemented with sugar phosphates. Figure 5.3A depicts pPL2(PprfA) 
growth in hexose phosphates and Gol-1-P. Replication did not significantly 
differ from basal level in any substrate (p=>0.05), indicating that this strain 
behaves in the same manner as background strain P14-A Δhpt. Figure 5.3B 
shows growth of Δhpt expressing listerial hpt in the same range of 
substrates. This strain replicates upon G-1-P and F-6-P to exponential 
growth efficiency similar to P14-A (Figure 5.1A). Growth upon G-6-P was 
marginally less efficient than G-1-P and F-6-P. By 18h, the growth yield 
reached in G-6-P and F-6-P was 3 fold greater than basal level (p=<<0.05) 
but 60-70% of the level reached by P14-A in the same substrates. G-1-P 
was utilised by pPL2(PprfA)hpt to the same capacity as P14-A.Gol-1-P was 
utilised to double the basal level and is comparable to P14-A growth.  
Figure 5.3C depicts replication of Δhpt expressing staphylococcal uhpT. G-
6-P and F-6-P were utilised with the same efficiency as P14-A, and reached 
the same stationary phase level of growth. G-1-P was used with equal 
efficiency as F-6-P and uptake through UhpT allowed for higher stationary 
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phase level of growth than P14-A. Gol-1-P was utilised by pPL2(PprfA)uhpT to 
the same capacity of growth as P14-A.  
Figure 5.4D depicts growth of Δhpt expressing staphylococcal glpT. As 
predicted, this strain was unable to derive growth from hexose phosphate 
sugars (G-6-P data not completed) with growth projections not surpassing 
basal level (p=>0.05). Gol-1-P was utilised to reach twice the basal level by 
18h (p=<0.05) and was comparable to the growth projection displayed by 
P14-A.  
Figure 5.3E compares growth of complemented strains upon LB 
supplemented with glycerol-3-phosphate. The basal level of growth upon 
LB was lower than normal in this analysis and so replication upon Gol-3-P 
was presented separately to appreciate the significant difference. Strains 
expressing hexose phosphate permeases used Gol-3-P to reach a level 0.5 
fold greater than negative control strain by 18h (p=<0.05). The Δhpt strain 
expressing staphylococcal glpT was able to replicate upon Gol-3-P to 1.5 
fold greater than basal level at 18h (p=<0.05).  
Under the control of the PprfA promoter, permeases are expressed to 
promote replication of complemented Δhpt strains upon sugar phosphates 
to growth efficiencies and stationary phase levels comparable to the 
positive background strain P14-A.  This expression system could therefore 
be used to directly compare complemented strains expressing permeases 
and P14-A during intracellular infection.  























































5.4.2.4 Fosfomycin susceptibility of pPL2(PprfA) complemented strains 
Strains were analysed by in vitro growth in fosfomycin to confirm the 
uptake of this antibiotic through S. aureus sugar phosphate transporters. 
Figure 5.4A shows the consistent, high capacity replication of background 
strains (P14-A, Δhpt), negative control (pPL2(PprfA)) and permease 
complemented strains in BHI medium. By comparison, Figure 5.4B shows 
replication of the same strains in BHI supplemented with fosfomycin. The 
projection of replication for Δhpt and pPL2(PprfA) remained consistent in 
fosfomycin, conferring resistance, as these strains do not express a sugar 
phosphate permease. P14-A, which expresses listerial Hpt, was completely 
inhibited by fosfomycin until 11h, which proves that Hpt is responsible for 
fosfomycin uptake. Beyond 11h, replication of resistant P14-A becomes 
noticeable. Complemented strains expressing hpt and uhpT were totally 
inhibited by fosfomycin for 6h until replication of resistant bacteria occurs 
to the same capacity. Finally, pPL2(PprfA) glpT was completely inhibited until 
10h, where replication of resistant bacteria occurred to more than 2 fold 
lower level than resistant growth of pPL2(PprfA) hpt and pPL2(PprfA) uhpT. 
These results confirm that fosfomycin enters bacteria through S. aureus 


































5.4.3 Intracellular replication of pPL2(PprfA) complemented strains 
Intracellular proliferation assays were performed using L. monocytogenes 
P14-A strains in order to measure the impact of S. aureus permeases in 
host cell replication relative to the listerial Hpt. Fixed numbers of cells, 
incubated in 5mM glucose, were infected with an equal number of 
bacteria. Listeria strains were allowed to replicate for 8h, at which point 
the intracellular numbers were counted. The intracellular growth 
coefficient (IGC) was calculated which compares the fold change in 
intracellular numbers from time 0h to time 8h. Figure 5.5A and B charts the 
average IGC of complemented strains against background strains in cell 
infections and divulges the significance of values VS P14-A (Figure 5.5C).  
Figure 5.5A compares intracellular replication of L. monocytogenes strains 
in HeLa cells. The IGC of P14-A, expressing hpt, was more than double that 
of P14-A Δhpt which highlights the value of sugar phosphate uptake during 
infection. The negative control strain, pPL2(PprfA) had an IGC that was not 
significantly different from P14-A Δhpt. Complemented strains expressing 
hpt ,uhpT and glpT reached IGCs which were statistically non-significant 
from P14-A. Figure 5.5B displays IGC values for the same strains in Caco-2 
cells, recreating infection of the human intestinal epithelium, the primary 
entry site for L. monocytogenes. This model consolidates results in HeLa, 
with all strains expressing permeases showing a non-significantly different 
IGC value to P14-A.  
The results demonstrate that expression of related sugar phosphate 
transporters restores the ability of P14-A Δhpt to replicate to the Hpt+ P14-































An expression system was developed which allowed constitutive 
expression of homologous sugar phosphate permeases in hpt deficient L. 
monocytogenes. This gene complementation allowed a more extensive 
characterisation of organophosphates that pass through S. aureus UhpT 
and GlpT as well as comparing the functionality of staphylococcal 
permeases to listerial Hpt in a bacterial system where sugar phosphate 
uptake is valuable.  
5.5.1 Further substrate specificity determination 
The substrate specificity of S. aureus UhpT and GlpT channels is 
summarised in Figure 5.6. 
 
Figure 5.6. Organophosphates that traverse the UhpT and GlpT channels 
of S. aureus. 
 
The glycerol phosphate transporter has a more explicit function in 
transporting C3 phosphorylated sugars to the bacterial cell. In vitro growth 
analysis using Gol-1-P and Gol-3-P suggested that UhpT can uptake the 
same C3 phosphorylated sugars with very similar capacity to GlpT. In vitro 
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growth using fosfomycin confirmed that both channels facilitated uptake of 
the antibiotic to cause inhibition of L. monocytogenes. This demonstrates 
an overlap in the function of these homologous transporters.  It was noted 
that Δhpt complemented with staphylococcal uhpT produced a resistant 
growth phenotype in broth supplemented with fosfomycin. By contrast, 
Δhpt expressing glpT displayed an unremarkable resistance growth 
phenotype. This may suggest a higher capacity of fosfomycin transport 
through the staphylococcal GlpT permease which increases the antibiotic 
pressure and reduces the frequency of resistance. In Chapter 4, the MIC of 
fosfomycin was greater for ΔglpT as compared to ΔuhpT, which may 
substantiate this theory. The GlpT channel contains specific side chain 
residues which are important in interacting with the fosfomycin structure 
(Law et al. 2009). This may contribute to an increased affinity for this 
substrate. 
 By constitutively expressing staphylococcal permeases in L. 
monocytogenes, it was revealed that G-1-P is transported via UhpT and 
Gol-3-P is facilitated via UhpT and GlpT. These substrates did not stimulate 
in vitro growth in S. aureus USA300 LAC which raises questions about the 
expression of transporters in the S. aureus background. S. aureus strains 
encode a putative phosphoglucomutase enzyme, responsible for 
interconversion of glucose-1-phosphate and glucose-6-phosphate. This 
enzymatic reaction is required to supply glucose-1-phosphate for the 
biosynthesis of glycolipids to form the Gram positive lipoteichoic acid cell 
wall structure (Gründling & Schneewind 2007; Richter et al. 2013). In 
addition, glucose-1-phosphate can be catalysed to glucose-6-phosphate, 
which can enter bacterial energy producing pathways present in S. aureus. 
It would seem unlikely that the lack of S. aureus USA300 LAC growth in 
glucose-1-phosphate is due to an inability to metabolise the substrate. 
Glycerol-3-phosphate is formed naturally by phosphorylation of incoming 
glycerol in the USA300 cell. There is no other metabolic enzyme encoded in 
S. aureus which diverts this immediate step. Glycerol must therefore be 
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immediately converted to glycerol-3-phosphate before this is metabolised 
for energy. The high capacity growth derived from extracellular glycerol, 
seen in Chapter 3, must directly be passed to the glycerol-3-phosphate 
pathway, before energy can be metabolised. Expression of glpT would, in 
theory, allow uptake of the immediate glycerol metabolite (glycerol-3-
phosphate) and allow growth of S. aureus USA300 LAC. As this is not the 
case, perhaps this introduces the issue of substrate specific induced 
transporter expression. 
5.5.2 Functionality of homologous sugar phosphate permeases 
In the established metabolic context of L. monocytogenes, staphylococcal 
permeases had an explicit gap to fill as metabolic virulence factors that 
directly benefit replication. In vitro analysis of growth upon selected sugar 
phosphates revealed that S. aureus UhpT and L. monocytogenes Hpt 
operate at a similar capacity for the same substrates. Uptake of Gol-1-P 
and Gol-3-P, which allowed replication, was remarkably similar between 
Δhpt strains complemented with hexose phosphate permeases. Replication 
of Δhpt expressing uhpT, due to uptake of G-6-P and F-6-P, reached higher 
levels of stationary growth than Δhpt expressing hpt, suggesting that 
staphylococcal UhpT has an even greater capacity for hexose phosphates. 
Both of these strains displayed similar growth projections in the presence 
of fosfomycin, which suggests an equal capacity for antibiotic transport.  
Intracellular replication analysis demonstrated that Δhpt strains 
complemented with S. aureus UhpT and GlpT restored replication to levels 
consistent with P14-A. In addition, the intracellular growth advantage 
gained by expression of staphylococcal permeases was statistically 
indistinguishable to a strain expressing listerial Hpt. All homologous 
proteins serve to acquire intracellular nutrients which increase growth of L. 
monocytogenes and provide the same function during cell infection. 
Staphylococcal permeases therefore have provable intracellular functions 
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which act to restore virulence to L. monocytogenes Δhpt by facilitating the 
import of nutrients for replication.  
Expression of glpT in P14-A Δhpt exposed a significant value for glycerol 
phosphates as exclusive intracellular growth sources. Glycerol metabolism 
is commonly implicated in bacterial nutrition during invasive cell infection. 
L. monocytogenes in particular is a pathogen in which glycerol metabolism 
has been strongly linked to virulence. Transcription profiling of L. 
monocytogenes in macrophage and epithelial infection has revealed up 
regulation of the glycerol uptake and metabolism genes (Chatterjee et al. 
2006; Joseph et al. 2006). Glycerol-3-phosphate dehydrogenase, 
responsible for converting glycerol-1/3-phosphate to glycerine phosphate, 
is strongly up regulated in these studies. Perhaps, glycerol 
monophosphate, acquired through the Hpt permease, may provide an 
important contribution to L. monocytogenes metabolism during infection. 
Indeed, deletion of glycerol metabolism enzymes contributes to 




















 The role of sugar phosphate 
transporters in S. aureus 






Research investigating the impact of listerial Hpt deficiency upon 
intracellular replication has established that sugar phosphates are 
accessible in the intracellular compartment by invasive bacteria (Chico-
calero et al. 2002). Substrate specificity of putative UhpT and GlpT 
transporters of S. aureus has been confirmed and compared to the listerial 
Hpt homolog. It was demonstrated that staphylococcal permeases 
scavenge sugar phosphates from the intracellular compartment allowing L. 
monocytogenes to replicate effectively. This provides evidence for the 
functional role of UhpT and GlpT towards intracellular bacterial nutrition. 
The impact of this function was investigated in the metabolic background 
of S. aureus USA300 LAC. 
Induction of sugar phosphate permeases has been previously reported 
during S. aureus epithelial cell infection. A clinical isolate, S. aureus 6850, 
was monitored during infection of human lung adrenocarcinoma cells 
(A549) (Garzoni et al. 2007). Expression of uhpT was up-regulated over 4 
fold greater by 2h intracellularly, compared to extracellular media, and this 
increase was maintained up to 6h infection. Expression of glpT was also up-
regulated and maintained intracellularly to a similar magnitude as uhpT. 
Infection of human blood with S. aureus USA300 revealed the expression of 
uhpT was 45 fold higher relative to in vitro tryptic soy broth culture 
(Malachowa et al. 2011). Significant up-regulation of UhpT and GlpT 
permeases during S. aureus human cell infection implicates these 
carbohydrate uptake systems as factors that enhance replication. As 
investigated in this study, hexose phosphates and glycerol phosphates 
influence significantly higher in vitro replication than any other single 
nutrient source.  S. aureus USA300 LAC UhpT and GlpT therefore exist as 
potential determinants of virulence which act to drive staphylococcal 





A mutant strain of USA300 LAC was created, ΔuhpTΔglpT, which is totally 
unable to use sugar phosphates as exogenous carbon growth sources. This 
strain was analysed against WT USA300 LAC in the ability to replicate inside 
mammalian cells to uncover a direct role for sugar phosphate acquisition in 
infection.  
To perform a reproducible and accurate analysis, a model of mammalian 
cell infection by S. aureus USA300 LAC was standardised and characterised 
in HeLa cells. This model was applied to epithelial cell lines relevant to 
studying the impact of replication due to UhpT and GlpT. Human lung 
adrenocarcinoma cells (A549) were selected due to the clinical relevance of 
USA300 associated pneumonia (Hidron et al. 2009) and the evidence 
showing significant uhpT and glpT expression during S. aureus A549 
infection (Garzoni et al. 2007). Rat hepatocytes (FTO2B) were selected due 
to their specialised metabolic functions.  Hepatocytes are specialised for 
glucose homeostasis and are able to rapidly uptake large amounts of 
surplus exogenous glucose (Sherwin 1980). Glucose must be converted to 
glucose-6-phosphate in order for glycogenesis to occur in hepatocytes 
(Cadefau et al. 1997). In the absence of glucose, glucose-6-phosphate can 
be equally replenished by gluconeogenesis of non-carbohydrate sources in 
FTO2B cells (Gomis et al. 2003) Furthermore, hepatocytes are specialised 
for lipid and cholesterol biosynthesis (Yang et al. 2001) which may offer 
alternative sources of bacterial nutrition. In this environment, the 
importance of sugar phosphates, among a diverse range of growth 
intermediates, was examined in S. aureus USA300 LAC replication. 
The intracellular fate of S. aureus USA300 LAC was characterised in order to 
investigate the accessibility to the cell cytosol, which contains sugar 
phosphates. The intracellular fate of L. monocytogenes determines the 
impact of the Hpt permease. Upon invasion of host cells, L. monocytogenes 
rapidly escapes the bacterial endosome to the cytosol (Dussurget et al. 
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2004) where sugar phosphates can be scavenged freely. The intracellular 
localisation after S. aureus invasion of epithelial cells is  variable among 
strains and cell types (Fraunholz & Sinha 2012). Studies have reported that 
USA300 localises to specific autophagosome vacuoles during infection of 
HeLa cells and osteocytes (Mauthe et al. 2012; Schnaith et al. 2007). This 
would introduce a barrier between S. aureus USA300 LAC and cytosolic 
sugar phosphates, meaning these substrates may not be readily accessible, 
in contrast to L. monocytogenes. It was therefore important to confirm the 
cellular localisation of S. aureus USA300 LAC throughout the course of 
epithelial cell infection.  
In order to visualise the localisation of S. aureus LAC, Rab7 GTPase was 
selected as a vacuole marker. Rab GTPases are initially soluble proteins 
that localise to the cytosolic face of intracellular membranes (Seto et al. 
2011). They are integral to the regulation of vesicle formation, motility and 
fusion (Stenmark & Olkkonen 2001). In particular, Rab7 is involved in the 
maturation of late endosomes, and typically localises with these 
membranes (Santillo 1997). Rab7 is routinely recruited to S. aureus 
containing endophagosomes in epithelial cells (Schnaith et al. 2007) and 
macrophages (Seto et al. 2011). In addition, Rab7 is found to associate with 
the autophagosome membrane and plays an important role in normal 
progression of mammalian cell autophagy (Gutierrez et al. 2004).  
6.3 Relevant materials and methods 
In vitro assays (2.4) Mammalian cell cytotoxicity (2.4.2) 
Mammalian cell culture (2.5) S. aureus infection (2.5.3.1); L. 
monocytogenes infection (2.5.3.2); Immunofluorescence microscopy (2.5.4) 






6.4.1 Standardisation and characterisation of S. aureus USA300 LAC 
intracellular infection 
In order to examine the role of S. aureus USA300 LAC sugar phosphate 
permeases, a reliable mammalian cell infection model needed to be 
established. Intracellular proliferation assays are used to monitor the 
replication of bacteria specifically inside the intracellular compartment. 
Using this technique, bacterial strains with mutants in metabolic genes can 
be compared to the wild type in the capacity for replication, uncovering 
determinants of virulence. 
Mammalian cells were added to 24 well plates and allowed to attach and 
grow until the well monolayer reached confluence. The number of cells per 
well was calibrated which would form the platform for repeatable bacterial 
infection. S. aureus USA300 LAC was exposed to the monolayer in numbers 
relative to the number of mammalian cells per well, known as the 
multiplicity of infection (MOI). After a period of incubation which allows 
bacteria to invade cells, any extracellular bacteria are killed by appropriate 
antibiotics. From this point, intracellular numbers of bacteria can be 
determined at recurrent time points by lysis of mammalian cells and 
nutrient agar plating of lysate. Parameters needed to be standardised for 
reproducible S. aureus USA300 LAC infection. 
6.4.1.1 Bacterial invasion 
Bacterial invasion of mammalian cells needed to be consistent in order to 
comparably measure replication. Invasion was compared between 
bacterial inocula that was either prepared in advance and stored at -80oC, 
or cultured on the day of infection and prepared freshly. Inoculums were 
applied to confluent cell monolayers and allowed to invade for various 
times after addition. After a period of extracellular bacterial inhibition, the 
intracellular bacteria were plated to determine the percentage of total 
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bacteria added that have invaded the monolayer (the % invasion). It was 
found that frozen inocula produced huge inconsistency in invasion 
numbers which were irreproducible (data not shown). Inocula prepared 
from S. aureus USA300 LAC freshly cultured to early exponential phase of 
growth demonstrated much greater stability of percentage invasion.  
Next, the invasion time was assessed, meaning the time that the cell 
monolayer would be exposed to the inocula before addition of antibiotic to 
kill the extracellular bacteria. Figure 6.1A shows the number of colony 
forming units per ml (CFU/ml) isolated from HeLa cells infected with S. 
aureus USA300 LAC after increasing invasion times. Invasion times ranging 
from 15 – 45 minutes was analysed before addition of antibiotic media. 
Inocula applied for 45 minutes lead to a 4 fold increase in bacterial 
numbers compared to 35 minutes. Incubation for periods less than 35 
minutes exhibited low invasion rates of less than 0.5%. As a result, bacterial 
inoculum was applied for 35 minutes, as this allowed suitable numbers of 
S. aureus USA300 LAC to invade. In addition the number was low enough to 
study the increase in replication more effectively. The corresponding 
invasion percentages for these assays are shown in Figure 6.1B.  
The next variable investigated was the minimum time required to kill 
extracellular bacteria. This needed to be adjusted to minimise replication 
of intracellular bacteria in the time frame before CFU/ml is measured at 
time 0h. Antibiotic media was applied for 30 minutes and 60 minutes and 
plated to determine the numbers of viable extracellular S. aureus USA300 
LAC. This revealed no difference in the CFU/ml, which were both negligible. 
Antibiotic media was therefore added for 30 minutes.  
The average percentage invasion of S. aureus USA300 LAC in HeLa cells 
could be investigated using these established parameters. Figure 6.2 
compares the average percentage invasion of HeLa cells by WT USA300 
LAC at MOI 10 and MOI 1. At MOI 10, tenfold more bacteria are exposed to 
the cell monolayer than MOI 1 which leads to 2 fold reduction in the 
[116] 
 
percentage invasion. Therefore the percentage of invasion is lower relative 
to the higher total inocula CFU/ml. These results show that S. aureus 
USA300 LAC has marked ability to invade human epithelial cells, which 

















6.4.1.2 Bacterial induced cytotoxicity 
During infection assays, it is critical that the integrity of the cell monolayer 
remains undisturbed, allowing for more accurate discrimination of 
intracellular replicating bacteria. The integrity of mammalian cells was 
monitored during infection of S. aureus USA300 LAC strains at MOI 10 and 
MOI 1 in the invasion conditions established. Figure 6.3 shows cell 
cytotoxicity assays to determine the percentage destruction of the cell 
monolayer in 24 well plates during infection. Cell media was collected from 
each well at successive time points. Any cells that were present in this 
media, due to detachment from the monolayer, can be lysed which 
releases lactate dehydrogenase enzyme (LDH). The activity of this enzyme 
can be quantitatively measured using the Sigma Tox7 kit. This is a direct 
measure of cell cytotoxicity caused by bacterial infection.  
 Figure 6.3A shows the standard curve of LDH activity according to the 
number of HeLa cells involved in the assay. HeLa cells were counted and 
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doubling dilutions were made, allowing different proportions of HeLa cells 
to be lysed and measure the LDH activity. The assay has been transposed 
onto a colour chart for easy distinction of the severity of detachment 
expressed as percentage cell cytotoxicity. Figure 6.3B shows the depiction 
of mammalian cell monolayer integrity during infection using this colour 
co-ordination. At MOI 10, the wild type USA300 LAC strain causes severe 
cytotoxicity of HeLa cells by 6 hours. Around 50% of the cell monolayer is 
destroyed at this time of infection. By contrast infections at MOI 1 do not 
cause any cell cytotoxicity. This evidence can be substantiated by viewing 
phase contrast microscopy slides of the monolayer during infection at MOI 
10 and MOI 1 (Figure 6.4). The evidence indicates that HeLa cell infection at 
MOI 10 can only be reliably measured until 4 hours. After this time, 
infection of S. aureus USA300 LAC becomes cytotoxic and the integrity of 
the monolayer decreases, meaning intracellular replication cannot be 
directly measured.  
An agr deficient USA300 LAC strain, Δagr, was introduced as a comparative 
avirulent control for establishing the factors involved in intracellular 
replication.  Infection of HeLa cells with Δagr at MOI 10 revealed a lack of 
cytotoxicity by 6h, which is in contrast to the virulent WT (Figure 6.3B). The 
cytotoxicity of WT USA300 LAC and Δagr was monitored inside A549 cells. 
At MOI 10, the integrity of the monolayer was undisturbed by infection, up 
to 8 hours post invasion, therefore intracellular replication could be reliably 















6.4.1.3 Intracellular replication 
Intracellular infection assays were completed in HeLa cells cultured at 
physiological blood glucose concentration (5mM) using the parameters 
established. Wild type USA300 LAC was infected at an MOI of 10 and 1 to 
compare the replicative ability. 
For each time point post bacterial invasion, intracellular numbers of S. 
aureus USA300 LAC WT were counted and an overall average CFU/ml was 
established. The averaged results for infections performed at MOI 10 and 
MOI 1 are presented in Figure 6.5A and 6.5B respectively. At time 0h, 
approximately 5.5 fold more bacteria invade the HeLa monolayer when 
exposed at MOI 10 compared to MOI 1.Figure 6.5A shows the significant 
increase in bacterial numbers between 2h and 4h of infection. By 4 hours, 
bacterial numbers proliferated to almost 10 fold higher than the average 
CFU/ml isolated at 2 hours and 36 times greater than CFU/ml at 0h. This 
major boost in proliferation yields intracellular numbers that are on the 
threshold of HeLa monolayer destruction. By contrast Figure 6.5B shows 
that S. aureus USA300 LAC infected at an MOI of 1 experience around an 8 
fold increase in numbers by 3 hours post invasion. Replication appears to 
be arrested for the remainder of the infection course. The replicative 
ability of S. aureus USA300 LAC is dependent upon the number of bacteria 













6.4.1.4 Infection characterisation by immunofluorescence microscopy 
Intracellular replication of S. aureus USA300 LAC within the HeLa 
monolayer was further characterised by immunofluorescence microscopy. 
Cells monolayers, infected at MOI 10 and 1, were visualised to quantify the 
percentage infection of the monolayer, and observe differences that 
underpin the gulf in replication dynamics seen in Figure 6.5.  
Intracellular S. aureus USA300 LAC was stained at infection time points 
with anti-Staphylococcus aureus Rabbit IgG antibody. Cell nuclei were 
stained using DAPI and phalloidin conjugated to Alexa fluor 488 was used 
to visualise cellular F-actin.  
Figure 6.6 displays representative immunofluorescence images throughout 
the infection time course at MOI 10. Upon infection it is noticeable that 
there are several freestanding bacterial clusters inside each cell at time 0h. 
As infection advances, USA300 clusters converge at a perinuclear location. 
By 4 hours post invasion, staphylococci are amassed in a perinuclear 
replication complex in the majority of infected cells. Figure 6.7A quantifies 
the percentage of infected cells at MOI 10 while Figure 6.7B quantifies the 
number of freestanding bacterial clusters inside each infected cell at MOI 
10. Over 80%± 5.95% of cells in the assay monolayer were infected with at 
least one S. aureus USA300 LAC bacterium. Figure 6.7A shows throughout 
the course of infection, the number of infected cells at 4h does not 
significantly differ from numbers at 0h (p= 0.84).  At time 0h, the average 
number of bacterial clusters stood at 3.74 ± 0.5 clusters per cell (Figure 
6.7B). By 4 hours post invasion, this number significantly dropped to 2.79 ± 
0.17 clusters (p= 0.02), which is consistent with the visual merging of 














HeLa cell monolayers infected with S. aureus USA300 LAC at MOI 1 were 
also quantified. Figure 6.8 shows immunofluorescence images of an 
infection time course spanning 24h at MOI 1. At time 0h, the number of 
intracellular clusters is sparse compared to MOI 10. However, by 5 and 8 
hours post infection, substantial perinuclear bacterial expansions are 
present. This provides evidence that single staphylococci are able to 
replicate to greater loads inside single mammalian epithelial cells. Figure 
6.9A shows the percentage of infected cells at corresponding time points. 
The average percentage of infected HeLa cells at MOI 1 is much lower, at 
27.9% ± 4.27%. This percentage does not significantly differ up to 8 hours 
(Figure 6.9A) (p =0.88). At 24 hours, the cell monolayer is confluent, and 
only 5.58% ± 1.45% of cells remain infected by S. aureus USA300 LAC 
(substantiated by Figure 6.8). Figure 6.9B quantifies the number of 
bacterial clusters per infected cell. On average, at time 0h each infected 
cell is inhabited by 1 bacterial cluster. By 5 and 8 hours, this figure had 
doubled, corresponding with the more expansive proliferation seen in 
Figure 6.8. By 24 hours, this figure drops to 1 bacterial body per infected 
cell again.  
In addition, the infection of A549 cells by S. aureus USA300 LAC at MOI 10 
was also quantified. At 0h, 64% ± 5% of the cell monolayer was infected. By 
6h post invasion, 66% ± 2.5% of cells contained S. aureus, which is 
statistically non-significant to time 0h (p = 0.74). Taken together, the 
epithelial cell infection results suggest that USA300 does not spread from 
cell to cell, in contrast to L. monocytogenes infection.  
This confirmed important differences between infection at MOI 10 and 1 
which accounts for variation in replication. At MOI 10 exposure, 2.8 times 
more cells become invaded by over 3 times more bacterial clusters than at 
MOI 1 exposure. The co-ordinated replication of several bacterial clusters 













6.4.2 Intracellular replication of S. aureus USA300 LAC deficient in 
sugar phosphate uptake 
Double mutant strain, ΔuhpTΔglpT was analysed relative to WT USA300 
LAC to determine whether uptake of sugar phosphates contributed to 
intracellular replication. Relevant mammalian cell lines were cultured in 
specific conditions and infected to monitor intracellular proliferation.  
6.4.2.1 HeLa cell infection 
The metabolism of HeLa cells was manipulated by exposing the cell 
monolayer to distinct glucose concentrations in the culture medium, 
25mM, 5mM and 0mM. As a positive control, L. monocytogenes P14-A and 
P14-A Δhpt were used to infect HeLa cells exposed to these glucose 
concentrations, which elegantly demonstrates conditions in which Hpt 
becomes an advantage to replication. 
Figure 6.10A plots the average CFU/ml of Listeria strains proliferating inside 
HeLa cells grown in 25mM glucose. P14-A and P14-A Δhpt had the same 
capacity for replication in these conditions substantiated by a similar mean 
generation time, the average time taken for the population to double 
(Figure 6.10D). Figure 6.10B compares replication when the exogenous 
glucose concentration is reduced to 5mM, the physiological blood glucose 
concentration. By 10h post invasion, P14-A Δhpt reached a CFU/ml 2.76 
fold lower than P14-A with a significantly increased mean generation time 
(Figure 6.10D). In epithelial cells cultured in 5mM glucose, sugar 
phosphates become a significant nutrient source which impacts replication. 
When HeLa cells were cultured in the absence of glucose, replication of L. 
monocytogenes was highly impaired (Figure 6.10C). In these cell conditions, 
expression of hpt is not advantageous to growth and the mean generation 
time of P14-A increased by 2.8 fold compared to growth in glucose exposed 
cells. These distinctive infection profiles are indicative of the nutrient 
requirements of L. monocytogenes. These results provide a comparative 






HeLa monolayers were infected by S. aureus USA300 LAC strains at an MOI 
of 1 and CFU/ml was determined up to 5h post invasion. The replication of 
agr deficient strain, Δagr, was monitored alongside WT and ΔuhpTΔglpT as 
an avirulent control for infection.  
Figure 6.11A shows replication of WT and ΔuhpTΔglpT in cells exposed to 
25mM glucose. By 5h, WT and ΔuhpTΔglpT replicated to 164 fold and 187 
fold greater CFU/ml than 0h respectively, and the final CFU/ml were 
statistically non-significant (p=0.73). The mean generation times of both 
strains were similar; around 40 minutes per generation (Figure 6.11D). 
Figure 6.11B compares the replication of WT and ΔuhpTΔglpT in HeLa 
(5mM glucose). There was no significant difference between the CFU/ml 
reached at 5h (p=0.75) and similar rates of doubling were observed over 
these infection times (Figure 6.11D). In these conditions, the WT and 
ΔuhpTΔglpT strains reached a bacterial yield of approximately half the 
CFU/ml to replication in HeLa (25mM glucose). Finally, in HeLa (0mM 
glucose) there was no significant difference in CFU/ml between WT and 
ΔuhpTΔglpT at 5h (p=0.60). Interestingly, the mean generation times of 
both strains in 0mM conditions was comparable to 25mM conditions, 
showing that glucose starvation does not affect replication proficiency 
(Figure 6.11D). In 0mM conditions, WT and ΔuhpTΔglpT numbers increased 
130 and 200 fold respectively over 5h in comparison to 60 and 70 fold in 
5mM conditions. In contrast to L. monocytogenes, this shows S. aureus 
USA300 LAC actually benefits from glucose starvation in HeLa cells. 
Compared with the WT, replication of avirulent Δagr was heavily impaired 
in HeLa cultured in 5mM and 0mM glucose conditions (Figure 6.11B – C). 
Despite invading to a similar CFU/ml, Δagr reached 16 and 14 fold lower 
CFU/ml than WT by 5h infection in 5mM and 0mM conditions respectively. 
The mean doubling time of Δagr was significantly longer than WT, with 2.4 







6.4.2.2 A549 cell infection 
Figure 6.12 illustrates replication of S. aureus USA300 LAC strains in human 
alveolar adenocarcinoma cells. Cell infections in 25mM glucose medium 
were not performed as these conditions displace sugar phosphates as a 
potential growth source. Figure 6.12A compares replication of WT and 
ΔuhpTΔglpT in 5mM glucose conditions. The mutant strain was able to 
reach 31 fold higher CFU/ml by 5h, by comparison to WT which reached 17 
fold higher. The average doubling times of these strains did not 
significantly differ in these cell conditions (Figure 6.12C). Figure 6.12B 
displays replication of the same strains in 0mM cell conditions. WT USA300 
LAC was able to replicate over 5h to reach a 57 fold greater CFU/ml, while 
ΔuhpTΔglpT proliferated to 40 fold higher CFU/ml in the same time. The 
mean generation times between these strains were not significantly 
different, and were not increased compared to rates in 5mM glucose cell 
conditions (Figure 6.12C).  
Figure 6.12A and B display the impaired growth of Δagr in cells cultured in 
5mM and 0mM glucose conditions. This strain replicated with a 3.3 fold 
and 7.7 fold increase in numbers over 5h in 5mM and 0mM glucose 
conditions respectively, which represented a significantly reduced rate of 








6.4.2.3 FTO2B cell infection 
S. aureus USA300 LAC strains were monitored inside rat hepatocytes. 
Replication of WT in 5mM and 0mM conditions was mirrored by 
ΔuhpTΔglpT (Figure 6.13A and B). Figure 6.13A depicts in 5mM conditions, 
both strains replicated over 5h to reach a CFU/ml 24 times greater than 
time 0h, with virtually identical average doubling times (Figure 6.13C). 
Figure 6.13B shows that ΔuhpTΔglpT replicated over 5h to 30 fold greater 
CFU/ml in 0mM conditions, compared to WT which proliferated to 24 times 
greater CFU/ml. The final CFU/ml for WT and ΔuhpTΔglpT did not 
significantly differ in either cell conditions (p = >0.05). The average 
doubling times did not significantly differ between WT and ΔuhpTΔglpT 
among cell conditions (Figure 6.13C).  
The replication of Δagr yielded a 2.6 fold and 6.3 fold reduction in final 
CFU/ml compared to WT in 5mM and 0mM glucose conditions respectively 
(Figure 6.13A and B). Impaired intracellular growth in 5mM and 0mM 
conditions was verified by doubling times of 1.5 and 2.6 fold longer than 
WT (Figure 6.13C).  
6.4.2.4 Summary of infection  
When mammalian cells were cultured in 5mM glucose, this provided 
conditions in which sugar phosphates become a valuable nutrient source 
for bacterial growth. The ability of ΔuhpTΔglpT to replicate in these cell 
conditions was completely unimpaired relative to WT USA300 LAC. Both 
the magnitude of bacterial growth yield and the average doubling times did 
not significantly differ between WT and ΔuhpTΔglpT in three epithelial cell 
lines. When WT and ΔuhpTΔglpT USA300 LAC strains were infected into 
glucose starved cells, the magnitude of replication was routinely greater 
than in cells cultured in 5mM glucose. Finally, the ability of avirulent Δagr 
to replicate was severely impaired in all cell types and conditions compared 








6.4.3 S. aureus USA300 LAC replication correlates with vacuole 
inclusion 
The intracellular localisation of S. aureus USA300 LAC was investigated to 
ascertain the compartment occupied during infection. As sugar phosphate 
permease deficiency does not affect replication, it was important to 
determine the accessibility to sugar phosphates as nutrient sources. The 
cellular GTPase Rab7 was selected as a vacuole marker to probe the 
localisation of WT S. aureus USA300 LAC within HeLa and A549 epithelial 
cell infection. 
Figure 6.14 and 6.15  shows immunofluorescence microscopy imaging of 
Rab7 and  S. aureus USA300 LAC  during infection of HeLa cells and A549 
cells, respectively at an MOI of 10. According to this infection assay, 
bacterial invasion events occur within the hour after first exposing inocula 
to cells. At this point, time 0 hours, the majority of bacterial clusters were 
clearly co-localised with Rab7 proteins. The merged image shows areas of 
distinct co-localisation are pink, produced by blue/red mixing. Greyscale 
single channels allow for distinct, explicit contrast, and show the most 
concentrated areas of S. aureus and Rab7. The aggregation of Rab7 at 
staphylococcal clusters, confirms co-localisation.  Throughout infection this 
association is prominent in both cell types. At later time points, large 
expanses of aggregated bacteria can be seen with defined, sharp red Rab7 
boundaries enclosing blue staphylococcal bodies (Figure 6.14, 6h  and  









































The number of intracellular USA300 clusters positively co-localised with 
Rab7 was quantified in infected cells an expressed as a percentage. Figure 
6.16A and 6.16B show that over 70%  co-localisation was observed at 0h in 
both HeLa and A549 cells. By 2-3 hours into the infection, Rab7 association 
is maximal, peaking above 80%. This association remained consistent to 4 
hours in HeLa cell infection (the final measureable time point before cell 
monolayer destruction) and to 6 hours in A549 cell infection. 
When HeLa cells were infected at an MOI of 10,  bacterial numbers were 
found to increase sharply between 2 and 4h (Figure 6.5A). Figure 6.16A 
confirms that proliferation in HeLa is principally intravacuolar. In order to 
confirm the same connection in A549 cells, intracellular replication assays 
were performed, infecting USA300 at MOI 10. Figure 6.17 shows the 
average CFU/ml of WT USA300 LAC inside A549 cells up to 6 hours post 
bacterial invasion. This confirmed that at MOI 10, the highest increase in 
proliferation occured between 4 and 6 hours, as the bacterial load 
escalates 5 fold. By 6 hours, almost 70% of USA300 clusters were co-
localised with Rab7 (Figure 6.16B). 
Crucially, the timing of greatest bacterial generation is consistent with 
vacuole inclusion. Immunofluorescence microscopy has verified that 
throughout the entire period of monitored intracellular bacterial 
replication, S. aureus USA300 LAC is principally residing within Rab7 













A robust intracellular model of S. aureus USA300 LAC epithelial cell 
infection was standardised which quantified replication. This research 
disclosed features of CA-MRSA invasive infection. The magnitude of 
intracellular replication varies depending upon the number of bacteria 
initially exposed to the monolayer. A significantly higher percentage of cells 
were subject to invasion by over 3 fold more bacteria per cell at an MOI of 
10 compared to an MOI of 1. In addition, this loading of cells with S. aureus 
contributed to a prolific increase in numbers which caused cytotoxicity, 
affecting half of the HeLa cell monolayer. By contrast, monolayers infected 
with S. aureus at an MOI of 1 were found to harbour on average 1 bacterial 
cluster per cell which replicated without damaging the integrity of the 
epithelial monolayer. The levels of infected cells remained stable 
throughout all USA300 LAC infection, suggesting that cell-to-cell spread is 
not a feature of pathogenesis. The bacterial load invading cells therefore 
commands pathogenesis. It is plausible that this feature can be attributed 
to the agr quorum sensing system, which may be synergistically up-
regulated in multiple S. aureus sharing the same infected cells (Novick & 
Geisinger 2008). As this system is responsible for up-regulation of various 
cytotoxic proteins that destroy tissue for dissemination (Gordon & Lowy 
2008), this explains why Δagr was non-cytotoxic to the epithelial 
monolayer compared to the destructive WT strain. Regulation by agr was 
also discovered to be essential towards effective intracellular replication. 
This finding is in agreement with a previous study that demonstrated S. 
aureus RN6390 replicates during bovine mammary cell infection, whereas 
an agr mutant derivative cannot (Wesson et al. 1998). In addition, a recent 
study also identifies three independent agr deficient strains of S. aureus 
that lack the capability to replicate efficiently inside HeLa cells (Schnaith et 
al. 2007). The replication deficiency of S. aureus USA300 LAC Δagr was 
further explored in Chapter 7. 
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6.5.1 Contextual role of sugar phosphate transporters 
Epithelial cell infection assays were performed to monitor replication of S. 
aureus USA300 LAC strains in cellular conditions which promote L. 
monocytogenes growth specifically due to expression of sugar phosphate 
permeases. S. aureus USA300 LAC unable to express functional sugar 
phosphate permeases, ΔuhpTΔglpT, was totally unaffected in growth 
capability compared to WT. In this model of infection, sugar phosphates 
are non-essential substrates towards intracellular replication of USA300, 
despite demonstrating they promote extensive in vitro replication. In the S. 
aureus background, sugar phosphate transporters UhpT and GlpT are 
dispensable to invasive pathogenesis. It was previously demonstrated in 
this study that complementation of L. monocytogenes P14-A Δhpt with 
homologous staphylococcal permeases restored intracellular replication to 
background level P14-A expressing listerial hpt. In the genetic background 
of L. monocytogenes, sugar phosphate uptake is an important function 
involved in invasive pathogenesis. By contrast S. aureus is able to employ 
other nutrient uptake mechanisms which promote WT level replication in 
the absence of sugar phosphate uptake. This distinction represents a 
contextual role for sugar phosphate permeases in which their significance 
is dependent upon the metabolic demands of the bacteria able to express 
them. 
Research in this thesis has contributed an additional bacterial species 
which possesses sugar phosphate permeases that have no palpable role in 
bacterial intracellular replication. Enteroinvasive Salmonella Typhimurium 
is an isolate that replicates largely within Salmonella containing vacuoles 
(SCVs) inside host cells (Knodler & Steele‐Mortimer 2003). A study noted 
no difference in the intracellular doubling time in Caco-2 cells when the 
uhpT permease was deleted (Götz & Goebel 2010). In addition, an 
enteroinvasive E. coli species, which escapes the endosome and replicates 
inside the cytosol was unhindered in growth without the UhpT transport 
system. Another study, using Shigella flexineri, demonstrated no marked 
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difference in Henle cell plaque formation between the wild type and the 
ΔuhpT strains (Runyen-Janecky & Payne 2002). Together with the infection 
results described in this chapter, the unessential role of UhpT has been 
reported for bacteria residing in two distinct cellular locations. E. coli and S. 
flexineri have unrestricted access to sugar phosphates in the cytosol. S. 
Typhimurium and S. aureus USA300 LAC are confined within a membrane 
bound vacuole, which impedes free uptake of cytosolic intermediates. 
Sugar phosphates have proven to be an excellent source of in vitro 
nutrition for every one of these species, and moreover significant up 
regulation of their homologous uhpT genes during cell infection is reported 
(Lucchini et al. 2005; Hautefort et al. 2008; Garzoni et al. 2007). In these 
cases, hexose phosphate transport is commonly implicated in host cell 
pathogenesis but is not effectual. 
6.5.2 Metabolic redundancy  
Redundancy of bacterial nutrient uptake systems and metabolic pathways 
may offer adaptability to the cellular environment.  A recent study 
monitored Caco-2 cell infection of invasive E. coli and S. Typhimurium (Götz 
et al. 2010). Successive mutants for each strain were created in metabolic 
transport genes. A single mutant of the UhpT permease, a double mutant 
removing the major glucose PTS uptake system (ptsG) and a mannose PTS 
uptake system (manXYZ) and finally a strain incorporating all three 
mutations were constructed. Intracellular replication assays showed that 
the mean generation time of each mutant strain was comparable to the 
respective wild type. This work also demonstrated that radiolabelled 
glucose is preferentially taken up by both wild type strains when it is 
available intracellularly. Similarly, a double mutant involving the two 
primary PTS uptake systems for glucose and mannose was analysed in L. 
monocytogenes (Stoll & Goebel 2010) . In epithelial cells and mouse 
macrophages grown in 10mM glucose, this strain was unaffected in growth 
despite exhibited severe impairment in glucose and mannose in vitro. In a 
Salmonella strain, the glucokinase enzyme was deleted in a strain already 
[146] 
 
containing a ΔptsGΔmanXYZ genotype. Only this additional mutation, 
which severed the glycolysis pathway at the initiating step, was able to 
significantly attenuate replication of Salmonella in macrophages (Bowden 
et al. 2009).  
The evolution and conservation of multiple, diverse bacterial transport 
systems is testament to the inherent function to parasitise host cells for 
growth (Pao et al. 1998; Lewis et al. 2012). Mutations in  carbohydrate 
transport systems largely do not affect virulence in distinctly 
compartmentalised  invasive bacteria (Götz et al. 2010; Stoll & Goebel 
2010; Bowden et al. 2009).  The likelihood is that redundant uptake 
mechanisms and metabolic pathways can fill the gap presented by 
mutational analysis. Indeed, the genetic background of S. aureus provides 
extensive redundancy of transport systems and metabolic pathways to 
ensure replication in a broad range of nutrients (Fuchs et al. 2012), which 
was confirmed in this study. Apparently non-essential systems, such as 
sugar phosphate permeases,  should therefore not be labelled impractical 
or non-contributory as they may provide a positive function when 
expressed, that may be masked during mutagenesis studies.  
6.5.3 Alternative intracellular nutrient sources for replication 
Replication of S. aureus USA300 LAC was compared in cells supplied with 
exogenous glucose and cells starved of any sugar supply. It was 
consistently reported that  S. aureus replicated with a greater magnitude 
within sugar starved cells than in cells with a physiological supply of 
glucose. These observations indicate that S. aureus USA300 can replicate 
with greater effectiveness in cellular starvation, in the absence of cellular 
glucose metabolism. Increased replication without glucose metabolites 
may suggest that alternative nutrition is driving pathogenesis.  
Using immunofluorescence to visualise infection, it was ascertained that 
the large majority of S. aureus USA300 LAC clusters were co-localised with 
Rab7 GTPase vacuole marker for a duration of pronounced replication. 
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Recent publications also verified S. aureus USA300 vacuole inclusion during 
epithelial cell infection and confirmed that the vast majority of clusters 
were co-localised with autophagosome membrane markers (Schnaith et al. 
2007; Mauthe et al. 2012).  Autophagosome formation is the initiating step 
of the mammalian cell autophagy process. Autophagy is the cellular 
recycling mechanism for catabolising and degrading excess or injured 
organelles (Yoshimori 2004). Normally, during steady state homeostasis, 
autophagy operates at a basal level. Autophagy is strongly induced during 
cellular stress and starvation as a response to meet energy demands. For 
example, during amino acid starvation, large protein complexes can be 
targeted for degradation to produce raw materials for synthesis of fresh 
macromolecules (Yoshimori 2004). Figure 6.18 outlines the autophagy 










Figure 6.18. Mammalian cell autophagy process. The schematic depicts 
the formation of the autophagosome, showing proteins that typically 
localise to this membrane interface, and fusion of cell vesicles to eventually 




During macroautophagy, autophagy related proteins such as LC3 and Atg18 
are recruited to organise the formation of a double membrane vesicle 
called a phagophore (Yang & Klionsky 2010). This phagophore expands and 
closes, capturing cytoplasmic components, and forming the double 
membrane autophagosome. Endosomes can fuse with the autophagosome 
to deliver contents into the lumen of the double membrane enclosure. 
Maturation occurs by lysosomal fusion, forming an autolysosome. The 
entire autophagosome structure and all of its contents are degraded by the 
injection of lysosomal acid hydrolases (Yang & Klionsky 2010).  
It has been demonstrated that S. aureus USA300 induces autophagosome 
envelopment upon infection and prevents autolysosome maturation to 
replicate within the autophagosomal compartment (Schnaith et al. 2007; 
Mauthe et al. 2012). Maintainance of Rab7 at the staphylococcal vacuole 
interface, as  confirmed in this chapter, may advocate maturation of the 
autopahgosomal membrane (Gutierrez et al. 2004). This can be 
substantiated by immunofluorescence microcopy vacuole detection using 
autophagosomal membrane markers. The induction of the autophagy 
pathway by S. aureus infection signifies a specific vacuolar niche in which 
replication occurs. The very nature of autophagy involves sequestering 
proteinous cytosolic components for digestion during cell stress, such as 
glucose starvation. Autophagy would deliver a source of peptides and 
amino acids to the staphylococcal inclusion, which have been confirmed as 
nutritious sources for replication. In addition, envelopment of the cytosol 
by the autophagy phagophore can enclose any cytosolic substrates that are 
present, including glucose and glucose derived compounds if provided to 
cells. Induction of the autophagic process could potentially provide a 
micro-environment of nutrients, into which S. aureus USA300 LAC is 
deposited.  
A feature shared by bacterial species in which Hpt related transporters 
have been found dispensible in infection is the possession of a complete 
tricarboxylic acid cycle. S. aureus,  S. Typhimurium, E. coli and S. flexineri  
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all have the ability to derive substantial growth from amino acids as a sole 
nutrient source (Erlandson & Mackey 1958; Dawes 1952; Gutnick et al. 
1969) which may be attributed to TCA cycle metabolism. By contrast, L. 
monocytogenes has a broken TCA cycle and cannot replicate using amino 
acids exclusively (Joseph & Goebel 2007). These intrinsic metabolic 
differences may account for impaired replication in the L. monocytogenes 
Δhpt mutant, as amino acids/peptides cannot offer a replaceable, effective 
nutrient source in this species. The opposite may be true for those species 
with complete TCA cycles, such as S. aureus, with proteinous sources 




















Host cell interactions that 
potentiate replication of            





In chapter 6, an epithelial cell infection model was established for S. aureus 
USA300 LAC, discovering that extensive replication correlated with 
majority vacuole enclosure. Intravacuolar pathogens are highly adapted to 
ensure survival and replication from within this niche (Kumar & Valdivia 
2009; Saka & Valdivia 2010; Knodler & Steele‐Mortimer 2003; Isberg et al. 
2009). Vacuole modification and  interaction with host cell signalling 
proteins is fundamental to the success of established vacuole based 
bacteria (Gruenberg & Van der Goot 2006). These mechanisms are 
essential in ensuring replication niches are established, and therefore can 
be the prerequisite for nutrient acquisition supporting growth (Heuer et al. 
2009; Kyei et al. 2006; Salcedo & Holden 2003).  
Research in this study indicates that WT Staphylococcus aureus containing 
vacuoles can competently establish a replication niche within the cell. By 
contrast, it was noted that a S. aureus USA300 strain with a defective agr 
regulatory system showed markedly impaired intracellular replication 
compared to the WT. As a functional agr system is apparently integral to 
intracellular replication, research was directed towards understanding the 
mechanisms and interactions that set apart WT S. aureus USA300 LAC and 
Δagr.   
7.2 Objectives 
In order to compare the capability of Δagr with WT USA300 LAC for 
replication upon nutrient sources, in vitro growth analysis was performed 
using Δagr. This was done in order to identify any metabolic defects, 
caused by agr deficiency, which may highlight nutritional differences that 
account for intracellular growth impairment.  
Recent publications have identified that Δagr mutants of other S. aureus 
strains do not follow the same vacuole inclusion dynamics as WT. In 
contrast to wild type strains , which typically acquire autophagosomal 
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membrane markers and proliferate, Δagr derivatives are found to remain 
closely associated with lysosomal associated membrane proteins (LAMPs) 
and fail to replicate (Schnaith et al. 2007; Jarry et al. 2008). This suggests 
that agr defective S. aureus containing phagosomes are subjected to 
lysosomal fusion and targeted for acid hydrolysis and proteolytic 
degradation (Ciechanover 2005; Levine & Kroemer 2008). To determine the 
cellular localisation of the S. aureus USA300 LAC Δagr compartment, 
immunofluorescence microscopy was used to investigate endocytic 
pathway marker associations. 
Visualisation of S. aureus USA300 LAC epithelial cell infection by 
immunofluorescence microscopy showed the routine convergence of 
separate staphylococcal clusters at a common perinuclear location. At this 
site, bacteria were seen to expand in a uniform mass which suggests that 
interaction of staphylococcal clusters at this cellular location is important in 
promoting replication. Most invasive vacuole based pathogens migrate to a 
perinuclear region of the cell (Gruenberg & Van der Goot 2006). Salmonella 
Typhimurium and Chlamydia trachomatis are invasive intravacuolar species 
which hijack host cell trafficking pathways to manoeuvre to the perinuclear 
replicative niche (McGhie et al. 2009; Méresse et al. 1999; Sinai & Joiner 
1997; Yasir et al. 2011). In both cases, bacterial inclusions become closely 
associated with markers of the Golgi apparatus (Salcedo & Holden 2003; 
Heuer et al. 2009). This association has proven to be integral to both 
nutrient acquisition and capability for replication of these species. 
Salmonella recruits cell trafficking protein Rab7 to the SCV, an interaction 
that is maintained for migration to the replication niche  (Méresse et al. 
1999; Harrison et al. 2004). S. aureus USA300 clusters remained largely 
associated with Rab7 until the aggregation of bacteria at the perinuclear 
region. Immunofluorescence microscopy was therefore employed to 
investigate associations between the Golgi apparatus and S. aureus 
USA300 LAC strains, with a view to uncovering the cellular niche which 
promotes replication.  
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7.3 Relevant materials and methods 
In vitro assays (2.4) Bacterial growth (2.4.1); Mammalian cell cytotoxicity 
(2.4.2) 
Mammalian cell culture (2.5) S. aureus infection (2.5.3.1); 
Immunofluorescence microscopy (2.5.4); Inhibitor treatment of 
mammalian cells (2.5.5) 


















7.4.1 In vitro growth of S. aureus USA300 LAC Δagr 
In vitro growth analysis was undertaken, assessing the ability of the Δagr 
strain to multiply in a variety of growth conditions and individual 
substrates. This would determine the metabolic capacity compared to WT 
USA300 LAC. 
Figure 7.1A and B shows in vitro growth analysis of Δagr in nutrient rich BHI 
and LB broth relative to WT. In these media, nutrients were utilised by Δagr 
to generate rapid, high yield replication that is not significantly different to 
the WT by stationary phase (p=>>0.05). Figure 7.1C demonstrates the 
growth of Δagr in minimal media supplemented with glucose, fructose-6-
phosphate and glycerol-1-phosphate indicating that growth was 
unimpaired in non-phosphorylated, C6 phosphorylated and C3 
phosphorylated nutrient sources relative to WT USA300 LAC. Figure 7.1D 
compares growth of WT LAC and Δagr in minimal media using RPMI amino 
acids as a sole nutrient source. Substantiating growth in LB, this shows that 
Δagr can derive high level growth from amino acids alone. These results 
demonstrate that the agr mutation confers no obvious defects in carbon 
nutrient acquisition or metabolism.  
Impaired replication could therefore potentially be the effect of defective 
vacuole maturation. In this situation, Δagr may be unable to affect the 
escape from the degradation pathway or fail to localise at a bacterially 












7.4.2 Cellular localisation of S. aureus USA300 LAC Δagr 
7.4.2.1 Rab7 co-localisation 
Co-localisation of Rab7 was investigated to compare the nature of the Δagr 
containing vacuole to the WT. Epithelial cell infections were performed 
with Δagr and the antibody markers and conditions for detecting Rab7 and 
S. aureus were utilised as described in Chapter 6.  
Figure 7.2 shows the infection time course of HeLa cells by S. aureus 
USA300 LAC Δagr. Representative images show that throughout the 
infection, the large majority of staphylococcal inclusions were not co-
localised with Rab7. However, Δagr clusters were not totally independent 
of Rab7 association. At 4h, an example is highlighted to convey that few 
clusters of Δagr can be positively co-localised with Rab7.  Greyscale images 
depict clearly, there were few visible concentrations of Rab7 protein in the 
same cell space as S. aureus USA300 LAC Δagr clusters.  
Figure 7.3 demonstrates the same experiment in A549 cells, modelling 
USA300 human lung cell infection. Again, throughout infection, the 
majority of intracellular inclusions could not be positively co-localised with 
Rab7. At 3h post invasion, an example of definite Rab7 co-localisation is 
shown to substantiate that lack of marker acquisition by Δagr was not 
absolute during infection.  
The quantification of S. aureus USA300 LAC Δagr infection in HeLa and 
A549 cells is shown in Figure 7.4. On average, fewer than 20% of bacterial 
clusters were positively co-localised with Rab7 at time 0h. By contrast, 
greater than 70% of wild type USA300 clusters could be positively 
identified at the same time (p=<<0.05). In HeLa cells, the number of Rab7 
co-localised clusters diminished to 4% by 8h (Figure 7.4A) while this figure 
fell to 10% by 6h in A549 cells (Figure 7.4B). The majority of Δagr inclusions 


















7.4.2.2 LAMP1 co-localisation  
Lysosomal associated membrane protein 1 (LAMP1) was targeted to mark 
cell lysosome localisation during Δagr infection. The presence of LAMP 
proteins 1 and 2 make up around 50% of all lysosomal membrane proteins 
and are thought to contribute to the protection and preservation of the 
membrane from acid hydrolysis action (Eskelinen 2006). These proteins are 
recruited specifically to lysosome membranes.  
Figure 7.5 and 7.6 depict infection of HeLa and A549 cells by S. aureus 
USA300 LAC Δagr highlighting lysosomes via LAMP1 detection. At earlier 
times during infection, co-localisation of Δagr with LAMP1 was not 
common. At time 0h the spatial distribution of lysosomes was in contrast 
to Δagr localisation. With each successive time point of infection, there 
was greater association of LAMP1 and Δagr. Expanded images at later 
times show clearly that LAMP1 protein encloses bacterial clusters, with an 
evident red border around the blue bacterial inclusion. White arrows 
highlight the higher number of clusters co-localised with LAMP1 at later 
time points.  
Figure 7.7 charts the percentage of cellular Δagr clusters co-localised with 
LAMP1 during infections. As illustrated in the immunofluorescence 
microscopy figures, co-localisation was on average much lower at earlier 
time points. However, progression of infection leads to greater numbers of 
bacterial clusters that were associated with LAMP1. In HeLa, 80% of Δagr 
inclusions were co-localised with LAMP1 by 4h (Figure 7.7A). Similarly, on 
average 70% of clusters were enveloped by LAMP1 by 8h in A549 infection 
(Figure 7.7B). The majority of intracellular S. aureus USA300 LAC Δagr 
compartments acquire LAMP1 markers by 4 hours in HeLa infection and by 





























Together these results suggest that WT USA300 LAC arrests the Rab7 
positive compartment which promotes replication, while Δagr cannot 
prevent phagolysosomal fusion which leads to inhibition of replication and 
degradation. However, further experiments are needed to quantify 
lysosome association of WT USA300 LAC and Δagr in order to affirm this 
distinction.  
7.4.3 Association of S. aureus USA300 LAC with the Golgi apparatus 
7.4.3.1 WT USA300 LAC inclusions acquire Golgi markers 
In order to visualise a co-localisation of S. aureus clusters and Golgi 
apparatus, immunofluorescence microscopy was employed to highlight 
these specific bodies during infection of epithelial cells. Epithelial Golgi 
membranes were visualised using the trans-Golgi associated marker, 58K 
protein. S. aureus were labelled using anti-Staphylococcus aureus Rabbit 
IgG. Cellular F-actin was visualised using Phalloidin to define the cell 
boundaries.  
Figure 7.8 and 7.9 depict representative images of S. aureus USA300 LAC 
infection of HeLa cells and A549 cells. The negative control shows clearly, 
the compact and orderly nature of the Golgi body in uninfected cells. 
Immediately after bacterial entry, at 0h, bacteria were spatially dispersed 
throughout cells and are not regularly localised at the perinuclear region. 
By 2 hours post invasion, bacterial clusters had migrated to periphery of 
the Golgi apparatus. As early as 2 hours into infection, expansive 
staphylococcal masses were co-localised with 58K. As highlighted in 
expanded sections, 58K markers are no longer compact and ordered in the 
periphery of the nucleus. The Golgi apparatus appeared to encompass the 
entire bacterial mass, which was characterised by a dispersal of 58K 
markers. Many examples are highlighted by white arrows and expanded 
sections in Figure 7.8 and 7.9 that this was a regular event occurring 
throughout invasive infection. The boundary of bacterial expanse and 58K 
dispersal was strikingly similar and consistent among cells. In addition, cells 
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that bare this bacterial load which is co-localised with 58K, are commonly 
rounded and shrivelled (Figure 7.8  2h). This may suggest cells become 
apoptotic in this situation which would correlate with the increasing 
cytotoxicity of the HeLa cell monolayer at later time points of infection. By 
contrast, infected cells can be seen, in which bacteria did not co-localise at 
the Golgi apparatus, for example in Figure 7.8 at 6h. These cells do not 
carry a significant bacterial load, and do not appear to be abnormal which 
suggests they are not subject to cell death. 
These results demonstrate that S. aureus USA300 clusters use cell 
trafficking pathways to migrate to the Golgi network. The expansion of 
Golgi membranes to encompass the replicating S. aureus mass implicates 














7.4.3.2 Δagr clusters fail to acquire Golgi markers 
S. aureus USA300 LAC Δagr containing vacuoles do not conform to wild 
type cell dynamics which relates to a severe impairment in replication. It 
was investigated whether Δagr clusters migrated and localised at the Golgi, 
as a cellular niche. 
Immunofluorescence microscopy was employed to image Golgi membrane 
structure during infection of HeLa cells and A549 cells by Δagr.  Figure 7.10 
and 7.11 shows representative imaging of the infection of HeLa and A549 
cells, respectively, by Δagr. As infection progresses, there was very little 
evidence to suggest that Δagr vacuoles localise to a common cell vicinity. In 
addition, by later time points of infection, there were virtually no clusters 
of Δagr that co-localised with Golgi 58K protein. All infected cell Golgi 
remained as compact and ordered as seen in negative controls. 
Throughout the chapter figures have been presented which reproduce 
Δagr infection. In each case, Δagr clusters fail to regularly migrate to a 
common location. This provides corroborating evidence that the cellular 
spatial distribution of S. aureus USA300 LAC Δagr infection differs from that 


















7.4.4 Golgi disruption to inhibit replication of S. aureus USA300 LAC 
Wild type USA300 migrates to the Golgi which appears to be a niche for 
substantial replication. By contrast, Δagr is unable to do so and instead 
most likely transits to the lysosome. The use of host cell trafficking to travel 
to and interact with the Golgi, is a critical mechanism in invasive USA300 
pathogenesis. Without the regulation of agr, virulence factors are non-
applicable and the process is not initiated. Ultimately, host cell 
interactions, mediated through agr effectors, is key to proliferation. 
As the Golgi apparatus is evidently the terminal replication niche of 
USA300, an effort was made to disrupt the interaction and inhibit 
replication. This has been demonstrated with Salmonella, as disassembly of 
the Golgi apparatus by a chemical inhibitor strongly reduced bacterial 
growth (Salcedo & Holden 2003). A Golgi inhibitor was utilised to disrupt 
the make-up of the Golgi apparatus during infection. Golgicide A is a highly 
specific, reversible inhibitor of the cis-Golgi associated protein GBF1. 
Inhibition of this interaction results in disassociation of Golgi membrane 
coat proteins and subsequently, the disassembly of the entire Golgi and 
trans-Golgi structure (Sáenz et al. 2009). Golgicide A has been reported to 
demonstrate effective fragmentation of Golgi vesicles in HeLa cells (Van 
der Linden et al. 2010). 
The effectiveness of Golgicide A was tested upon HeLa and A549 cells. 
Golgicide A treatment was monitored over 2 hours. Immunofluorescence 
microscopy was used to view Golgi membranes during treatment. Golgi 













Figure 7.12 and Figure 7.13 show treatment of HeLa and A549 cells 
respectively, with Golgicide A over the course of 2 hours. Negative controls 
were put in place to show the assembled and compressed nature of 
untreated Golgi apparatus. Inhibitor treatments in both cell types lead to 
scattering and disassembly of Golgi into the cytosol over the 2 hour time 
period. The cell Golgi looked to be disrupted, which may interfere with the 
natural localisation of WT USA300 vesicles.  
Intracellular infections were performed alongside treatment of Golgicide A. 
Bacterial inoculum was added and allowed to invade untreated cells for the 
allotted incubation time. This was in an effort to ensure that entry rates of 
bacteria was unaffected by Golgicide A treatment. Inhibitor was added to 
the antibiotic media, which was applied to cells directly after the invasion 
period and was left for the remainder of the assay. From this point, the 
intracellular replication of bacteria was monitored. While the main 
objective was to observe any negative effects upon WT S. aureus USA300 
LAC replication, Δagr was monitored in parallel as a control, as this strain 
typically did not associate with the Golgi.  
Infections of WT and Δagr in GCA treated HeLa cells revealed a major 
discrepancy. Figure 7.14 shows phase contrast imaging of the HeLa cell 
monolayer during treatment with Golgicide A. The integrity of uninfected, 
treated cells remained resolute throughout the time points monitored 
during infection. In contrast, the monolayer of treated cells infected with 
Δagr was subject to extensive destruction by 6 hours of infection. This 
reproducible detachment did not occur during Δagr infection of untreated 
cells. These observations were substantiated using an LDH cytotoxicity 
assay. Culture media was analysed at various time points during infection 
to quantify the breakdown of the HeLa monolayer. Figure 7.15 shows a 
colour schematic of LDH cytotoxocity assays which correlate with 
monolayer detachment. S. aureus USA300 LAC Δagr infection caused 












As Δagr is normally non-cytotoxic up to this time point at MOI 10, this 
raised concerns about the viability of investigating intracellular replication 
of USA300 LAC strains in Golgicide A treated HeLa cells.  
Figure 7.15 also models cytotoxicity testing of WT USA300 infection in 
Golgicide A treated A549 cells at MOI 10. LDH cytotoxicity analysis shows 
that the cell monolayer remained largely unaffected over the infection 
period. This shows that infection of Golgicide A treated A549 cells did not 
potentiate monolayer destruction. Infections of inhibitor treated A549 cells 
were therefore considered for intracellular replication analysis. 
Figure 7.16 shows the average CFU/ml of S. aureus USA300 LAC strains 
during intracellular proliferation assays in A549 cells. Figure 7.15B 
compares the intracellular replication of Δagr in cells with and without 
treatment of Golgicide A. Replication was comparable in both cellular 
conditions and therefore served as a negative control for intracellular 
growth without Golgi affiliation.  Figure 7.16A shows the average bacterial 
numbers of WT USA300 in A549 cells. Replication in A549 cells was not 
affected by inhibition of Golgi assembly by Golgicide A. The mean 
generation times of LAC WT and Δagr in A549 cells with and without 
Golgicide A treatment are shown in Figure 7.16C. Golgi disruption did not 
have a negative effect upon the average doubling time of either strain. 
Immunofluorescence microscopy was used to authenticate replication of S. 
aureus USA300 LAC in inhibitor treated A549 cells. Figure 7.17 images the 
infection of WT and Δagr using 58K labelling to visualise the Golgi. 
Throughout infections, dispersal of the Golgi was observed. During WT 
infection, by 6 hours there were numerous examples of large expansive 
staphylococcal masses, highlighted by white arrows. Greyscale contrasting 
of 58K and S. aureus at 6 hours shows that for the most part, there is still 
an apparent co-localisation of Golgi 58K and USA300 WT. Infection of Δagr 
shows no obvious difference in spatial localisation during A549 cell 














The intracellular associations elucidated in this study, which are involved in 
replication and pathogenesis of S. aureus USA300 LAC, are summarised in 
































7.5.1 agr-dependent interactions promoting migration to the Golgi 
for replication 
Invasive infection of a USA300 LAC strain lacking the agr regulatory system 
displayed different dynamics to the wild type. This strain does not 
commonly localise to Rab7 associated inclusions and does not migrate to 
the Golgi apparatus. Instead, Δagr becomes increasingly co-localised with 
lysosomal membrane protein LAMP1 as the infection progresses. According 
to existing literature, co-localisation with lysosomal membrane associated 
proteins is a common observation among S. aureus Δagr infections 
(Schnaith et al. 2007; Jarry et al. 2008). These publications strongly suggest 
that Δagr becomes sequestered inside the lysosomal compartment, the 
antimicrobial degradation niche.  
S. aureus USA300 LAC Δagr is not noticeably impaired in important carbon 
based nutrient sources compared to the wild type. The differences in 
cellular localisation can therefore be significant and linked to the inability 
of Δagr to divert the lysosomal degradation pathway and transport to the 
Golgi replication niche. Effector proteins which are expressed under the 
control of agr can be crucial in manipulating host cell trafficking to ensure 
co-ordinated migration and proximity of invasive USA300 clusters. It has 
been demonstrated that single phagosomal S. aureus bacterium can auto 
regulate the agr quorum sensing system to induce expression of virulence 
factors (Carnes et al. 2009). Perhaps upon cell invasion, cellular effectors 
are expressed and secreted due to autoactivation of agr, and this 
modulates trafficking of the phagosome to the Golgi. Convergence of 
multiple USA300 clusters into the uniform mass seen at the Golgi would 
potentiate proximal agr quorum sensing. This would increase cytolytic 
toxin expression and secretion which would provide an escape mechanism, 
most probably explaining the cell cytotoxicity observed at later time points 
of infection. Recent publications have proposed that USA300 subverts the 
autophagy pathway to avoid seclusion in the lysosomal compartment 
(Schnaith et al. 2007; Mauthe et al. 2012). This not only ensures survival, 
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but also replication inside this specific vacuolar niche. Induction of 
autophagy by rapamycin treatment has shown to increase the number of 
autophagosome specific USA300 vacuoles and in turn, significantly increase 
bacterial multiplication. A study reported that agr deficient S. aureus 
localises at the lysosomal vacuole and did not exhibit intracellular growth.  
Rapamycin treatment of cells infected with agr deficient strains promotes 
localisation of these bacteria to WT autophagosomes and induces 
replication and even restores cytotoxicity (Schnaith et al. 2007). This 
evidence further promotes the notion that agr effector(s) control cell 
trafficking to induce specific vacuole inclusion which ultimately leads to 
replication.  
Various studies have investigated the virulence of USA300 mediated by the 
agr system (Li et al. 2010; Montgomery et al. 2008; Montgomery et al. 
2010).In general, the high concentrations of secreted toxins and proteases, 
that are under the control of agr, are thought to be the central factors that 
make USA300 pathogenesis so destructive. Necrotising pneumonia is a 
particular infection caused by USA300 that has been consistently linked to 
agr dependent pore forming toxins (Wardenburg et al. 2007). Observations 
in human lung carcinoma cells, presented in this chapter, suggest that agr 
dependent host cell interactions are the underlying cause of necrotising 
pneumonia, and subsequent agr dependent toxin secretion is the effect.  
The agr dependent phagosome migration seems to be necessary to access 
nutrient sources providing energy for replication. As the Golgi network is 
evidently the niche for replication, nutrients may be provided by vesicle 
trafficking pathways. Chlamydia exploits the host Golgi vesicle trafficking 
network to deliver specific nutrients into the bacterial inclusion. 
Sphingolipids, cholesterol and lipid droplets are directed to Chlamydia to 
provide the sustenance needed for intravacuolar replication (Saka & 
Valdivia 2010). A recent study in Chlamydia has reported a fragmentation 
of the HeLa cell Golgi network into mini stacks during infection. 
Disassembly of the Golgi network by knock down of Golgi associated 
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proteins actually potentiated Chlamydia replication. Prevention of Golgi 
breakdown reduced the availability of lipid vesicle and severely inhibited 
the growth of Chlamydia (Heuer et al. 2009). In addition, Legionella 
pneumophila diverts and fuses with ER-Golgi trafficking vesicles to acquire 
proteinous materials for nutrition (Robinson & Roy 2006).  
The interaction of USA300 at the Golgi network can be a crucial event in 
pathogenesis. In an attempt to validate this notion the Golgi apparatus was 
disrupted using Golgicide A. In A549 cells, the treatment was ineffectual 
upon bacterial localisation and replication. Further studies need to be 
implemented in demonstrating the importance of this interaction. Perhaps, 
similarly to Chlamydia, the apparent fragmentation of the Golgi by USA300 
may be bacterially induced in order to potentiate replication.  
The agr system of USA300 has a pivotal role in regulating host cell 
molecular interactions. Pathogenesis of invasive infections can be 
dependent upon agr mediated maturation and transport of Staphylococcus 
aureus containing vacuoles. This implies that important infections such as 
necrotizing pneumonia can be targeted at the molecular level. In 
Salmonella Typhimurium, targeting of the bacterial vacuole to the Golgi 
network has been narrowed down to a single protein, encoded by sseG. 
Removal of this protein eliminates interaction with the Golgi complex, 
inhibits replication and impedes pathogenesis (Salcedo & Holden 2003). S. 


























S. aureus USA300 is a sophisticated pathogen with an enhanced ability to 
extract and metabolise diverse carbon compounds from the surrounding 
environment to benefit fitness. This advanced metabolic capacity may 
reflect the versatility of this pathogen to colonise many host niches and 
adapt to the variable microenvironments to inflict destructive infection. 
Sugar phosphate transporters, UhpT and GlpT, operated with overlapping 
function, readily ingesting sugar phosphates to support tremendous 
replication of USA300 in vitro. These transporters functioned in L. 
monocytogenes to exploit substrates from the intracellular compartment 
and promote replication, demonstrating a purposeful role in pathogenesis. 
However, in USA300 the purpose of UhpT and Glpt was not explicit, as they 
were dispensible to intracellular replication. Further to this, USA300 could 
parasitize carbohydrate starved mammalian cells with even greater 
efficiency than glucose metabolising cells, highlighting the persistence of 
this pathogen in disparate conditions. It is highly plausible that multiple 
redundant transport systems exist to compensate for metabolic fluxes in 
host niches, and maintain growth in the absence of specific permeases, 
such as UhpT and GlpT. The interconnecting metabolic pathways encoded 
by S. aureus offer malleable, biosynthetic routes by which essential 
intermediates can be replenished using changeable exogenous nutrients. 
Ultimately, this can ensure that USA300 proliferates to increase the effect 
of proximal quorum sensing and promote co-ordinated virulence.  
Further examination of USA300 infection determined that replication was 
confined within Staphylococcus aureus containing vacuoles and was closely 
linked to Golgi apparatus association. In the absence of the agr system, 
USA300 vacuoles did not co-ordinately migrate to the Golgi which was 
connected with impairment of replication. In order for vacuole based 
replication to occur, USA300 must affect the host cell phagosome 
membrane and hijack host cell proteins to manufacture a favourable 
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intracellular environment. A crucial aspect of this process may be mediated 
by agr. As agr deficient USA300 had no obvious metabolic impairment, agr 
mediated host cell modifications may be critical in introducing the 
pathogen to a microenvironment containing growth promoting nutrients. It 
is therefore important that host cell vacuole manipulation and bacterial 
metabolism are jointly considered to expose the source of USA300 
pathogenesis. This research may lay the foundation for innovative 
approaches in CA-MRSA prevention, especially in more serious invasive 
forms of infection. 
8.2 Future work 
8.2.1 Growth substrate characterisation 
A narrow selection of sugar phosphate compounds were confirmed in this 
thesis as substrates of S. aureus USA300 LAC UhpT and GlpT transporters. A 
diverse range of organophosphates have been identified which traverse 
bacterial membranes through homologous hexose phosphate permeases. 
These intermediates include fructose-1-phosphate, mannose-6-phosphate, 
galactose-6-phosphate, glucosamine-6-phosphate, glyceraldehyde-3-
phosphate, pentose phosphates and heptose phosphates (Dietz 1976; 
Chico-calero et al. 2002; Schwöppe et al. 2002; Gluth et al. 1980; Eidels et 
al. 1974). In the context of homology, it is important to determine whether 
the S. aureus UhpT protein exhibits the same substrate flexibility. 
Conducting a more extensive substrate characterisation will also determine 
the value of phosphorylated intermediates in staphylococcal replication, 
especially if encompassed by the single UhpT transporter. 
A limitation of investigating the substrate specificity of many bacterial 
organophosphate transporters is the issue of inducible expression. The 
homologous UhpT transporter of E. coli is only inducibly expressed upon 
highly specific substrate interaction. The only known extracellular inducers 
of this system are glucose-6-phosphate and 2-deoxyglucose-6-phosphate 
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(Dietz 1976). In order for transported substrates to be identified, the 
system needs to first be induced by glucose-6-phosphate. Similarly, 
glycerol monophosphate is the only extracellular nutrient which can induce 
expression of GlpT in E. coli (Lemieux et al. 2004). Although demonstrated 
to be inducible, the expression systems of putative sugar phosphate 
permeases of S. aureus have not been elucidated. It is probable that these 
homologous transporters require substrate specific induction of 
expression, which is necessary to determine transported substrates. 
Alternative approaches could therefore be taken in order to characterise 
uptake of substrates through the inducible sugar phosphate transporters of 
S. aureus. Expression analysis can be performed in vitro in order to confirm 
exogenous compounds which induce the expression of S. aureus uhpT and 
glpT. This may provide evidence that accounts for lack of USA300 LAC 
replication in glucose-1-phosphate and glycerol-3-phosphate, for example. 
A study investigated the substrate specificity of the E. coli UhpT permease 
by using 14C glucose-6-phosphate to induce the UhpT system and monitor 
the rate of uptake of G-6-P (Schwöppe et al. 2002). The uptake of 14C G-6-P 
was monitored after substrate competitors were added to determine if 
they displaced G-6-P and were imported through the UhpT channel. As 
glucose-6-phosphate induces expression of uhpT in S. aureus (Winkler 
1973), this technique could provide subsidiary analysis on substrates that 
may traverse the channel. 
Further investigation of substrates promoting replication of S. aureus 
USA300 LAC is required. The most comprehensive and high-throughput 
approach involves conducting a phenotype microarray characterisation. 
This technique would test countless metabolic intermediates, in a minimal 
growth media, to expose a wider range of substrates that singularly 
stimulate growth. The metabolic compounds range from extensive carbon 
sources to nitrogen, phosphorus and sulphur sources. A plethora of 
peptides can also be scrutinised. A recent study presents phenotype 
microarray analysis of S. aureus strain COL, an early MRSA isolate (Eiff et al. 
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2006). This work cites alternative carbon based substrates as growth 
stimulants such as fatty acids, nucleosides, nucleotides and urea. Perhaps 
similar phenotypes can be attributed to USA300 and uncover a wider range 
of intermediates which can be scavenged from the intracellular 
compartment to enhance replication. Diverse mechanisms of nutrient 
acquisition can then be targeted by mutagenesis to further explore 
nutritional determinants of CA-MRSA pathogenesis.  
8.2.2 Fosfomycin resistance 
During in vitro fosfomycin susceptibility testing, S. aureus USA300 LAC 
exhibited resistance to highly inhibitory concentrations. Isolate WT, ΔuhpT 
and ΔglpT colonies which grow within the zone of fosfomycin inhibition can 
be selected to investigate resistance mechanisms. The ability of these 
isolates to replicate upon sugar phosphates can be analysed to indicate 
whether genetic mutations have conferred structural changes to UhpT and 
GlpT which affect transport. Sugar phosphate permease genes can be 
sequenced, in addition to murA gene (encoding the target protein of 
fosfomycin), to build an extensive library of possible mutations which 
influence fosfomycin resistance in S. aureus USA300. 
8.2.3 Further analysis of sugar phosphate permeases in S. aureus 
USA300 LAC infection 
It was established that sugar phosphate permeases are not required for 
promoting WT S. aureus USA300 LAC intracellular replication in the 
epithelial models tested in this thesis. However, expression of uhpT and 
glpT needs to be monitored over the course of infection to determine 
whether these genes are induced intracellularly. Confirmation of up-
regulation would implicate staphylococcal permeases as supplementary 




The role of S. aureus USA300 LAC permeases should be robustly 
investigated in vivo. In animal models of infection, bacteria can be 
subjected to changing microenvironments, rather than metabolically 
controlled ex vivo cancer cell monolayers. Ultimately, this would provide 
realistic and comprehensive data to conclude the importance of UhpT and 
GlpT as nutritional determinants of CA-MRSA infection. In particular, 
human blood may provide a microenvironment that uncovers a role for 
UhpT. A recent study reported that S. aureus USA300 uhpT expression was 
up-regulated by 45 fold upon infection of human blood (Malachowa et al. 
2011). The hexose phosphate transporter was the most highly induced of 
any other metabolic gene in USA300, which suggests that sugar phosphates 
are valuable to growth in this niche. Human erythrocytes must combat 
oxidative stress using only the pentose phosphate pathway, which is 
initiated exclusively by converting glucose-6-phosphate to gluconate-6-
phosphate (Capellini & Fiorelli 2008). Erythrocytes must ensure a constant 
supply of G-6-P to promote the pentose phosphate pathway and avoid lytic 
damage. Erythrocytes therefore may provide a valuable supply of sugar 
phosphate which necessitates metabolic adaptation by S. aureus and hence 
intense induction of UhpT expression. Models of S. aureus USA300 
bacteremia have been well established in mice and in rabbits (Diep et al. 
2008; Wang et al. 2007). It is crucial that these models are tested using at 
least the ΔuhpT mutant created in this study. This could unvail a significant 
role for UhpT in CA-MRSA bacteremia and possibly highlight a scenario in 
which this transport system is a virulence determinant.  
Listerial hpt expression is inducible by PrfA activation, which is intensely 
up-regulated during cell infection (De las Heras et al. 2011). This control 
system eliminates exogenous G-6-P as the inducer of expression and 
guarantees rapid deployment of Hpt transporter upon infection. By 
contrast, the UhpT transporters in S. flexineri, S. enterica, E. coli and S. 
aureus are only inducibly expressed by the  extracellular presence of 
specific substrates e.g. glucose-6-phosphate (Island et al. 1992; Runyen-
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Janecky & Payne 2002; Winkler 1973). In addition it has been established 
that sugar phosphate permeases of Gram negative bacteria are subject to 
catabolite repression, especially by glucose (Elashvili et al. 1998; 
Verhamme et al. 2002; Merkel et al. 1995). S. aureus permeases are under 
regulation by carbon catabolite control protein A, the Gram positive 
metabolic effector activated by glucose metabolism (Seidl et al. 2009). The 
expression status of sensory inducible sugar phosphate permeases during 
the changing microenvironment of the cell compartment is therefore 
ambiguous, and depends upon the cellular nutrient conditions. This 
introduces further complexity into the issue of sugar phosphate 
involvement during pathogenesis of S. aureus. A strategy can be 
implemented in which expression of sugar phosphate permeases are 
placed in the same context as L. monocytogenes. S. aureus USA300 LAC 
ΔuhpT and ΔglpT can be complemented with their respective wild type 
genes under the control of a consitutive gene promoter. In this 
background, UhpT and GlpT can be definitely expressed in the glucose 
incorporated models of infection. The capability for specific substrate 
acquisition in the same cellular environment would be constant. Perhaps 
this may potentiate bacterial replication, increase virulence and expose 
whether sugar phosphates can be accessible from the vacuolar niche of S. 
aureus USA300. 
8.2.4 Investigation of amino acids / peptides as nutrient sources for 
intracellular S. aureus USA300 LAC 
Amino acids/ peptides were postulated to be potential sources of 
intracellular nutrition for S. aureus USA300 which are metabolised to drive 
vacuole based replication. Interference with amino acid transport and/or 
amino acid biosynthetic enzymes has shown to have a negative impact 
upon the intravacuolar replication of several invasive bacterial species 
(Wieland et al. 2005; Foulongne et al. 2000; Klose & Mekalanos 1997). As S. 
aureus USA300 may exhibit similar intravacuolar dependence, the impact 
of amino acids should be investigated. Clinical S. aureus strains have been 
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constructed with insertion mutations in the chromosomal aconitase gene, 
the enzyme of the TCA cycle that converts citrate to isocitrate (Sadykov et 
al. 2010). These mutant strains have a broken TCA cycle and have been 
characterised with an incapability to replicate upon amino acids as a sole 
carbon source for growth. This mutation can be constructed in S. aureus 
USA300 LAC to investigate replication during infection without the 
capability to metabolise amino acids as growth sources. Prospective 
replication attenuation of an aconitase mutant can direct attention 
towards individual amino acid transport systems and/or anapleurotic 
pathways which are crucial to infection. Perhaps single virulence factors 
could then be identified to characterise pathogenesis of USA300.  
8.2.5 Trafficking of S. aureus USA300 to the host cell Golgi 
Despite showing strong evidence for WT S. aureus USA300 LAC Golgi 
association in two independent epithelial cell lines, redundant intracellular 
markers need to be visualised to provide robust evidence of infection 
dynamics. Giantin and GM130 are commonly used as immunofluorescence 
markers to visualise the cis-Golgi while TGN46 can also be used to highlight 
the trans-Golgi (Salcedo & Holden 2003).  
The fact that S. aureus USA300 LAC is rapidly co-localised with Rab7 upon 
cell entry indicates that this pathogen is integrated into the phagocytic 
pathway (Santillo 1997). Migration of Staphylococcus aureus containing 
vacuoles (associated with Rab7) to the Golgi apparatus signifies that 
cellular trafficking is employed to establish a common replication niche. 
Retrograde transport from the endosomal compartments to the trans-
Golgi network is an important trafficking process in mammalian cells 
(Johannes & Popoff 2008). Receptor proteins, enzymes and lipids are 
directed to the trans-Golgi by specific transport proteins for recycling 
through the biosynthetic and secretory compartments (Johannes & Popoff 
2008). Rab9 is typically recruited to late endosomes that require transport 
of mannose-6-phosphate receptors to the trans-Golgi and motility is 
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microtubule dependent (Barbero et al. 2002). Perhaps immunolabelling of 
Staphylococcus aureus containing vacuoles with Rab9 may support the co-
option of retrograde trafficking proteins to allow migration to the trans-
Golgi network. A highly specific and potent inhibitor of Rab7 has been 
described which can be applied to block the maturation of the 
staphylococcal phagosome (Agola et al. 2012). In addition, inhibitors of 
microtubule dependent motility of endosomal vesicles, such as nocozadole 
and dynamitin have shown to significantly reduce trafficking to the trans-
Golgi network (Itin et al. 1999). These strategies could be employed to 
disrupt trafficking of USA300 vacuoles and potentially correlate Golgi 
migration to replication. The importance of host cell trafficking could be 
elucidated as a major factor in the virulence of invasive USA300 lung 
infection.  
8.2.6 agr-dependent host cell interactions 
Further observations need to be confirmed for definite localisation of S. 
aureus USA300 LAC Δagr to the phagolysosome compartment. For 
example, antibody labelling of LAMP2 can offer a redundant lysosome 
localised protein for co-localisation studies. In addition, increased 
acidification of lysosomal compartments can be mapped by chemical dyes 
such as LysoTracker, which can determine the localisation of Δagr in an 
unfavourable niche (Jarry et al. 2008). Of course, these investigations need 
to be compared to WT USA300 LAC in order to differentiate the cell 
dynamics. Complementation of the agr mutant is also essential in 
demonstrating restoration of wild type host cell dynamics to prove that the 
observations reported are not non-specific artefacts of agr mutant 
construction. 
Transcriptome analysis can be employed to compare the global gene 
expression of WT and Δagr USA300 LAC strains during epithelial cell 
infection modelled in this thesis. Discovery of significantly up regulated, 
agr dependent genes can provide a starting point for targeting potential 
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effectors that play a role in subversion of cellular trafficking and Golgi 
transit. Perhaps a novel therapeutic target can be uncovered to fight 
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DH5α Cloning host strain Our laboratory
DH10β Cloning host strain Our laboratory
DH5α : pMAD-Cm Carries shuttle vector for mutant 
construction
Wilson et al. 
2011
DH10β :pTOPO UhpT 
REC
Carries the recombinant mutant 
uhpT  allele (S.aureus )
This study
DH10β : pCR Blunt GlpT 
REC
Carries the recombinant mutant glpT 
allele (S.aureus )
This study
DH5α : pCR Blunt uhpT 
SA
Carries high fidelity uhpT  gene (S. 
aureus )
This study
DH5α : pCR Blunt  glpT 
SA
Carries high fidelity glpT  gene (S. 
aureus )
This study
DH5α: pMAD-Cm UhpT Carries shuttle vector construct for 
mutant uhpT  allele
This study
DH5α: pMAD-Cm GlpT Carries shuttle vector construct for 
mutant glpT  allele
This study
DH10β: pMAD UhpT Carries shuttle vector construct for 
mutant uhpT  allele
This study
DH10β: pMAD GlpT Carries shuttle vector construct for 
mutant glpT  allele
This study
DH5α : pCR Blunt hpt 
LM
Carries high fidelity hpt  gene (L. 
monocytogenes P14)
This study
DH5α: pPL2 Carries listerial integrative shuttle 
vector
Lauer et al. 
2002
DH5α: pBC(gfp )Psod Carries fluorescence reporter 
plasmid
Köhler et al . 
2000
DH5α: pPL2(Psod) Carries Listeria shuttle vector- sod 
promoter construct
This study
Table A1. Bacterial strains used in this thesis.  
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DH5α: pPL2(Psod) hpt  LM Carries pPL2-Psod complement 
construct for hpt gene (L. 
monocytogenes P14)
This study
DH5α: pPL2(Psod) uhpT  SA Carries pPL2-Psod complement 
construct for uhpT  gene (S. aureus )
This study
DH5α: pPL2(Psod) glpT  SA Carries pPL2-Psod complement 
construct for glpT  gene (S. aureus )
This study
DH5α : pCR Blunt PprfA Carries L. monocytogenes  PrfA 
promoter sequence for hpt  gene
This study
DH10β: pPL2(PpfrA) Carries Listeria  shuttle vector - PrfA 
promoter construct
This study
DH10β: pPL2(PprfA) hpt 
LM
Carries pPL2-PprfA complement 
construct for hpt  gene (L. 
monocytogenes P14)
This study
DH10β: pPL2(PprfA) uhpT 
SA
Carries pPL2-PprfA complement 
construct for uhpT  gene (S. aureus )
This study
DH10β: pPL2(PprfA) glpT 
SA
Carries pPL2-PprfA complement 




P14 Wild type clinical isolate (Serovar 4b) Our laboratory 
(Ripio et al. 
1996)
P14-A PrfA* mutant of P14. PrfA regulation 
is constitutively active
Our laboratory 
(Ripio et al. 
1996, 1997)
P14-A Δhpt In-frame deletion mutation of the 
hpt  gene of P14-A
Our laboratory
Δhpt  :pPL2(Psod) hpt  LM
AKA pPL2(Psod) hpt
P14-A Δhpt  complemented with L. 
monocytogenes  P14 hpt  gene.
This study
Δhpt: pPL2(Psod) uhpT  SA
AKA. pPL2(Psod)uhpT
P14-A Δhpt complemented with S. 





Δhpt: pPL2(Psod) glpT SA
AKA. pPL2(Psod) glpT
P14-A Δhpt  complemented with S. 




P14-A Δhpt complemented with the 
empty vector (negative control)
This study
Δhpt: pPL2(PprfA) hpt  LM 
AKA. pPL2(PprfA) hpt 
P14-A Δhpt complemented with P14 
hpt  gene.
This study
Δhpt: pPL2(PprfA) uhpT  SA
AKA. pPL2(PprfA) uhpT 
P14-A Δhpt complemented with S. 
aureus  uhpT  gene.
This study
Δhpt: pPL2(PprfA) glpT SA
AKA. pPL2(PprfA) glpT 
P14-A Δhpt complemented with S. 




8325-4 Laboratory strain; a prophage cured 
derivative of a streptomycin 
resistant mutant of NCTC 8325
Novick 1967 
USA300 LAC (WT) Human clinical isolate. CA-MRSA. 
Pulsed field type USA300
Wilson et al. 
2011
WT (-pUSA03) WT cured of the pUSA03 native 
plasmid
This study
ΔuhpT In-frame deletion mutation of uhpT 
gene in USA300 LAC. Cured of 
pUSA03 native plasmid
This study
ΔglpT In-frame deletion mutation of glpT 
gene in USA300 LAC. Cured of 
pUSA03 native plasmid
This study
ΔuhpTΔglpT In-frame deletion mutation of uhpT 
& glpT genes in USA300 LAC.  Cured 
of pUSA03 native plasmid
This study
Δagr::Tet Insertion mutation spanning the 
entire agr  locus of USA300 LAC
Benson et al. 
2011
RN4220 Laboratory strain cloning 






















Carries recombinant mutant uhpT 
allele (S. aureus )
This study
RN4220: pMAD-Cm GlpT Carries recombinant mutant glpT 
allele (S. aureus )
This study
LAC: pMAD-Cm UhpT Carries recombinant mutant uhpT 
allele (S. aureus )
This study
LAC: pMAD-Cm GlpT Carries recombinant mutant glpT 
allele (S. aureus )
This study
LAC ΔglpT: pMAD-Cm 
UhpT
Mutant glpT  strain carrying 
recombinant uhpT  allele (S. aureus )
This study
LAC: pMAD-Cm UhpT 
(1st REC)
USA300 LAC with UhpT construct 
integrated into chromosome
This study
LAC: pMAD-Cm GlpT (1st 
REC)
USA300 LAC with GlpT construct 
integrated into chromosome
This study
LAC ΔglpT: pMAD-Cm 
UhpT (1st REC)
Mutant glpT  USA300 LAC strain with 









Thermosensitive E. coli -S. aureus  shuttle 
vector for generating  S. aureus  mutants. 
Eryr Ampr Cmr LacZ
Memmi et al. 
2008
pMAD-Cm UhpT
Contains recombinant mutant uhpT  allele 
cloned in BamHI -EcoRI  restriction sites
This study
pMAD-Cm GlpT
Contains recombinant mutant glpT  allele 
cloned in BamHI -EcoRI  restriction sites
This study
pPL2(Psod)
Allows constitutive gene expression via the 
listerial sod gene promoter cloned in SalI  – 
PstI  restriction sites
This study
pPL2(Psod) hpt  LM
Contains L. monocytogenes  P14 hpt  gene 
cloned in BamHI-SpeI  restriction sites
This study
pPL2(Psod) uhpT  SA
Contains S. aureus  uhpT  gene cloned in 
BamHI-SpeI  restriction sites
This study
pPL2(Psod) glpT  SA
Contains S. aureus  glpT  gene cloned in 
BamHI-SpeI  restriction sites
This study
pPL2(PpfrA)
Allows constitutive gene expression in L. 
monocytogenes  via the hpt  gene PrfA box 
promoter (L. monocytogenes  P14) cloned 
in KpnI – BamHI  restriction sites
This study
pPL2(PprfA) hpt  LM
Contains L.monocytogenes  P14 hpt  gene 
cloned in BamHI-SpeI  restriction sites
This study
pPL2
Site specific integration vector for L. 
monocytogenes. Provides stable, single 
copy gene complementation. Cmr
(Lauer et al. 
2002)

























pPL2(PprfA) uhpT  SA
Contains S. aureus  uhpT  gene cloned in 
BamHI-SpeI  restriction sites
This study
pPL2(PprfA) glpT  SA
Contains S. aureus  glpT  gene cloned in 





















































































S. aureus  USA300 
uhpT  gene
L. monocytogenes 
P14 prfA  gene
S. aureus  USA300 
glpT  gene
L. monocytogenes 














































































































































*All primers amplify with an annealing temperature within the range 55-
60oC.   
















Beef heart 5 (infusion from 250g)
Calf brains 12.5 (infusion from 200g)
Disodium hydrogen phosphate 2.5
D(+) Glucose 2
Peptone 10
Sodium chloride 5
BHI
Composition Concentration (g/L)
Tryptone 10
Yeast extract 5
Sodium chloride 10
LB
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